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A B S T R A C T
Alzheimer disease, like many neurodegenerative diseases, has become a tremendously im-
portant subject of research in our over-ageing society. People suffering from Alzheimer
experience loss of memory and basic cognitive functions. The main hallmark of Alzheimer
disease is the post-mortem observation of amyloid plaque composed of aggregated amyloid-
β (Aβ peptides surrounding dead neuron cells). The reasons why Aβ , which is naturally
produced from a transmembrane protein in healthy individuals, become triggered to aggre-
gated and promote the death of neuron cells are currently investigated. Aβ is also known
to interact with the membrane of neurons before and during the aggregation phase, prob-
ably causing its toxicity. The effects of such toxic interaction on the cell membrane are also
under debate among the scientific community.
The purpose of this Ph.D. thesis was to improve the understanding of the abnormal effects
promoted by the interaction of two types of Aβ (40 and 42) with an artificial membrane
model, a supported lipid bilayer (SLB). Supercritical angle spectroscopy, a spectroscopic
technique developed in our lab, provided a selective detection of the sample molecules of
interest at the very level of the SLB. This technique was combined with both fluorescence
and Raman signal, providing a broad insight in many aspects of the interaction between
Aβ and the SLB.
At first, Fluorescence experiments were performed to elaborate a model for the adsorp-
tion of Aβ on the SLB. In this hypothetical model, Aβ adsorbs weakly and reversibly on
the surface of the SLB but can undergo a transition of state or structure which strengthens
the adsorption of the peptide. Peptides durably adsorbed act as a seed for the cooperative
adsorption of more peptides in their vicinity, hence promoting aggregation and oligomer-
ization if the local concentration in Aβ is high enough.
It was also found out that Aβ (1-42) was more prone than Aβ (1-40) to form aggregates,
supposing it also undergoes the structure transition faster than its counterpart.
Then, the impacts of this adsorption on the membrane model were investigated. Fluo-
rescent SLBs were incubated with an increasing concentration of Aβ and their integrity
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as well as their intrinsic mobility were measured. It was observed that Aβ promoted a
concentration-dependent extraction of lipid molecules from the bilayer. At low concentra-
tion, this effect was just observed as a decrease of fluorescence. But as the concentration
of peptides increased, lipid clusters were observed above the surface of the SLB and the
bilayer could event present signs of disruption.
The average mobility of the lipids within the SLB was only decreased by high concentra-
tion of Aβ (1-42) while Aβ (1-40) only hindered the diffusion of lipids locally, around the
membrane damages.
Finally, Raman spectroscopy was performed to analyse the structure of Aβ responsible
for the above-mentioned effects. Comparison between surface selective and classical Ra-
man signal permitted to sort the secondary structure exhibited by the peptides in func-
tion of their proximity with the SLB. Aβ (1-42) situated directly on the surface of the SLB
preferably adopted an α -helix structure, while peptides situated further away from the
lipids folded as a great amount of β -sheet structure. On the other side, Aβ (1-40) exhib-
ited almost exclusively a β -sheet structure. The presence of α -helix structure in the first
Aβ can explain why its adsorption and aggregation seemed more durable and faster than
its shorter version, since this structure is more stable in non-aqueous environment. It is
smoothly combined with previous data to explain the hypothesis elaborated so far.
In conclusion, the experiments performed during this Ph.D. project allowed to design a
detailed model for the adsorption of Aβ on membrane and its impact on the lipids. Aβ
potentially fold into α -helix once inserted within the bilayer, which can act as a nucleus for
the aggregation of the peptide into β -sheet oligomers. If the aggregation process is severe
enough because of the local concentration in Aβ , lipid molecules might be extracted from
the bilayer by the motion of aggregating peptides, hence causing various impairments due
to the modified membrane integrity.
While this pathway is theoretical and based on an in vitro simplified model, it brings a
good amount of details in the usual description of the mechanism of Aβ and could be of
help in the general understanding of the disease correlated with this peptide.
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I N T R O D U C T I O N A N D M E T H O D S

1
I N T R O D U C T I O N
1.1 alzheimer disease and amyloid-β
1.1.1 Presentation of Alzheimer disease and symptoms
Alzheimer disease was first described in the early 20th century by Alois Alzheimer, who
acknowledged and presented the case of a 51-years-old woman suffering of a "peculiar dis-
ease of the cerebral cortex"[1]. Among the symptoms exhibited by Alzheimer patients, pro-
gressive memory and language impairment, disorientation, behavioural symptoms (hallu-
cinations, delusions, paranoia), and psychosocial impairment are the most widely known.
Alzheimer is therefore sorted as an illness of dementia - characterized by multiple cognitive
troubles - but distinguishable from other form of dementia by the predominance of mem-
ory loss in the symptoms, and the absence of any motor symptoms (unlike i.e. Parkison’s
disease) except for excessively late stages of the disease[2]. Among irreversible dementia
diseases, Alzheimer is dominant since it gather approximately 70% of all dementia cases
in the United States[3]. Several risk factors are associated with Alzheimer disease (i.e. ab-
normal blood pressure, diabetes, traumatic brain injury, etc) but the major non-genetic risk
factor remains the age[4]. The likelihood of developing Alzheimer increases exponentially
with age beyond 65 years old and reaches more than 6% probability every year after 85
years old[5]. People suffering from Alzheimer disease after 65 years old are said to ex-
hibit a "late-onset" or "sporadic" form of the disease and represent the majority (> 95%) of
Alzheimer patients. People can also bear the symptoms of Alzheimer before the age of 65,
then known as "early-onset" or "familial" disease. People with familial forms of Alzheimer
have an autosomal dominant mutation in one of the presenilin genes located on chromo-
somes 1 and 14 or in the amyloid precursor protein (APP - cfr. Section 1.1.2) gene located
on chromosome 21. In addition, people suffering from Down’s syndrome (trisomy 21) have
an increased risk of developing the early-onset disease[6]. All the symptoms encountered
by patients suffering from any form of Alzheimer are due to a progressive damaging of
brain normal structure and functions. At cellular level, Alzheimer is characterized by a loss
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of cortical neurons, especially pyramidal cells, and synaptic dysfunction which hinders the
communication in neuronal circuits necessary for cognitive functions[7, 8]. Degeneration
starts in the medial temporal lobe, more accurately in the entorhinal cortex and hippocam-
pus[9]. These damages yield the deficits in memory observed in the early-stage of the
disease. Damaging then progresses throughout the temporal association cortex towards
parietal areas. Eventually, degeneration is observed in the frontal cortex, neocortex and
within the limbic system[10].
1.1.2 Correlation between Alzheimer disease and Amyloid-β peptide
The neuron degeneration mentioned in the previous section is thought to be the conse-
quence of abnormal intra and extracellular deposition of protein aggregates. These depo-
sitions constitute the hallmark pathological lesions of Alzheimer, known as "tangles" and
"plaques". "Neurofibrillary tangles" are deposited inside the neuron cells and constituted
of aggregated, abnormally hyper-phosphorylated, protein tau. Proteins tau in normal form
serve as stabilizing microtubules and help intracellular transport along the axon[11]. "Se-
nile plaques", on the other hand, are extracellular accumulation of amyloid proteins and
mainly composed of a small peptide called Amyloid-β (Aβ ). These two forms of aggregates
are thought to interfere with the normal neuron functions and metabolism, eventually caus-
ing the cells to die. Some works have attested that the amyloid deposition of aggregated Aβ
is one of the earliest stages in the progression of Alzheimer disease within the brain, and
can precede the cognitive impairments by more than 10 years[6]. Aβ is released outside
the neurons by the cleavage of a transmembrane protein, the amyloid precursor protein
(APP). However, production of Aβ peptide occurs normally in healthy people as well as
Alzheimer patients, therefore its production itself cannot be considered as the main cause
of Alzheimer[12].
1.1.3 Remedies and therapeutic approach against Alzheimer disease
Medicine is currently unable to reverse or even prevent the progression of Alzheimer dis-
ease. Therapeutic drugs are used nowadays essentially for symptomatic relief. For example,
cholinesterase inhibitors prevent the degradation of acetylcholine, a molecule improving
the communication between neurons, hence slowing down or stabilizing the cognitive im-
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pairments of the disease by maintaining the levels of acetylcholine. Blocking the damaging
effect of glutamate against neurons by the use of NMDA-receptor antagonist (meman-
tine) is another strategy[13]. However, the increasing number of patients suffering from
Alzheimer, in parallel with the increasing lifetime, makes an urgent need for the elabora-
tion of an efficient treatment. Strategies acting on the different proteins (Aβ , protein tau)
have been developed and reached the clinical test phase but with small success. The op-
tions currently exploited to act on Aβ are focused either on the production and release
of the peptide, preventing its aggregation or reducing its deposition on the neurons[14].
Preventing the release of Aβ is done by up-regulating the activity of the enzyme cleav-
ing the APP (cfr. Section 1.1.2). There are, however, several drawbacks about this strategy.
The first one is that the alternative product of APP cleaving, although considered non-
amyloidogenic, is highly hydrophobic and has been reported to be also present in senile
plaque (see Section 1.1.4.3)[15]. Another problem is the difficulty to specifically target, and
with the proper dosage, the enzymes responsible for the cleavage of APP[16, 17]. More-
over, reduction of the release of Aβ could also induce side effects since some scientists
argue that the peptide performs essential functions, although no definite one has been
found out yet[18]. Inhibition of the enzyme generating Aβ is also problematic because
of collateral clearance of other important molecules produced with the same enzyme[19],
although specificity toward one bio-product can be tuned due to the variability of the
enzyme-complex[20]. Another option is to prevent the aggregation of Aβ and the forma-
tion of toxic species. Synthetic glycosaminoglycan 3-amino-1-propaneosulfonic acid (3APS)
has been evaluated in clinical trial, with a decreased level of the more toxic Aβ (1-42) but no
cognitive improvements[21]. Aggregation of Aβ is also inhibited in vitro by metal chelators,
therefore trial was made with zinc and copper binding drugs, with significant reduced
plasma Aβ levels for patients bearing mild disease but no influence on severe cases[22]. A
third option is directed toward the prevention of senile plaque deposition by the use of
immunotherapy. Promising results were obtained with Aβ -vaccination in animal studies,
but despite a significant reduction of plaque load, no cognitive improvements nor delay
for the progression of the disease were obtained in clinical trial[23]. As mentioned previ-
ously, Aβ is produced naturally in healthy people therefore there is a natural regulation
of production and clearance of the peptide, accomplished by several enzymes. Abnormal
accumulation of Aβ can be the consequence of enhanced production or hindered clear-
ance. Degradation of the peptide has been reported in vitro by various enzyme such as in-
sulin degrading enzyme, angiotensin-converting enzyme, neprilysin and cathepsin D[24].
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Alzheimer patients have been reported to suffer from defective clearance of the peptide.
Upregulation of Aβ clearance instead of its production could be an alternative approach
for therapeutics. In addition to the focus on Aβ , drugs promoting neuroprotection are be-
ing explored. Compounds inhibiting or reducing oxidative stress, neuroinflammation or
mitochondrial dysfunction in neurons could prevent neuronal damage and help to protect
cognitive function[25].
1.1.4 Amyloid-β peptide
1.1.4.1 General structure and functions of proteins
Proteins are synthesized from the information contained in the DNA of the cell nucleus.
Transcription into messenger RNA and exploitation of the nucleotides sequence in the ri-
bosomal machinery of the cell ends up with the production of a corresponding chain of
amino acids. The succession of amino acid residues is thoroughly optimized to permit
the proteins to adopt a structure specific to their function (catalysis, transporter, etc). The
ability of a given protein to fulfil its function is often represented by the scheme of a lock
exactly shaped for the proper key, the protein being the lock and the co-factor of the pro-
tein being the key. The three-dimensional structure - or conformation - exhibited by the
protein determines whether or not the protein is able to interact with and only with its
co-factor[26]. The forces which guide a newly synthesized protein toward its proper struc-
ture are mainly entropy (favourable/unfavourable interaction of residues with water) and
Van der Waals interactions. The information about the structure of proteins is sorted be-
tween different levels of organization: the primary structure refers to the number, the type
of residues and the exact sequence of amino acids in a given protein. Hydrogen bonding
between specific amino acids (more precisely between the amide and the carbonyl group
of the protein backbone) forms local three-dimensional structures that help the protein to
reach its proper conformation in a decent span of time. Such local structures are called sec-
ondary structures. The different secondary structures, although specific of every protein
and localization, have two most represented shapes: α -helix and β -sheet. The global three-
dimensional structure of a protein, obtained by combination of all local structures and
orientations, is defined as tertiary structure. Tertiary structure is generally considered as
the global conformation of the protein and determinant for its function. When the tertiary
structure of a protein is suited for the execution of its biological function, such structure or
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conformation is called "native". Some proteins gather into complexes which are required
for their function, the structure of such assembled complexes being considered as a quater-
nary structure. The conformation of protein is a dynamic feature: proteins start to shape
or reshape toward their native structure when they are synthesized (phenomenon known
as "folding") and the structure evolves according to the necessity of a given function to be
fulfilled or not. However, this dynamism per se can lead to mistakes during the folding or
functional pathway of proteins, especially when considering the concentration of various
molecules of the medium in which the proteins are to be fold. Part of the proteostasis (the
pathways processed in living organisms to control the network of their proteins) consists
to prevent such erratic misfolding by the use of chaperone proteins which help to reach
the native conformation, or by degradation of these misfolded proteins by proteases[27].
Misfolding of proteins often causes toxicity for the organism, either by loss of important
biological functions or through the gain of toxic properties. In addition, misfolded proteins
can also expose hydrophobic residues or patches to the cell medium, sometimes interacting
with the hydrophobic patches of other proteins. These interactions result in the clustering
of the proteins, a process known as aggregation. Protein aggregates adopt various struc-
tures which stabilize the misfolded molecules by lowering its energy and might become
too stable to be properly refolded by chaperones[28]. Among the conformations observed
for protein clusters, fibrillar aggregates composed of a common structure received great
interest and were named as "amyloid" fibrils[29, 30].
1.1.4.2 Overview of amyloid fibrils
Electron microscopy and atomic force microscopy (AFM) were used to characterize these
amyloid fibrils and reported results described them as long, twisted structures with a
diameter of 7-13 nanometers. They are formed from the combination of aligned smaller
protofilaments of 2-5 nanometers diameter each[31]. Protofilaments themselves are shaped
as cross-β structures (β -sheet, turn, β -sheet) with the β -strands stacked perpendicular to
the filament axis. Consecutive strands are spaced by 4.7 Å and the distance between oppo-
site β -sheet is 10 Å (Figure 1)[32]. Different proteins without homology in their sequence
can reach this fibrillar structure, therefore the main interactions of the amyloid core come
from the common protein backbone[33]. However, variations can be observed in the num-
ber of strands, their length and orientation, or in the structure of the intermittent loops
in the protein chain. The tendency of a protein to aggregate and form amyloid fibril is
dependent of its electrical charge, hydrophobicity and propensity to adopt β -sheet struc-
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Figure 1: Representation of the structure of amyloid fibrils.
ture. Sequences with high hydrophobicity, and neutral or low net charge are more prone
to cluster into fibrils[34]. Aggregation can occur at almost any stage of protein folding: un-
folded, partially folded and even native structures can evolve into various aggregate states
and fluctuate until the ordered amyloid structure is reached[35]. The formation of these
structures is highly sensitive to the protein environment and concentration. Variation of
pH, temperature or the presence of salts can affect the interactions between molecules and
hence determine whether amyloid or amorphous aggregates are formed[36, 37].
The fibrillation of various proteins has been studied to elucidate the mechanism of ag-
gregation. The models elaborated through these studies share the common condition of a
critical protein concentration to exceed in order to form a nucleus of aggregation before
the elongation of the fibril takes place[38, 39]. Before nucleation of the protein, the addi-
tion of monomers/oligomers is thermodynamically unfavourable. Nucleation requires a
minimum protein concentration but when this ordered-aggregated state is formed, further
addition of proteins becomes favourable. Therefore, nucleation is the rate-limiting step.
Elongation of the fibril upon nucleation proceeds by addition of monomers or oligomers.
Two models describe the elongation with monomers, with a one-step or two-step mecha-
nism. The one-step model assumes that the conformation of the monomers fluctuates and
eventually adopt a structure prone to aggregation which adsorbs directly on the growing
filament[40]. The two-steps model rather suggest that monomers first adsorb at the end
of the filament, then undergo conformational changes which stabilize and lock the new
monomers on the aggregate[41]. According to recent theories, the small oligomers formed
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Figure 2: The two proteolytic cleavages of APP. Non-amyloidogenic pathway starts with α -secretase
and finally generates a specific p3 fragment. Amyloidogenic pathway is started by β -
secretase and generates the Aβ peptide (Figure from [43]).
in the early stage of aggregation are supposed to be more harmful for the neurons than the
late fibrillar aggregates, although this assumption still has to be proven[42]. Experiments
have been designed and still have to be performed in order to understand the cause of the
toxicity arising from the smaller oligomeric species.
1.1.4.3 Generation and structure of Amyloid-β peptide
Aβ seems to be a key factor of Alzheimer disease and the main target of many studies.
However, it was previously mentioned that this peptide was also produced in the brain of
healthy people[12]. The role of this peptide when normally produced is still elusive. Sev-
eral functions were hypothesized without being confirmed: reduction of metal ions which
would be either a protection against oxidative damage[44] or conversely a potential cause
of toxicity[45]; signaling function in secretase activity[46]; implication in cholesterol trans-
port[47] or transcription factor[48]. The Aβ peptide is generated from APP by two succes-
sive proteolytic cleavages. Two pathways can occur during the cleavages of this transmem-
brane protein (Figure 2). Both pathways release an extracellular soluble fragment (APPs)
and a second membrane-spanning C-terminal fragment (CTF)[43]. The non-amyloidogenic
pathway is determined during the first cleavage when subjected by α -secretase, releasing
APPsα and α -CTF (or CTF83). This pathway prevents the generation of Aβ since the α -
secretase cleavage site is located within the Aβ sequence. The amyloidogenic pathway
occurs when the first cleavage is produced by β -secretase instead, at the N-terminus of
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Aβ sequence, releasing APPsβ and β -CTF (or CTF99). Both APPsα and APPsβ are then
cleaved a second time by γ -secretase, generating p3 fragment and Aβ peptide respectively,
as well as an APP intracellular domain (AICD). The p3 fragment is generally defined as
non-amyloidogenic although it has been reported as highly hydrophobic and found in
amyloid plaque[15]. Aβ fragments undergo a succession of proteolytic cleavages by γ -
secretase which release a 38, 40 or 42 amino acids-long peptide (Aβ (1-38), Aβ (1-40) and
Aβ (1-42)), depending on the initial length of the Aβ fragments[49]. These different pep-
tides represent approximately 90% of the content in Aβ with minor amount in Aβ (1-42).
Further heterogeneity of Aβ is introduced at the N-terminus during or after release by
modifications such as oxidation, isomerization or racemization which can modify its hy-
drophobicity or resistance to degradation, with consequences on Alzheimer disease pro-
gression[50]. Predominant Aβ (1-40) and Aβ (1-42) peptides were intensively studied since
they were identified as the main components of senile plaque, with higher proportion
of Aβ (1-42) and smaller amount of the other peptides and other molecules[51]. The 42
amino acids-version of Aβ only contains an additional isoleucine and alanine but was
found to polymerize more rapidly into fibrils than Aβ (1-40), which exhibits a nucleation
lag phase before aggregation[52]. Not only are their pathways of aggregation different, but
they are also mutually dependent when the two peptides are mixed. Aβ (1-40) moderates
the aggregation process of Aβ (1-42) and reciprocally Aβ (1-42) enhances the aggregation
of Aβ (1-40)[53, 54]. Aβ (1-40) was found to be protective against plaque formation in vivo,
hence the higher proportion of the longer Aβ in the fibrillar aggregates[55]. Fibrils com-
posed of Aβ adopt the common structure of amyloid fibrils described in Section 1.1.4.2,
characterized by a stack of β -sheets perpendicular to the fibril axis. Each peptide adopt a
"hair pin" shape of β -strand, turn, β -strand with the N-terminus side of the peptide taking
no part in the structure, as it is thought to be unstructured (and more hydrophilic due to
the number a charged residues)[56, 57].
Both Aβ (1-40) and Aβ (1-42) can adopt this aggregated structure. Residues 25 to 29 com-
pose the turn of the hairpin, while residues 23 and 28 stabilize the structure by formation of
a salt-bridge. discrepancies occur between the two peptides considering the stabilizing in-
teractions between two β -strand. Aβ (1-40) makes intramolecular interactions between the
two strands of the same peptide separated by the turn, while Aβ (1-42) makes intermolec-
ular interactions between the shifted strands of two peptides[57, 58]. However, the suspi-
cions against the toxicity of Aβ shifted from fibrillar aggregates toward smaller oligomeric
species. As an example, studies showed that the progression of Alzheimer disease was not
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Figure 3: Primary structure of Aβ (1-40) and Aβ (1-42). Negatively charged residues are highlighted
in blue, positively charged residues in red and hydrophobic residues in yellow.
necessarily correlated with the plaque load[59]. On the other side, experiments showed
that the aggregation of synthetic monomeric Aβ into oligomers was required for the pep-
tides to exert neurotoxicity, hence suggesting that the monomers are in fact innocuous[60].
Additionally, studies with various amount of oligomers correlated well with the level of de-
mentia[61], and memory impairment could be observed for transgenic mice before plaque
deposition[62]. Another evidence came from anti-Aβ treatment which reversed memory
loss in mice, but had no impact on the plaque burden[63]. Various toxic soluble species
have been identified for Aβ such as protofibrils[64], Aβ -derived diffusible ligands (ADDLs
- or oligomeric species formed with clusterin)[65], a 56 kDa species (Aβ *56)[66] and amylo-
spheroids (or spherical aggregates)[67]. Heterogeneity of these oligomeric species conduct
to think that the global toxicity of Aβ is related to more than one assembly, or that a com-
mon key feature between all these structures is yet to be identified. It must be mentioned
though, that the toxic oligomers formed by different polypeptides (i.e. Aβ , α -synuclein,
insulin or prion protein) are all recognized by a single oligomer-specific antibody (A11).
This result indicates a correlation between a structural feature and toxicity[68].
1.2 membranes
1.2.1 Composition and function of natural membranes
Apart from fulfilling functions of energy storage, lipids are the major component of natu-
ral membranes which defines the border of a biological cell with its surrounding, crucial
for sustainability of life. Membranes are formed spontaneously by the natural tendency
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of amphipathic polar lipids to self-aggregate in a defined lipid bilayer structure: the hy-
drophobic parts of the molecules associate together, entropically driven by water, while the
hydrophilic part interacts with water molecules. This principle allows the cell to separate
its constituents from external environment. The same process is recapitulated inside the
cell to segregate multiple compartments and organelles for specific functions[69]. This com-
partmentalization increases the efficiency of biochemical reactions to a specific organelle
and limits the dispersion of reactants and products. In addition to segregation properties,
lipid membranes are subject to tubulation, fission and fusion, all these processes being
determinant for cell division, reproduction and trafficking of molecules within the cells.
Lipids also render some proteins able to interact with the membrane, by adsorbing, ag-
gregating, dispersing or going through the bilayer. Membrane proteins are present with
approximately the same mass than the lipids, meaning one protein for 50 - 100 lipids
considering the discrepancy in molecular weight[70]. The major lipids which constitute
eukaryotic membrane are the glycerophospholipids such as phosphatidylcholine (PtdCho
- PC) and phosphatidylethanolamine (PtdEtn - PE). In neurons, phospholipids account for
more than 50% of the total mass of lipids, with approximately 27/29% of PtdCho and 16.5
to 22% of PtdEtn in neuron bodies and dendrites respectively[71]. PtdCho molecules have
a nearly cylindrical shape and assemble into a planar bilayer with hydrophobic tails facing
each other. Additionally, most of PtdCho molecules have one cis-unsaturated fatty acyl
chain, which renders them fluid at room temperature. In contrast, PtdEtn exhibits a more
conical shape due to its small polar head group, and its insertion in the membrane induces
curvature stress for budding, fusion and fission[72]. Sphingolipids such as sphingomyelin
(SM) and glycosphyngolipids (GSLs), more precisely gangliosides (GSLs terminated with
a sialic acid), are also important compounds of the neuron membrane. Sphingolipids have
saturated (or trans-unsaturated) chains and exhibit narrower cylinder shapes than PtdCho
of the same chain length, hence they pack more tightly. This tight association forms what is
called "solid-gel" (or So, see below) phase within the membrane. These phases are fluidized
by the insertion of sterols. The sterols are non-polar lipids, among which cholesterol is the
most common in mammals. Sterols are preferentially mixed with sphingolipids because of
a shielding of these non-polar lipids with the sphingolipids headgroup, called "umbrella"
model[73].
Membranes are in most cases represented by a rather simple structure, first proposed
in 1972 and still valid today : the fluid-mosaic membrane model (F-MMM, Figure 4)[74,
75]. this model describes membrane as a fluid bilayer of phospholipids with mobile glob-
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Figure 4: The fluid-mosaic membrane model (F-MMM) proposed by Singer and Nicholson. Proteins
are integrated within the bilayer formed by phospholipids. According to the F-MM model,
the bilayer is a dynamic structure whose topology is stabilized by an internal cytoskeleton.
ular integral membrane proteins and glycoproteins that are intercalated into the bilayer.
However, this model suffers from limitations and criticism made up decades after its elab-
oration - including the description of recently discovered "lipid-raft"[76] or the dynamics of
some membrane components - and has been refined over years. It must be included in the
representation of membranes that there is an asymmetry of lipid and protein distribution
between the two leaflets of the bilayer[77, 78]. This asymmetry is necessary to maintain
the proper display of receptors and adhesion molecules on one side of the membrane,
and other molecules on opposite membrane surface. The basic phospholipids constituents
of the membrane are also asymmetrically distributed[79]. For example, amine and serine-
containing phospholipids are found essentially on the cytoplasmic side of the membrane
while choline-containing phospholipids and sphingomyelin (consequently enhancing the
insertion of cholesterol) are concentrated within the outer bilayer leaflet. This might be
simply considered as a mechanism to improve enzymatic activities or association of mem-
brane proteins but there is also a critical need for maintaining this asymmetry. Indeed,
the loss of membrane asymmetry is generally associated with cell activation (activation of
cell adhesion, aggregation, apoptosis, etc.), and with pathologic conditions[79]. The asym-
metry of the membrane is also a guide for its curvature[80]. Composition of the leaflets
indicates that the outer layer exhibits a rather neutral curvature, whereas the cytoplasmic
layer tends toward negative curvature, because the inner phospholipids have a small polar
head compared with the hydrocarbon chain. This feature induces a net curvature to mini-
14 introduction
mize the total curvature energy of the bilayer[81]. Since the asymmetry of the membrane is
so important, various molecules defined as lipid transporters have the function to displace
lipids from one leaflet of the membrane to the other. These transporters can be monodirec-
tional transporter, bidirectional transporter, ATP-dependent or independent[82]. Not only
are the lipids asymmetrically distributed in bilayers but they are also heterogeneously and
dynamically distributed in the membrane plane[83]. The heterogeneity and preferential as-
sociation of some lipids yields the appearance of different "phases" within the membrane.
Each phase features a specific behaviour which is defined by its order and its diffusion
velocity. The two extremes are the solid-gel phase (So) and liquid-disordered phase (Ld).
Solid-gel phase is characterized by a high ordering between long, saturated hydrocarbon
chains (i.e. sphingomyelin) and a slow diffusion. Liquid-disordered phase, on the contrary,
are formed of low-ordered, unsaturated lipids (i.e. PtdCho) and fast diffusion. Some lipids
such as cholesterol change the fluidity, the dynamics and the lateral diffusion of some ar-
eas of the membrane. The association of cholesterol with sphingomyelin or PtdCho allows
the formation of liquid-ordered phase which combine a higher ordering of lipid chains
with a faster diffusion[84]. Moreover, cholesterol also influence the partitioning of trans-
membrane proteins by modifying the core thickness of the bilayer, hence the hydrophobic
matching between the bilayer and the size of inserted proteins[85]. These local modifica-
tions of the membrane brought the elaboration of the membrane domain and lipid-raft
hypotheses. Basically, the interactions between the lipids (hydrogen bonding, hydrophobic
entropic forces, charge pairing and van der Waals forces) can lead to the formation of dy-
namic and reversible nano-scale domains (mostly 10–200 nm)[86, 87]. When specific lipids
belong to transient membrane meso-sized domains in cell membranes, the structures that
are formed are called lipid rafts. Rafts containing specific lipids, integral proteins or periph-
eral proteins can constitute compartmentalized signaling platforms for cellular functions
like apoptosis and intracellular lipid transport[88].
1.2.2 Neuronal cell membranes
The main function of neuron cells is the transduction of nervous signal and their mem-
brane is adapted to fulfill the propagation of this electric signal. The neurons membrane
contains a higher amount of lipids and carbohydrate to account for the need of high elec-
trical resistance, and to prevent propagation of random electrical impulse[89]. Besides,
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the ratio of cholesterol/phospholipids is also increased as the formation of lipid rafts is
enhanced[90]. This outstanding amount of lipid rafts is necessary for the multiple func-
tions of the neuron membrane. These ordered domains act as anchor points for signaling
molecules like GPI-receptors or lipid second messengers[91]. Rafts also account for the
presence of adhesion molecules permitting contact of the neuron cell with its surround-
ing, required for guidance and transmission of the nerve impulses between neurons[92].
Protein channels involved in the propagation of neurotransmitters are also located in the
rafts domains[93]. As stated in Section 1.1.1 the age is a critical factor for the development
of Alzheimer disease. Experiments in mouse models have shown that aging is not just a
chronological delay for the illness to manifest itself but that the effects of equivalent Aβ
injections strongly depend on the age[94]. Therefore, the impact of aging on the neurons
and neuron membrane have been studied extensively.
Electrical properties of the neurons membrane evolve with aging. This is critical since
the very objective of neurons is to transmit nerve impulse upon the excitation, transduc-
tion and release of neurotransmitters, each of them relying on variation of the membrane
potential. Aged mollusc neurons have been showed to be less reactive than young neu-
rons, with an increase of the threshold current needed to trigger an action potential[95].
Electrical properties of the membrane are linked to the lipid composition of the brain,
subject to change with aging and dependent of the region of the brain which is studied.
Most of the lipid levels are reduced but some specific lipids are increased with age[96,
97]. Special attention is accorded to cholesterol, linked to important lipid rafts. They are
contradictory results concerning the change in cholesterol levels in the brain, some studies
reporting increased levels[98] while others indicate a decreased amount of this lipid[99],
or even the absence of notable change in certain brain areas[100]. These discrepancies in
results suggest a specificity of the evolution of the cholesterol content, depending on the
region of the brain which is studied. However, a consensus is found describing how ag-
ing actually affects the asymmetry of cholesterol which tends to enrich the outer leaflet of
the membrane compared with younger subjects[100]. Sphingomyelin content also evolves
with age, with an increase of the general SM levels and a higher ratio of unsaturated (mo-
noenoic) aliphatic chains compared with saturated chains[101]. Gangliosides, also playing
important role in cell functions, are subject to alteration over aging. Not only does their
content decline beyond 70 years of age[102], but the proportion of C20-lenght to C18-lenght
aliphatic chain gangliosides is greatly increased[97]. Poly-unsaturated fatty acids (PUFAs),
including linoleic and alpha-linoleic acids, exhibit a decreased level in the brain of aged
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rats[103]. In parallel, a decline of saturated fatty acid and reciprocal increase of mono-
unsaturated fatty acids is observed[104], with the ratio between saturated and unsaturated
fatty acids being one of the key factors influencing the cell membrane fluidity[105]. The
ability to change the strength of a synaptic connection is called synaptic plasticity and is
correlated to memory and learning processes. The decline of synaptic plasticity is there-
fore correlated with neuro-cognitive impairments[106]. On molecular scale, the plasticity
of neurons relies on various factor such as the probability of neurotransmitters release and
response during the fusion of synaptic vesicles. Fusion occurs when two bilayers merge
together and is highly dependent on the curvature and fluidity of the membrane[107]. In
the previous section, these two parameters have been correlated with the lipid composi-
tion and their physical properties, which is subjected to change upon aging. Cholesterol,
when asymmetrically distributed, induces an intrinsic negative curvature which support
fusion between membranes[108]. Depletion of Cholesterol or reduced asymmetry would
both result in an inhibition of the rate and kinetic of fusion[109]. The subsequent reduc-
tion of membrane fluidity also hinders the mobility of neurotransmitter receptors[110].
Similarly, the enrichment of membranes in sphingomyelin also reduces the efficiency of
vesicles fusion through a modified organization and integrity of lipid rafts. SM-enriched
membranes also exhibit a lower curvature[111, 112]. Gangliosides influence the synaptic
plasticity due to their concentration on the outer leaflet and the bulky structure of their
sugar headgroup. These features confer a positive curvature to membrane rafts which facil-
itates membrane fusion. Therefore, the decrease of ganglioside content reported previously
diminishes membrane curvature and fusion ability[113]. A specific increase of C20-GM1 is
observed in aged brain[114]. The large oligosaccharide of C20-GM1 promotes their cluster-
ing in lipid rafts and attenuates the positive curvature gangliosides normally provide[115].
Furthermore, C20-ganglioside species tends to reduce the membrane fluidity compared
with C18 species[97], hence disturbing the function of neurotransmitter receptors which
require dynamic clustering within the membrane[116].
Counterintuitively, aged brain without specific pathologies exhibits but few dead neurons,
yet the function of remaining neurons explicitly decline over aging[117]. Results of in vitro
and in vivo experiments point at reactive oxygen species (ROS) produced by respiration as
main culprits for this dysfunction. Cells control the amount of ROS through detoxification
pathways involving antioxidants, and adapt themselves and their function when the level
of ROS exceeds their detoxification capacity. These adaptation processes in neurons have
different consequences influencing cognitive functions (i.e. reduced dendritic remodeling),
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reducing their efficiency as a price for improving neuronal survival[118]. The alteration of
lipid levels, such as the ratio between cholesterol and sphingomyelin, modifies the organi-
zation of lipid rafts and triggers the activity of survival receptors[119, 120]. Oxidative stress
also favours the lipid peroxidation in cell membrane, especially in the brain where not less
than 20% of the oxygen intake is used[121]. Lipid peroxidation occurs through the high
amount of PUFAs, easily damaged by oxidation[122]. Intermediate peroxidation products,
which include radical species, stabilize themselves by abstracting hydrogen atoms from
neighbouring PUFAs, hence perpetuating the oxidation damages[123]. One of the effects
of lipid peroxidation is to promote "flip-flop" motion between the leaflets of the membrane,
hence perturbing the asymmetry of lipids whose synaptic plasticity is dependent[124]. A
loss of membrane fluidity, influenced by unsaturated lipids, is another consequence of
oxidation damage. A higher activity of lipoxygenases, the enzymes which catalyse the ox-
idation of unsaturated fatty acids, is associated with neurodegenerative diseases such as
Alzheimer[125] while it has been showed that oxidized lipids increase the adsorption of
Aβ peptide on the membrane[126]. In animal models, this higher activity of lipoxygenases
is correlated with the vulnerability of neurons to excitotoxicity, namely the toxicity arising
from excessive stimulation by neurotransmitters[127]. Therefore, the decrease of PUFAs
level with age that was reported above could be a protection mechanism against perox-
idation, by limiting the amount of available oxidation sites and products. Similarly, the
reduced efficiency of neuronal main functions could be a protection against the excitotoxi-
city associated with the activity of lipoxygenases.
1.3 investigation techniques for the interaction between aβ and mem-
branes
1.3.1 Description of the models used to mimic natural membranes
Several models exist to mimic the natural membrane, though bypassing the complexity
of living cells. Some of these models are notably used to study lipid-protein adsorption
processes and they differ in their properties or relevancy, or are more or less suitable for
specific experiments.
One of the easiest model to assess the binding of proteins onto lipids is to use an overlay-
assay, namely to incubate proteins on spots of lipid molecules immobilized on various
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supports (nitrocellulose, polyvinylidene difluoride (PVDF), or streptavidin solid-support
for biotonylated lipids)[128, 129]. While this has the advantage of simplicity and relative
high throughput to collect great amount of data on various interactions, it suffers many
disadvantages. Lipids are not presented in the physiological context of the lipid mem-
brane and little information can be gained about the impact of protein adsorption on lipid
molecules. In addition, homogeneity between the spots of lipids is difficult to reach due
to the deposition method and the different solubility of different lipid headgroups[130].
After an overlay-assay, further tests on membrane mimetic models are often required.
A lipid monolayer is a film of one single molecule thickness formed at the interface be-
tween air and water, with the hydrophobic tails directed toward the air and the polar head-
groups immersed in water. It mimics a single leaflet of a membrane and exhibit the same
thermodynamic properties than a bilayer at the "monolayer–bilayer equivalent pressure"
(i.e. the force that balances the internal lateral pressure between lipid components, and
allows the hydrophobic chains escaped from water to reach an equilibrium)[131]. Briefly,
this system allows the detection et quantification of proteins through the change in sur-
face pressure provoked by their insertion within the monolayer. The surface pressure is
monitored and associated first with the initial lipid composition, then with the amount of
adsorbed proteins[132]. Additionally, the initial surface pressure of the monolayer can be
tuned and correlated to the capability of proteins to insert afterwards. Such measurement
allows to determine if a protein is peripheral (its function depends on membrane penetra-
tion) or not[131]. The main disadvantages of this model are that the leaflets coupling effects
of a bilayer are absent from this configuration, and it is suitable to form planar monolay-
ers only hence prohibiting the study of curvature-related effects. following the so-called
"Blodgett" deposition approach - a slow vertical lift of the slide from the solvent phase to
air at constant surface pressure - the monolayer can be transferred onto a solid support. By
doing so, the sample can be subjected to scanning technique (AFM, electron microscopy,
...) and permits to characterize the morphology or the organization of adsorbed proteins
as a function of surface pressure[133].
Lipid bilayer models mainly regroup two configurations. The first is the hybrid bilayer
or hemi-lipid layer, composed of a monolayer of phospholipids deposited onto a sen-
sor surface which is previously coupled with another monolayer of organic, hydrophobic
molecules[134]. Often composed of a self-assembled monolayer of alkanethiol, the choice
of base components (i.e. different chain length or ethylene oxide spacer units) can tune
the biophysical properties of the phospholipids layer. The advantage and limitation of this
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model are both correlated to the interaction of the phospholipids with a monolayer fixed on
the substrate. This feature renders the hybrid bilayer model more stable than a supported
lipid bilayer, but at the same time decreases its fluidity and increases its packing density.
Supported lipid bilayers (SLBs) are more commonly used, and formed by the absorption
and fusion of small or large unilamellar vesicles (SUVs or LUVs, respectively) onto a hy-
drophilic substrate[135]. Compared with the hybrid bilayer, a real lipid bilayer is obtained.
Its physical properties strongly depend on ionic interactions between lipids and the sup-
port substrate, although a water gap of 10-20 Å is reported between the substrate and the
bilayer[135]. This gap is sufficient to increase the membrane fluidity, although some resid-
ual frictional coupling with the support still hinders the diffusion of the lower leaflet. Com-
bination with Langmuir technique permits the addition of a monolayer or vesicles of given
composition on a pre-deposited phospholipid monolayer. This process allows formation of
a lipid bilayer with asymmetric leaflets[136]. SLB are suitable for a great variety of measure-
ments (AFM[137], total internal reflection fluorescence microscopy[138], surface plasmon
resonance[139], etc...) providing information about the kinetic of protein binding[140] but
also various structural data about the proteins or the lipids[141, 142]. Recently, protocols
using micro-beads as substrate yielded the formation of SLBs exhibiting uniform curvature
for the study of proteins involved in curvature-sensing mechanisms[143]. Although this is
an interesting way of using the substrate, it should be emphasized that the support will
always have some influence on the SLBs, sometimes undesirable. Another disadvantage of
SLBs is the relatively poor membrane integrity due to the frequent defects in the bilayer.
Pore-suspending membrane is another model where the equivalent of a lipid bilayer is
formed on a substrate presenting an open aperture, hence cancelling the influence of
the support on the membrane within this aperture area[144]. They are generally formed
through Langmuir–Blodgett transfer of lipid monolayers on a grid, or by painting of the
lipid solution on a pierced hydrophobic material[145]. The free-standing part of the mem-
brane has both leaflets in contact with the buffer, sometimes different on each side, and can
be used to study transport phenomenon or ion-channel activity with electrodes. However,
in parallel with the independence from the support comes a lower stability of the model.
Some alternative influence on lipid diffusion can also arise from residual organic solvent
used to cover the grid[146].
Another model freed from the influence of support is the liposome. Liposomes are aqueous
filled vesicles formed from bilayer-thick lamellae resulting from the dispersion of phospho-
lipids in buffer (Unilamellar (UVs) and multilamellar vesicles both exist, depending on the
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lipids) [147]. The hydration of a dry lipid film is used to generate heterogeneous vesicles,
whose diameter size can be decreased by further sonication, and are then sorted between
small (SUVs, d < 100 nm) and large (LUVs, d > 100 nm) vesicles. Concerns about the size
of the liposomes come from the constraints it imposes on protein-lipid interactions[148].
However, the remaining of stable small vesicles unaffected by sonication or extrusion and
the consequent heterogeneity of the liposome sample may have an undesired influence on
experimental results[149].
Finally, giant unilamellar vesicles (GUVs) is a model similar to the liposomes, the main
difference being the cell-sized diameter of the vesicles (10-100 µm). This large diameter
makes GUVs local structure comparable to SLBs, although completely free of any support
and hindrance of the lipid diffusion [150]. Formation of these GUVs requires the use of
charged phospholipids or electroformation to promote the swelling and curvature of a bi-
layer[151]. The disadvantage of this model is the poor control on the lipid composition of
individual vesicles. The discrepancies between individual vesicles have repercussions on
the interaction of proteins with a given population of GUVs. However, it has been used
to study membrane partitioning, lipid phases and the preferential association of proteins
with these domains[152].
1.3.2 Techniques for the investigation of protein-lipid interactions
Several techniques exist to detect, measure or characterize the interaction of proteins with
a membrane model. They differ by their method of detection, the amount of information
that can be gained and the necessity - or not - to chemically modify the sample (label and
label-free techniques).
Surface plasmon resonance spectroscopy (SPR) is a label-free technique which allows the
detection of membrane-protein interactions and to characterize their affinity and kinetic of
binding[153]. The principle is to detect the adsorption of the target near a surface coated
with metal (typically gold) through the change in refractive index of the surrounding
medium. This change in refractive index induces a shift of the angle at which an incident
light excites the electron in the upper layer of metal. This excitation is called plasmon res-
onance and by measuring the shift in the angle of maximum excitation, quantitative data
about the adsorption of the analyte can be collected. The plasmon generates an electric
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field whose extending range is about 300 nm from the metal surface and limits the region
susceptible to influence the plasmon resonance, hence making SPR a surface-sensitive tech-
nique[154]. The layer of metal can be functionalized with proper receptors for the target
and the limit of detection of SPR biosensors can go as low as 10 pg/mL. SPR can also
be used to detect a conformational change among the adsorbed proteins, although the
technique can merely correlates a structural transition with a change of affinity and/or re-
fractive index[155]. However, the technique does not possess the capability to characterize
the structure on its own.
Quartz crystal microbalance (QCM) is another label-free detection technique. A piezoelec-
tric crystal is sandwiched between two electrodes and the alteration of the crystal natural
oscillation frequency in response to small changes of mass is measured[156]. First designed
to work in gaseous or vacuum media, QCM measurements were successfully extended to
biosensing in aqueous media[157] with the oscillation frequency shift incorporating a com-
bined effect of mass, temperature and viscosity changes. As for SPR, the QCM biosensor
can be functionalized to detect specifically one adsorbate (i.e. proteins). QCM was notably
used to correlate the progressive increase in mass deposited with the kinetic of aggregation
and growth of Aβ [158].
Like the two previous techniques, X-ray reflectometry is a surface sensitive method of ob-
servation since X-rays possess a very small penetration depth. The specular reflection of
a X-ray beam from the sample surface is analyzed, with the reflectivity influenced by the
electron density gradient normal to the surface[159]. This allows to measure the electron
density profile of a SLB and the insertion of proteins within the bilayer[160]. However, the
use of X-rays induces severe degradation on biological samples like membranes[161]. This
effect can be countered by the use of neutrons beam instead of photons, but at the cost of
a lower beam flux and spatial resolution.
However, the three techniques described above present the disadvantage to yield informa-
tion about the whole average surface of the sample. No lateral differentiation is possible
and therefore the exact localization of protein adsorbate on the surface plan remains un-
known.
Atomic force microscopy (AFM) can fulfil the need for lateral resolution down to the
nanometer scale. The principle is to scan the surface of the sample with a micro-machined
cantilever probe and a sharp tip. The deflection of the tip while scanning the surface at a
constant force, or constant height, is monitored by a beam reflected on the cantilever hence
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establishing a height profile of the sample. Different mode of scanning are used, such as
non-contact mode to probe electric, magnetic or atomic attractive forces acting at short
distance (50-150 Å)[162]. Tapping mode alternates between contact and contactless scan-
ning by oscillating the cantilever tip at or near its natural resonance frequency. Changes
in the frequency of oscillation due to interaction with the sample are detected to construct
the surface topography[163]. AFM has been used extensively to study the progression of
amyloid-related diseases and notably the morphology of Aβ ’s fibrils[164]. Alternatively,
the interaction between a single molecule attached to the tip and the substrate can be mea-
sured in force spectroscopy mode via scanning tunneling microscopy (STM)[165]. Current
can flow between the single molecule and the substrate without direct contact because
of the tunneling effect. Measurement of this current in function of the oscillations of the
cantilever is used to quantify the forces of interaction between the tip and the substrate.
Force-distance profile gives information about the elasticity and stability of the substrate,
i.e. conformational changes of a protein layer[166]. The disadvantage of AFM is that de-
spite being considered as a label-free technique, measurements rely on the perturbation of
the sample with the tip and bring additional interactions on the sample.
Another label-free technique is circular dichroism spectroscopy (CD), which is used to
characterize the secondary structure of proteins. The technique consists to measure the
difference of absorption of a sample between left and right circularly polarized light[167].
Active sample such as proteins have different absorption coefficient for each of these po-
larized light. The amide band of proteins is the most prominent chromophore group ob-
served by CD spectroscopy. Electronic transitions promoted by far UV excitation beam are
dependent on the hydrogen bonds and specific absorption profiles are obtained for the
main secondary structures of the protein backbone. However, CD spectra only display the
average of all structural contributions and can correspond to a mixture of the secondary
structures adopted by the protein. This drawback is sometimes avoided by using a combi-
nation of shorter synthetic peptides composing the full-length protein[168].
Polyacrylamide gel electrophoresis (PAGE) is a method to gain insight about the structure
of proteins (but provides no information on membrane). The method consists to force pro-
tein diffusion through a polyacrylamide gel by application of an electrical current. The
diffusion through the gel, called electrophoretic mobility, is influenced by intrinsic proper-
ties of the proteins such as the mass, the charge or the conformation[169]. The influence
of the global charge and shape of the molecule can be cancelled by the use of denatur-
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ing buffer (i.e. containing sodium dodecyl sulfate, SDS) hence sorting the proteins only
by their mass. Blue native (BN) PAGE is used to separate proteins while conserving their
mutual interactions and structure. Coomassie dyes are introduced to induce a charge shift
on the proteins which are not separated according to the charge/mass ratio but according
to size[170]. However, BN-PAGE suffers from a poor resolution compared with denaturing
electrophoresis. SDS-PAGE is still one of the most used technique to characterize rapidly
the oligomers of various proteins, although the method is blamed for introducing some
artefacts in the results[171].
Nuclear magnetic resonance (NMR) can also be used to characterize the structure of pro-
teins. The resonance of atom nuclei aligned according to a magnetic field and subjected to
an electromagnetic excitation pulse is correlated with the chemical environment of these
nuclei[172]. Atoms abundant in proteins or added by labelling, such as hydrogen and iso-
topes of carbon and nitrogen, possess a nuclear spin that allows them to interact with a
magnetic field. Interactions between nuclei, such as dipole and scalar coupling, chemical
environment (hydrogen bonding) and a massive set of techniques to interpret these pieces
of information (2D and 3D spectra, NOE, COSY) allow to construct a 3-dimensional struc-
ture of proteins. A rather limiting factor is the insensitivity of NMR technique, hence the
need of high concentration of proteins. Required concentration can lead to aggregation
of the proteins in the sample. NMR can also be used to investigate the effect of protein
interaction on a membrane model, although this technique considers membranes as in
solid state due to the anisotropic dynamic motion of the lipids. The so-called "solid-state
NMR" requires the use of the magic angle spinning (MAS) technique - namely to rotate
the sample at specific orientation with the magnetic field - to obtain good resolution on
NMR spectra[173]. The relative alignment of lipid molecules as well as the thinning of the
membrane or pore formation could be resolved with NMR[174].
Apart from isotope labelling for NMR, the other most common technique using labels
to investigate protein-lipid interactions is fluorescence microscopy.
On the other hand, Raman spectroscopy is another label-free method, that allows to gain
precious information about the structure of studied molecules, including the local confor-
mation of proteins. However, due to their use in this thesis, these last two techniques will
be described more extensively in the following sections.
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Figure 5: Jablonski diagram describing the electronic levels of a fluorophore and the possible tran-
sitions between different electronic states (from [175]).
1.3.3 Fluorescence microscopy
Fluorescence is a phenomenon used extensively for research purpose in order to locate
and observe a target. Fluorescence occurs when a chromophore absorbs light at specific
wavelength and undergoes an excitation toward a higher energy electronic state (S1), then
relaxes to the ground electronic state (S0) by re-emission of light at another specific wave-
length[175]. Fluorescence is then one of the many mechanisms by which a molecule can
release the excess of energy following the absorption of light. Those mechanisms are rep-
resented on the Jablonski diagram and fluorescence is generally in competition with other
radiationless or phosphorescence processes (Figure 5). Many commercial chromophores
are available and usually optimized to favour the fluorescence process with good yield,
stability over excitation and often straightforward labelling protocols. The high sensitivity
of fluorescence microscopy is a major advantage of the technique, in addition to a good
signal-to-noise ratio due to the difference of wavelength between excitation and emission
photons[176]. The diffraction limit imposes physical constraint to the maximum resolution
of fluorescence (200-300 nm), typically too low to differentiate two biomolecules interact-
ing together or simply too close. Several techniques have been developed to overcome this
limit, such as structured illumination microscopy (SIM)[177], stimulated emission deple-
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tion (STED)[178], saturated structured illumination microscopy (SSIM)[179] and the indi-
rect stochastic optical reconstruction microscopy (STORM)[180] allowed to reach a resolu-
tion between 50 and 20 nm.
However, other adaptations of fluorescence microscopy are available to gain specific infor-
mation about protein-lipid interactions, without the need to increase the resolution. An
option is to adapt fluorescence in a surface-sensitive technique where lipids are deposited
on the surface. These techniques provide a selective excitation of the fluorophores near
the interface, hence gathering information mostly from proteins interacting with the lipids
while discarding the influence of non-interacting molecules.
One of these surface-sensitive techniques is the total internal reflection fluorescence (TIRF)
microscopy. TIRF exploits the difference of refractive index between two media (the sample
and the substrate, generally water and glass respectively) and its influence on the refrac-
tion/reflection properties of light[181]. Due to the different refractive indexes, a light beam
directed toward the interface between the two media above a specific angle (called critical
angle) will be totally reflected. The critical angle (θ) is determined by the refractive index





For classic water/glass sample, this critical angle is 61◦ from the normal of the surface.
However, the reflected light generates a thin electromagnetic field (the evanescent wave)
beyond the interface with the same frequency than the incident light and the ability to
excite fluorophores within the field range. The depth of this field is dependent of the in-
cident illumination angle, wavelength, and refractive index differences but generally, only
molecules within a range up to 100-200 nm from the surface are efficiently excited. The
disadvantage of TIRF is the inconvenient to provide high angle of illumination. This is
achieved by the use of a prism-configuration and/or by high numerical aperture objec-
tives[182].
Another surface-sensitive technique based of the critical angle is the supercritical angle
fluorescence (SAF), developed in the group of Prof. Seeger[183]. When an excited fluo-
rophore is situated near an interface, a substantial part of the emitted fluorescence will be
directed toward the medium of higher refractive index, above the critical angle. SAF uses
a specific objective with high numerical aperture and parabolic mirrors to collect this light
emitted above the critical angle (Figure 6 a,b). One of the advantage of SAF is that its selec-
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Figure 6: (a) Plot of the emission of a fluorophore directly adsorbed on a glass/water interface. (b)
Scheme of the SAF objective collecting light from a surface-bound emitting fluorophore.
(c) Comparison of the penetration depths of the observation volumes between SAF and
TIRF with different angles of illumination (from [183]).
tivity for surface-bound fluorophores depends on their own features of emission related
to their position, and is independent of the largeness of the illumination angle as long
as the fluorescence is collected above the critical angle. Accomplishing similar selectivity
with TIRF requires to decrease the depth of exciting field, by illuminating the sample at
angles largely exceeding the critical angle (Figure 6 c). On the other side, since the selec-
tivity of SAF does not depend on the illumination angle, the sample can be illuminated
below the critical angle. In this way, fluorophores within the bulk solution can be excited
and detected through their emission below the critical angle while fluorescence emitted
above the critical angle is still collected selectively and simultaneously. Therefore, both the
selective detection of surface-bound emitters and the observation of fluorophores in the
bulk solution are accomplished.
SAF is not only used as independent fluorescence microscopy but its selectivity can also be
combined with other techniques relying on the signal of labelled targets. Förster resonance
energy transfer (FRET) is one of them. The technique relies on the radiationless transfer
of energy from a first excited fluorophore (donor) toward a second fluorophore (acceptor)
whose emission and excitation spectra partially overlap. This transfer occurs beyond in-
teratomic distance, typically between 10-100Å, and the separated collection of donor and
acceptor signal yields information about the interaction and the distance between the two
molecules[184]. FRET has been notably used to study the folding of protein[185] or com-
bined with SAF to monitor the aggregation of α -synuclein near a SLB[186].
Fluorescence correlation spectroscopy (FCS) was also used in conjunction with SAF. The
1.3 investigation techniques for the interaction between aβ and membranes 27
Figure 7: Depiction of the processes observed by FCS according to the time delay of the autocorre-
lation procedure.
basic principle of FCS is to monitor the fluctuations of fluorescence signal - generally of a
highly diluted solution - during a fixed amount of time, then to mathematically correlate
the signal with itself in function of an increasing time delay. This correlation output is
associated with the persistence of the signal over time, hence with the speed of diffusion
of the fluorophores in and out of the detection volume. The faster the fluorophores diffuse,
the more the signal will fluctuate and the faster the autocorrelation value will decrease
with delay. Therefore, the average mobility and amount of fluorescent molecules within
this volume can derived from the autocorrelation process[187]. FCS can also be used to
monitor other events, since the diffusion of fluorophores out of detection is actually the
slowest way to alter fluorescence signal. Hence, interpretation of the autocorrelation func-
tion with shorter time delays can cover the effects of photon antibunching (impossibility
for a fluorophore to emit more than a single photon at any given time)[188], rotational dif-
fusion (polarization differences between absorption and emission dipoles)[189] and triplet
states (Figure 7).
SAF-FCS is a direct application of the autocorrelation procedure to the signal collected
from SAF detection. The fluctuations of the signal coming from the interface are moni-
tored and interpreted selectively, with an increased effect of the fluorophore’s remoteness
from the surface due to exponential decrease of the detection efficiency (described more
extensively in the next Chapter).
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1.3.4 Raman spectroscopy
Raman spectroscopy is a label-free and non-destructive technique whose main result is to
characterize the molecular bonds within a molecule, hence helping its identification. Ra-
man Spectroscopy is based on the inelastic scattering of an incident monochromatic red
or (near) infra-red light upon interaction with the sample. This occurs when the beam
promotes transitions of the molecular bonds from lower to higher energy vibrational lev-
els[190], but unlike fluorescence there is not requirement for matching the energy gap
between the vibrational levels. From the shifts in frequencies between the incident and the
diffracted light, a spectrum of the sample is extracted and the type of chemical groups con-
stituting the molecule can be elucidated. Compared with the incident light, the energy of
the scattered photons can either be identical (elastic scattering forms the "Rayleigh" peak
of Raman spectrum), smaller (Stokes shift resulting from transition toward higher vibra-
tional level) or even bigger (due to the depopulation of excited states toward the lowest
vibrational level). However, inelastic scattering is a rare event as approximately one photon
out of 108 is inelastically scattered. Furthermore, the condition for a vibration to be visible
on Raman spectrum is to induce change in polarizability during molecular vibration (by
contrast with infra-red spectroscopy for which the molecule must undergo a change of
dipole moment during vibration). When applied to the study of proteins or polypeptides,
the analysis of specific peaks of the Raman spectra (i.e. the peaks of amide bonds) allows
to characterize the secondary structures present in the conformation of the molecule[191].
Indeed, the chemical environment (such as hydrogen-bonding) relative to the secondary
structure of proteins has an influence on the energy required to promote vibration of the
amide bond, yielding recognizable shifts for each structure. However, the detection of pro-
teins by Raman spectroscopy is limited by the small cross-sections of the chemical groups
present in such biomolecules.
There are different ways to improve the low signal of Raman spectroscopy. One of them
is the use of resonance Raman spectroscopy (RRS). In RRS experiment, the sample is still
subjected to a monochromatic light but the laser wavelength is tuned to be as close as
possible of an electronic absorption band (resonance). This feature enhances the light scat-
tering by a factor of 104. However, the very principle of using resonant light makes the
sample subject to fluorescence as well[192]. Another consequence is that the specificity of
the wavelength, optimized for one transition, renders the other non-enhanced vibrations
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hard or even impossible to characterize. This could be considered either as a drawback for
identification, or as an advantage when aiming for specific chemical bounds in a crowded
environment. Rejection of fluorescence background is often the critical step of RSS exper-
iments. It is often achieved by exploiting the difference of time scale between "instant"
scattering and longer (nanoseconds) fluorescence processes[193].
Another very common technique that improves Raman signal is called surface-enhanced
Raman spectroscopy (SERS). When compared with RRS, SERS is effective with a wider
range of target molecules and gives a bigger enhancement in sensitivity (factor of 106).
SERS is based on the interaction of the target molecule with the high local electromagnetic
field generated from plasmon resonance (excitation of the electrons cloud) near the rough-
ened surface or nanostructure of a noble metal, typically gold or silver[194]. The effec-
tiveness of SERS is strongly dependent on the strength of the electromagnetic field, hence
on the substrate producing plasmon resonance. Size, shape, and the spacing between the
metal edges or particles strongly influence the electromagnetic enhancement[195]. Since
the strongest part of the electromagnetic field arises in small gaps of 1-5 nm between
metal edges (called "hot-spot")[196], only the molecules in the close vicinity of specific
metal structures will be subjected to the enhancement, hence making SERS not only more
sensitive but also surface selective.
SAR is the supercritical angle version of Raman spectroscopy, which was recently applied
to Raman scattering as well. Characterization of polystyrene microspheres demonstrated
the surface selectivity of supercritical angle detection applied to scattered photons instead
of fluorescence signal[197]. SAR is an interesting alternative to SERS for the study of inter-
facial molecules. Despite the lack of signal enhancement compared to SERS, a discrimina-
tion between molecular vibrations occurring at the surface and vibrations taking place in
the bulk of the sample is possible. In addition, SAR is as straightforward to prepare than
classical Raman and eliminates the requirement of nanostructures which may influence
the behaviour of targeted molecules.

2
M AT E R I A L S A N D M E T H O D S
2.1 handling and labelling of the peptides
Monomeric Aβ (1-40), Aβ (1-42), Aβ (1-40)-Hylite Fluor 647 and Aβ (1-42)-Hylite Fluor 647
(Anaspec) were reconstituted in a 1% NH4OH solution, then immediately diluted in PBS.
Solution were centrifuged at 12,000 rpm during 10 min and any undissolved material was
removed. Non-labelled peptides were aliquoted at a concentration of 1 mg/mL and kept at
-20°C until use (before 6 months of aging). Labelled peptides were aliquoted at the desired
concentration and kept frozen until use.
Monomeric Aβ was also subjected to labelling procedure for the first experiments. One of
the most frequently used method for labelling proteins is to covalently bind a dye with N-
hydroxysuccinimide-ester (NHS) function to the primary amino group of the polypeptide.
Here, Atto647-NHS was used and dissolved in DMSO. For the first labelling procedure,
Aβ was dissolved in PBS, stabilized at pH 8 with HCl and KOH. The dye was added to
the peptide solution with a 5-fold molar excess. The mixture was let to steer at room tem-
perature for 2 hours. A second labelling procedure was tested by repeating the previous
protocol in a carbonate-bicarbonate buffer at pH 9.2.
Solution was purified with the same buffer through a superdex 75 10/300 GL column (GE,
healthcare) at a flow rate of 0.5 mL/min. The protein concentration and the ratio of suc-













Streptavidin (Lucerna Chem AG) was dissolved in deionized water just before Raman
measurements, at a concentration of 60% (m/w) or 10 mg/20 µL. Streptavidin-Atto633
(Sigma-Aldrich) was dissolved in PBS at a concentration of 10 µg/mL. Bovine serum albu-
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min powder (BSA, Sigma-Aldrich) was dissolved just before measurements in deionized
water at the desired concentration.
2.2 protocol for native-page and gel staining
A NuPAGE 12% bis-tris mini gel (Thermofisher) was used for the separation of peptides
according to their mass and aggregation state. The separation protocol was adapted from
the work of Itkin et al[198]. The samples were prepared to load 10 µg of peptides in each
well. Each sample was composed of the peptide load, 0.5 µL of NuPAGE LDS (lithium
dodecyl sulfate) sample buffer and deionized water up to 10 µL. Running buffer was
composed of 25 mM Tris, 192 mM Glycine and deionized water. Migration of the peptides
through the gel was done with a constant voltage of 100 V for 1h at room temperature.
In order to observe the bands of peptides, the gel was incubated into a Coomassie blue
solution (Roti blue) for 2 h, then destained with an aqueous solution of 40% ethanol and
10% acetic acid for 15 min. The remaining coloured bands correspond to the protein bands
of different mass.
2.3 pre-treatment of glass slides and sample plate/cells
Glass coverslips (Menzel-Gläser, Thermo scientific) were cleaned with ethanol in ultrasonic
bath during 15 min, rinsed with water and dried with nitrogen before being subjected to
plasma activation. They were placed in an ozone plasma chamber (Femto plasma cleaner,
Diener electronic) for 10 min at 100 W in order to make the glass surface hydrophilic.
Plasma treatment let the glass slide hydrophilic for few hours but the coverslips were used
immediately.
Measuring cells (steady-state and flow-cell) were both cleaned with a three washing-steps
procedure in ultrasonic bath. Each washing lasted for 15 min in the following solutions
: Deconex Cip7 (1% in H2O), ethanol and deionized water. The cell were coated with a
Plastik 70 spray (Kontaktchemie, CRC Industries) to protect them against corrosion and
homogenize the surface. The spray was let to dry for 1 h.
The activated glass slide and the measuring cells were glued together with Loctite 3311
(Henkel corporation). The closed flow-cells were connected to a rotating pump through a
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Figure 8: Picture and cross-section of the measuring cells. The left-one can be connected to a tubing
and pump system for measurements including a flow of buffer. The right-one consisted
of simple well-plate used for steady-state measurements.
tubing previously washed with a flow of Deconex Cip11 (10% in deionized water), then
pure deionized water (3 mL/min during 30 min).
2.4 handling of lipids and formation of slb
1,2-dioleoyl-sn-glycero-3-phosphocholine (DOPC); 1,2-Dioleoyl-sn-glycero-3-phospho-L-serine
(DOPS) and brain porcine sphingomyelin (SM) in chloroform were used as received (Avanti
Polar Lipids). Ganglioside GM1 (Ovine Brain) was received as a powder and diluted in
chloroform (Scharlab S.L.). Fluorescently labelled 1,2-dioleoyl-sn-glycero-3-phosphoethanolamine
powder (DOPE-Atto647; Atto-tec) was diluted in chloroform. When experiments required
fluorescent SLB, DOPE-Atto647 was added to the lipids mixture to achieve a mass ratio
of 1/62500. This amount was determined to give an optimum fluorescence signal with the
SAF technique.
The following protocol was used to form both fluorescent and non-fluorescent SLB. The
lipid solution was stirred under nitrogen then left under vacuum (10 mbar) overnight
to remove any trace of solvent. Dried lipids were resuspended in degassed “membrane
buffer” (NaCl (150 mM), CaCl2.3H2O (5 mM), Tris (10 mM), pH 7.4; Sigma Aldrich) and
extruded at least 20 times through a porous membrane (0.1 µm pore size) to yield unil-
amellar vesicles with homogeneous size distribution. For solutions of vesicles containing
sphingomyelin, the extrusion was carried out at approximately 45◦C (above the transition
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Figure 9: Different mechanisms of vesicles disruption and SLB formation. (a) Isolated vesicles dis-
ruption induced by the deformation upon adsorption on the substrate. (b) Fusion and
disruption of neighboring vesicles. (c) Vesicles adjacent to a SLB patch disrupt under the
influence of the patch active edges. (d) Collapsing of one vesicle under the pressure of
neighbouring vesicles, turning into active SLB patch. Taken from [199].
temperature of SM, 37◦C). The vesicles solution was then diluted in the membrane buffer
to a concentration of 0.1 mg/mL. In constant-flow experiments, the vesicles solution was
then passed through a circulating flow system (0.25 mL/min) connected to the flow-cell
(see previous section). The solution circulating through the pump was changed following
the protocol below (at constant flow-rate) :
- 10 min with the vesicles solution.
- 20-30 min rest with the pumping turned off.
- 15-30 min washing with "membrane buffer"
- (15 min with EDTA buffer (NaCl (133 mM), Na2EDTA.2H2O (5 mM), Tris (10 mM), pH
7.4; Sigma Aldrich))
Variations of this protocol and their explanations are described in Section 3.2.1.
When a steady-state measurement was required, 50 µL of the lipid solution was poured in
the well of the sample plate (see previous section).
In both case, when the lipid vesicles adsorbed on this coverslip reached a critical concen-
tration, vesicles fused to form a SLB (Figure 9). Non-disrupted vesicles were removed by
extensive washing with the membrane buffer, either by incoming flow of the pump or by
pipetting. Finally, SLB was let to stabilize for at least one hour before any measurement.
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2.5 protocol for biotinylation of the glass slides
Glass microscope slides were first cleaned by immersion in piranha solution for 2 h, then
thoroughly rinsed with deionized water.
Clean slides were immersed into freshly prepared 3-Aminopropyltriethoxysilane (APTES)
solution (2% in toluene) at room temperature for 2 h. Following immersion, the glass slides
were rinsed with toluene, methanol, and finally deionized water.
APTES-functionalized slides were incubated overnight in a solution of 10 mM biotin-NHS
in DMF, then rinsed with deionized water.
The different steps of the functionalization were controlled by infra-red spectroscopy. At-
tenuated total reflectance (ATR) IR spectroscopy was performed using a Vertex 70 spec-
trometer (Bruker) with an ATR accessory. Samples were scanned from 500-4000 cm−1
with 252 scans. Spectrum of uncoated glass substrate immersed in pure toluene was taken
as background spectrum.
2.6 supercritical angle spectroscopy set-up
All the spectroscopic measurements reported in this thesis (fluorescence and Raman) were
accomplished using a special custom-built microscopy set-up developed in the group (Fig-
ure 10). This set-up included a home-made microscope objective composed of multiple
lenses and parabolic mirrors to collect and transmit light coming from both above and un-
der the critical angle of total internal reflection (cfr. Section 1.3.3) of a glass/water system
(typically 61◦). A power-tuneable diode laser at 633 nm (Toptica) provided the excitation
beam. Two concentric collimated beams resulting from supercritical angle (SA) and un-
dercritical angle (UA) collection were transmitted through the setup prepared for imaging
and spectral analysis. These two concentric beams were separated by a 45◦ mirror mounted
on a glass window before detection. Afterwards, each beam proceeded on a distinct path
and could be focused into two identical single-photon avalanche diodes (SPADs) with an
active area of 180 µm. These SPADs detectors were used for fluorescence measurements
and imaging. For Raman measurements, the beams could instead be injected through fiber
couplers into a 200 µm core multimode fiber. The fiber output was connected to a spec-
trometer equipped with a low-noise CCD camera cooled to −70◦C (iHR320, Horiba). The
choice of the spectroscopic method was applied by the means of flip mirrors. Fluorescence
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Figure 10: Experimental set-up scheme. Legend : DBS, dichroic beam splitter; FM, flip mirror; BS,
beam splitter, referring to the 45° split mirror; FC, fibre coupler; OF, optical fibre; and
SPAD, single-photon avalanche diode. The detailed view of the objective shows the mul-
tilens focusing and far-field collection system as well as the parabolic element for super-
critical angle collection. Taken from [197].
images were recorded by using a custom-written Borland C++ program, whereas LabSpec
(Horiba, Irvine, CA, USA) software was used for Raman measurements. The images and
spectra were then processed in MATLAB and Origin.
2.7 supercritical angle fluorescence (saf) scans
When performing fluorescent measurements of the peptides, fluorescent Aβ represented
1% of the total amount of peptides. When monitoring fluorescent lipids, a mass ratio of
1/62500 (labelled/unlabelled) was used. The scanning images were obtained by scanning
a square area of various edge size, commonly between 9.8 and 37.5 µm (whole scanning
time of approximately 1 and 5 min respectively). Excitation light at 633 nm was cut by the
use of spectral filter (616-646 nm effect). When measuring fluorescence signal, separate op-
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tical path allowed for simultaneous collection of supercritical (SAF) and bulk/undercritical
(UAF) fluorescence.
2.8 fluorescence correlation spectroscopy (fcs)
FCS was used to investigate and quantify the mobility of fluorescent lipids and peptides.
The principle is to monitor the fluctuation of fluorescence intensity within a defined de-
tection volume during a finite amount of time, then to autocorrelate the signal in order
to extract information about the speed of different processes (cfr. Section 1.3.3). The range
of delay used for the autocorrelation function determines which parameter of the fluores-
cence fluctuation is analysed (cfr. Figure 7). Generally, several autocorrelation processes
(at least 3) were measured at different points of the SLB and results were averaged. The
signal was monitored during 1 minute for every FCS measurement. In addition, the re-
sultant autocorrelation curves must be fitted with an appropriate model to quantify the
parameters influencing fluorescence fluctuation. In this study, the translational diffusion
(i.e. the diffusion of the molecule in space) is the only parameter that was investigated.
The data within the biggest range of delay (from 10−3 to 1 sec) permitted to analyse this
translational diffusion. Three different models were used to fit the FCS curves:
2.8.1 2-dimensional diffusion with two diffusion coefficients
This model is adapted for the study of a supported lipid bilayer (SLB) with components
moving freely in the xy-direction. The following equations introduce two diffusion coeffi-
cients (Da and Db), either to account for the two leaflets moving differently or for errors
that occur at higher τ values. These errors arise when the measuring time is too short
to compensate all irregularities. However, short measuring time can be necessary when
targeting a specific fluorescent aggregate moving along the SLB.
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Where G is the autocorrelation value, G0 is the value at the y intercept, N is the aver-
age number of fluorescent molecules in the detection volume, τ is the time delay for the
autocorrelation and ω0 is the radius of the detection volume.
2.8.2 Anomalous diffusion
Anomalous diffusion occurs when the diffusion of the lipids within the SLB is not free
anymore, for example in the presence of lipid rafts. In this case, the time dependence of
the mean square displace-ment (i.e. average translational diffusion along the surface) is no
longer linear[200]. An anomaly factor or temporal factor (0<α<1) is introduced to fit the
displacement of the molecules and the equation for the model becomes :





2.8.3 3-dimensional diffusion (SAF)
Fluorophores in bulk solution are expected to move freely in the three dimensions if there
is no external perturbation. A 3D model was elaborated to fit the displacement of such type
of sample[201]. However, the standard 3D model cannot be used when fitting the motion
of fluorescent molecules in solution using the supercritical angle signal. The reason is
that an exponential decay along the optical axis applies to the efficiency of detection of
the supercritical angle spectroscopy (which is exactly what grants its surface selectivity) :
e−2ω(θ)z. Therefore, the fluorescence signal decreases even faster than with standard 3D
model when the molecules recede from the surface. An appropriate 3D-SAF-FCS fitting
was developed by Ries et al., taking the efficiency of detection into account. The complete
set of formulas can be found in his paper[202].
2.9 supercritical angle raman (sar) scans
For Raman measurement, a 200 µm core multimodes fiber was used to transmit the micro-
scope set-up output to a separated spectrometer. Due to the optical set-up, the fiber needed
to be connected to each coupler separately. Therefore, only one range of detection angle
(supercritical angle or undercritical angle) could be transmitted at one time. The power of
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the excitation beam was set between 10 and 70 mW to maximize the amount of scattered
photons. The general configuration for the Raman detector was an opening slit of 50 to
100 µm, a grating of 300 grooves/mm and an accumulation of approximately 20-30 scans.
The acquisition time depended on the sample, but was generally between 1 and 10 sec.
Peptides required longer acquisition time than lipids.
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3-Aminopropyltriethoxysilane (APTES) TCI Europe, Boerenveldseweg, Belgium
Acetic acid Merck and Co., Inc., New York, USA
Amyloid-β (1-40) human Anaspec, California, USA
Amyloid-β (1-40)-HyliteTM Fluor 647 Anaspec, California, USA
Amyloid-β (1-42) human Anaspec, California, USA
Amyloid-β (1-42)-HyliteTM Fluor 647 Anaspec, California, USA
Atto647, Atto 647N Atto-TEC GmbH, Siegen Germany
Biotin-NHS Lucerna Chem AG, Luzern, Switzerland
Bromophenolblue Sigma-Aldrich Co. LLC, Buchs, Switzerland
Calcium chloride dihydrate Sigma-Aldrich Co. LLC, St. Louis, USA
Chloroform Scharlab S.L.; Barcelona, Spain
Coomassie blue (Roti-Blue) Carl Roth GmbH + Co. KG, Germany
Deconex 11UNIVERSAL Borer Chemie AG, Zuchwil, Switzerland
Deconex CIP seven Borer Chemie AG, Zuchwil, Switzerland
Dimethyl sulfoxide (DMSO) Sigma-Aldrich Co. LLC, Buchs, Switzerland
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Ethanol Reuss-Chemie AG, Tägerig, Switzerland
Ethylenediaminetetraacetic acid (EDTA) Sigma-Aldrich Co. LLC, St. Louis, USA
Methanol Merck and Co., Inc., New York, USA
Sodium azide Sigma-Aldrich Co. LLC, St. Louis, USA
Phosphate buffered saline (PBS) Sigma-Aldrich Co. LLC, St. Louis, USA
Protein Standard : SeeBlue Plus2 Pre-
stained
Thermo Fisher Scientific, Carlsbad, USA
Sodium chloride Sigma-Aldrich Co. LLC, Buchs, Switzerland
Streptavidin Lucerna Chem AG, Luzern, Switzerland
Streptavidin-Atto633 Sigma-Aldrich Co. LLC, St. Louis, USA
Toluene, anhydrous, 99.8% Sigma-Aldrich Co. LLC), Buchs, Switzerland
Tris(hydroxymethyl)aminomethane
(Tris)
Sigma-Aldrich Co. LLC, Buchs, Switzerland

Part II
R E S U LT S A N D D I S C U S S I O N
The results presented in the following part are sorted between those obtained
with the supercritical angle fluorescence and the supercritical angle Raman
spectroscopy, but also between the results concerning the supported lipid bi-
layer and the Amyloid-β peptide. Since the project of this thesis consisted
to monitor both lipid bilayer and Aβ in successive distinct experiments, spe-
cial attention is accorded towards the observable target of each measurement.
However, it is likely that discussions about the mechanism of interaction will
spread beyond one single result. Relevant hypothesis regarding the adsorption
and toxicity of the peptide require correlations between the behaviour of both
molecules: Aβ and the lipid membrane.

3
F L U O R E S C E N C E M E A S U R E M E N T S
3.1 fluorescent peptides
3.1.1 Fluorescent labelling of Amyloid-β
Figure 11: Reaction of NHS-ester function with the primary amine of proteins. The R-group is
bound covalently with the protein through amide bond.
In order to detect Aβ peptides at the interface with the SAF technique, fluorescent la-
belling of the peptides was required. Atto647N is a rhodamine derived fluorophore which
possesses outstanding quantum yield, photostability[203] (i.e., resistance to irreversible,
light-induced reactions) and does not exhibit triplet blinking. A spectral analysis of this
dye was conducted by Dempsey et al[204]. The structure of Atto647N reveals a posi-
tive charge which resonates between two structures. Among the commercially available
Atto647N used for labelling, the N-hydroxysuccinimide-ester (NHS) dye-tag was selected
for the simplicity of its functionalization procedure. NHS-ester chemical groups allow a
convenient labelling of compounds with the dye through reaction with the primary amines
of proteins to form a new and stable amide bound (Figure 11). All aliphatic amines can
react with NHS-esters, therefore Aβ has three potential sites of binding available: the α -
amino group at the N-terminus and two lysine residues (Lys16, Lys28). This could yield an
over-labelling of the peptide with more than one fluorophore moiety. Such situation would
be problematic since both the positive charge of several Atto647N’s and their molecular
size could hinder the natural functions of Aβ . However, the free base form of amino group
is necessary to proceed the acylation reaction.
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Figure 12: SEC elution spectra of the samples from the labelling procedure of Aβ with Atto647N-
NHS-ester (a) at pH 8. (b) at pH 9. (c) UV-Vis spectra of the three fractions from labelling
at pH 8.
The proportion of this free base form of amine is very low, i.e. below pH 8. Depending
on their surroundings, ε -amino groups of lysine residues have a pKa range of 9.8 - 10.4
while α -amino groups have a pKa range of 8.0 - 9.0[26]. Therefore, the kinetic of functional-
ization with NHS-ester is highly pH dependent. It means that a neutral or slightly basic pH
is optimum to proceed the acylation with α amino groups only, and avoid multi-labelling
of one peptide. Additionally, working below pH 9 slows down the hydrolysis of the NHS-
ester into an unreactive carboxylic acid[205]. Aβ (1-40) was subjected to labelling at pH
8 following the procedure described in Chapter 2. While the protocol provided by the
Atto-company advised to use a 3-fold molar excess, here a 5-fold molar excess was used to
compensate the hydrolysis side-reaction and the limited amount of available labelling sites.
The sample was purified after reaction using a size exclusion chromatography (SEC). The
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Figure 13: (a) BCA assay and absorbance at 562 nm of the fractions eluted from Aβ labelling proce-
dure with Atto647N-NHS-ester at pH 9. (b) BCA assay standard curve with BSA.
elution spectrum displayed three peaks, collected and analyzed individually as fraction
1, 2 and 3 (Figure 12 a). The first peak was identified as the protein fraction. The second
and third peaks were respectively attributed to Atto647N-NHS-ester and the smaller hy-
drolyzed Atto647N-COOH. From the elution spectra, the success of labelling of Aβ (1-40)
was uncertain. This assumption came from the absence of overlapping between the absorp-
tion at 280 nm (characteristic of the peptide) and at 647 nm (characteristic of the fluorescent
moiety). The concentration of protein and the labelling ratio of fraction 1 were calculated
by UV-Vis absorbance (Figure 12 c) and with equation 2 and 3. Data are reported in Ta-
ble 1. The extreme low values of the labelling ratio suggests that the functionalization of
the peptide actually did not occur. To overcome this result, the reaction was repeated at
pH 9 to increase the amount of free amine available. However, the elution spectra of this
new attempt did not show a better labelling but the amount of hydrolyzed ester (fraction
3) increased, as expected at basic pH (Figure 12 b).
In addition to UV-Vis, a bicinchoninic acid (BCA) assay was carried out to calculate the
protein concentration of every fraction. The reduction of Cu2+ into Cu+ by proteins and
its chelation by BCA produces a purple colored compound. The intensity of the coloration
and its adsorption at 562 nm was related to the amount of peptide in solution (Figure 13).
The concentrations calculated from a standard curve using BSA protein are displayed in
Table 1. Unlike the UV-Vis data, the amount of peptide obtained with the BCA assay was
possible. Although it was slightly smaller than the total amount of peptide used for the
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labelling, it suggested that the whole amount of peptide is concentrated in the unlabelled
fraction 1.
Molar amount of peptide used 23 nmol
Fraction 1 at pH 8 (Figure 12 a)
Average absorbance at 280 nm (a.u.) 0.2185± 0.0313
Average absorbance at 647 nm (a.u.) (1.104± 0.841)× 10−4
Concentration of proteins (Mol) 1.71× 10−4
Labelling ration (DOL) 4.29× 10−6
Molar amount of proteins in 1 mL 171 nmol
Fraction 1 at pH 9 (Figure 12 b)
Average absorbance at 280 nm (a.u.) 0.2881± 0.0139
Average absorbance at 647 nm (a.u.) 0.0182± 0.0004
Concentration of proteins (Mol) 2.25× 10−4
Labelling ration (DOL) 5.34× 10−4
Molar amount of proteins in 1 mL 225 nmol
BCA assay of fractions at pH 9 (Figure 13 a)
Molar amount of peptides in fraction 1 (14.99± 6.53)nmol
Molar amount of peptides in fraction 2 (0.41± 0.06)nmol
Molar amount of peptides in fraction 3 (0.24± 0.03)nmol
Table 1: Values obtained for the concentration and labelling ratio determined with UV-Vis spec-
troscopy, and the molar amount measured from BCA assay.
It is assumed that the amount of free amine was too limited to obtain an effective flu-
orescent labelling of the peptide with NHS-ester, when compared with other peptides or
proteins. This labelling reaction depends of a competition between the acylation process
and the fast hydrolysis of the ester moiety. Longer polypeptide chains highly influence
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the success of the procedure by increasing the probability of reaction between the dye and
a free amino group (i.e., α -Synuclein possesses 16 lysine residues and BSA has 59 lysine
residues, among which 30-35 residues can react with linkers). Eventually, it was decided to
use a commercially available fluorescent Aβ , selectively tagged on the α -amino group with
HiLyte FluorTM647. Other studies were performed using Aβ labelled with analogue fluo-
rophores, and showed that the tag moiety did not hinder the typical aggregation process
of the peptide[206].
3.1.2 Dependency of the adsorption of Amyloid-β on the composition of the lipid bilayer
The SLB model is renowned for its simplicity of use and adaptation. The composition of
the bilayer can be tuned following the need of a particular experiment with only slight
modifications of the protocol of formation of the SLB (Chapter 2). When applied for the
study of the interaction between Aβ and lipid membrane, various compositions were exper-
imented. Cholesterol (Chol), sphingomyelin (SM), and gangliosides (especially GM1) have
been reported to trigger the interaction between the peptide and the lipids by formation
of micro-domains within the bilayer[207, 208]. Therefore, the adsorption of Aβ has been
monitored on different SLBs as a preamble to the study of its toxic effects, and in order to
select a proper SLB model. The different ratios of lipids were:
1. (DOPC:DOPS) with a lipid ratio of (65:35)
2. (DOPC:DOPS:Chol) with a lipid ratio of (50:25:25),(50:20:30),(50:15:35),(50:10:40) or
(50:0:50 without DOPS)
3. (DOPC:DOPS:Chol:SM) with a lipid ratio of (40:10:25:25)
4. (DOPC:DOPS:Chol:SM:GM1) with a lipid ratio of (40:10:20:20:10)
The more complex SLBs are closer to the biological lipid composition of the neurons,
either the soma or dendrites part of the cells[71]. They are not only more biologically rele-
vant but were supposed to promote the interaction between the peptides and the SLB. 500
nM of fluorescent Aβ (1-40) have been incubated with each of these SLBs and the maxi-
mum of change in SAF intensity was measured after 2 hours of incubation and correlated
to the amount of adsorbed peptides (Figure 14 a). Since the SAF technique only detects
photons arising from the interface, its collection was assumed to be representative of the
signal of Aβ adsorbed on the surface of the SLB. The background signal due to peptides
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Figure 14: Maximum of change in SAF intensity after 2 hours of incubation of 500 nM Aβ (1-40) (a)
on SLBs of different lipid compositions, (b) on SLBs 2 with different cholesterol content.
floating in the bulk of solution was not detected in SAF. Considering the deviation of the
data, the values of adsorption on the SLB 1, 2 and 4 did not exhibit an important variation.
It is obvious though, that the presence of cholesterol and GM1 molecules within the bilayer
slightly enhanced the adsorption of Aβ . Other studies state that not only the presence but
also the proportion of each lipid molecule is an important parameter in the enhancement
factor of the interaction with the peptide. In the experiments performed by other scientists
on a similar topic, cholesterol content varies from 20% to 40% of the total lipid amount,
and yields an increase of the adsorption of Aβ within this range[209–211]. GM1 content
varies from 3% to 50% while some groups affirm that 30% is required to obtain the associ-
ation between the gangliosides and the peptides[211–213].
Among the four SLBs detailed above, the cholesterol content was systematically in the
range required for an enhancement of the interaction with Aβ . The influence of the choles-
terol was studied by comparing the SAF intensity of adsorbed Aβ (1-40) between SLBs 2
formed with different proportions of cholesterol (Figure 14 b). The amount of DOPS was
inversely proportional to the amount of cholesterol. The membrane with the lowest choles-
terol content barely yielded any enhancement compared with SLB 1. When increasing the
cholesterol content, the SAF intensity increased as well until a maximum value at 40% of
cholesterol. When increasing this amount up to 50%, SAF intensity slightly decreased. This
could be due to the absence of any charged lipid (DOPS) to drive the electronic interac-
tions between the peptides and the bilayer, as a similar effect was observed with SLB 3 (see
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Figure 15: Maximum of change in SAF intensity after 2 hours of incubation of 500 nM Aβ (1-40) on
SLBs of different lipid compositions.
below).
The adsorption of Aβ on SLB 3 was unexpectedly lower than on the other SLBs. Although
the amount of cholesterol is lower than in SLBs 2, its mixing with sphingomyelin was
supposed to form lipid-raft domains which are known to favor the adsorption of Aβ . A
possible explanation is based on the electrical charge of the bilayer and the great influence
of electrostatic interactions regarding the adsorption of Aβ . Both cholesterol and zwitte-
rionic lipids (DOPC, SM) exhibit a net zero charge, which left only 10% of net charged
lipid (DOPS) in SLB3, limiting the electrostatic interactions. Although the incorporation
of cholesterol is supposed to strengthen local electrostatic interactions with zwitterionic
lipids, this effect is reported to arise only when cholesterol represents 40% of the lipids
content[210]. These two simultaneous considerations based on electrostatic interactions
could explain the low number of adsorbed peptides.
Since the amounts of both cholesterol and charged lipids are important, the efficiency of
SLB 4 is likely related to the presence of GM1 which is also a trigger of interaction with
the peptide. SLB 4 exhibits the same limiting factors as SLB 3 but the presence of only 10%
of GM1 was sufficient to enhance the adsorption of the peptide.
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In addition, these experiments showed that not only the amount of adsorbed peptide
but also the mechanism of adsorption depended on the composition of the SLBs. SLB 1
and 3 showed some small fluorescent clusters, likely corresponding to small protein ag-
gregates (Figure 15 a,c). On the other side, SLB 2 showed none of these clusters after 2
hours of incubation, but rather a homogeneous fluorescent layer (Figure 15 b). It seems
that the cholesterol content of SLB 2 indeed enhanced the adsorption of fluorescent Aβ
without promoting local aggregation. This could also be due to the absence of lipid-rafts
when sphingomyelin is not present to interact with cholesterol. Finally, SLB 4 exhibited
both features. The average fluorescence of the entire area was more intense, but the im-
age also displayed distinct fluorescence aggregates, bigger than those observed previously
(Figure 15 d). These aggregates are thought to be caused by the presence of GM1 within
the SLB, as this lipid molecule is known to promote the seeding of Aβ aggregation and
fibrillation.
Eventually, the models SLB 1, 2 were selected for further experiments. The former was
chosen for its simplicity and comparison purpose with previous research. The latter was
selected because it combined both simple composition and the highest degree of adsorp-
tion of the peptide. SLB 3 and 4 were discarded despite of their physiological relevancy
because the reproducibility of their formation was very poor and susceptible to more de-
fects than the two other SLBs.
3.1.3 Dependency of the adsorption of Amyloid-β on the peptide concentration
Before studying the adverse effects of the peptides on the SLB models, the affinity of Aβ for
SLB 1 (DOPC:DOPS) was measured. In order to characterize the early-stage adsorption of
Aβ , SLBs were incubated with two types of fluorescently labelled peptides (Aβ (1-40) and
Aβ (1-42)) at various concentration. For each sample, 1% of the peptides were fluorescently
labelled. The SAF collection was used to detect the emission of lipids-bound peptides only
and the fluorescence of supernatant peptides in bulk solution could be neglected. SAF
signal was monitored over a fixed area of the SLB ((9.8× 9.8)µm2 or (37.5× 37.5)µm2),
with peptide concentrations ranging from 1 µM to 40 µM, during at least 6 hours after the
start of the incubation. The fluorescence intensity was averaged over the complete area of
each scan.
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Figure 16: Evolution of the SAF signal over incubation of SLB with fluorescent peptides. (a) Long-
time adsorption of Aβ(1-40) and Aβ(1-42). Short-time adsorption is highlighted in red.
(b) Detailed short-time adsorption for low concentrations of Aβ. (c) Comparison between
SAF/UAF imaging of 5 µM Aβ(1-40) and Aβ(1-42) after 4 hours of incubation.
The evolution of the fluorescence intensity was then plotted as a function of the incuba-
tion time (Figure 16 a). Results revealed a particular evolution of the signal divided in two
time-ranges. For an incubation time up to 30 minutes, all solutions showed a fast increase
in fluorescence intensity, followed by a systematic decrease of fluorescence intensity. These
results were interpreted as a fast adsorption of the peptides followed by a partial desorp-
tion due to weak unspecific interactions. This behavior is well known as “overshooting”
and known also from the adsorption of other proteins[214–216]. Different hypotheses have
been formulated to explain the overshoot, but the most accurate for this experiment is
based on the surface coverage and lateral protein-protein interactions. Briefly, many pep-
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tides continuously adsorb on the surface in a metastable conformation. As the density
of adsorption increases, electrostatic repulsions between peptides bearing net charges of
equal sign promote the desorption of these metastable adsorbates, unless some of them un-
dergo conformational changes which enhances their binding[214, 215]. This overshooting
time range is hereafter referred to as short-time adsorption (depicted by the red shade on
Figure 16 a). During the short-time adsorption, Aβ (1-40) displayed a higher fluorescence
increase than its more toxic counterpart Aβ (1-42) for concentrations between 1 µM and 5
µM (Figure 16 b). However, this tendency was reversed beyond 10 µM, namely at concen-
trations equal or superior to the critical micellar concentration (cmc) of Aβ ’s[217]. Around
and beyond cmc range, Aβ (1-42) is known to exist as higher order aggregates than Aβ (1-
40). This explains Aβ (1-42) subsequent higher fluorescence intensity during overshooting,
since the first adsorbed species already are bigger aggregates.
Once the minima of SAF intensity have been reached after the overshooting described
previously, extended time of adsorption yielded different behaviour for each type of pep-
tide. Aβ (1-40) exhibited either a plateau or a slow increase when the time of incubation
was prolonged beyond 24h. On the other hand, Aβ (1-42) showed a further increase in flu-
orescence intensity after only one hour: Aβ (1-42) accumulates several irregular jumps of
intensity before reaching another plateau. SAF imaging of the area allowed to correlate
these fluctuations with the appearance of fluorescent aggregates on the SLB (Figure 16
c). On the UAF imaging, bright stripes are visible and attributed to the motion of these
fluorescent aggregates in the bulk solution during the scanning process. Some of them
will eventually adsorb durably on the interface and increase the SAF intensity. These flu-
orescent aggregates are thought to be the result of peptides oligomerization. As shown
by the comparison of imaging between the two peptides, Aβ (1-42) exhibited a stronger
and faster tendency than Aβ (1-40) to form these aggregates and nucleation sites on top
of the SLB after the short-time adsorption/desorption phase. This was especially obvious
at concentrations above 5 µM. This outcome is also in accordance with previous reports
showing the higher propensity of Aβ (1-42) to aggregate, due to the influence of the longer
C-terminus[52, 218].
Therefore, the outstanding signal of Aβ (1-42) could have three explanations. It was either
due to the adsorption on the SLB of peptide aggregates pre-formed in solution ; or caused
by peptides stacking on aggregates already adsorbed ; and/or simply caused by an en-
hanced adsorption of monomers due to a higher affinity for the lipids. The quantification
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Figure 17: Maxima of fluorescence intensity after 6 hours of incubation as a function of Aβ concen-
tration.
Kd (µMol) Imax (a.u.)
Aβ (1-40) 4.24± 0.28 39.96± 1.27
Aβ (1-42) 3.48± 0.37 110.17± 9.08
Table 2: Values obtained from the Langmuir isotherm fitting of the graph in Figure 17 with equa-
tions 8,9.
of Aβ (1-40) and Aβ (1-42) respective affinity was required to assess this hypothesis. To
quantify the affinity of the peptides for the SLBs, the maxima of the average intensity of
the area after 6h of adsorption were plotted as a function of the peptide concentration
(Figure 17). This curve was then fitted with a Langmuir isotherm (equation 8)[219]. Fitting
yielded values for the unspecific adsorption constant (Ku), which were then expressed as












Where I is the measured fluorescence intensity, Imax is the maximum fluorescence inten-
sity reached at higher concentration, and ka, kb being the kinetic constants for unspecific
adsorption and desorption respectively (results depicted in Table 2). The values calculated
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for Kd were (4.24± 0.28)× 10−6 M for Aβ (1-40) and (3.48± 0.37)× 10−6 M for Aβ (1-42).
Despite the high limitation of the Langmuir isotherm model to describe protein adsorption
events, the range of these values is in accordance with other studies[212, 220]. From these
data, it is supposed that the slightly higher Kd value for Aβ (1-40) reflects a weaker inter-
action with lipid molecules than Aβ (1-42). This could be expected for the less toxic type
of peptide, although the difference of affinity is too small to justify all the discrepancies
encountered in SAF.
Despite having a similar values for Kd, the Imax of each peptide is drastically different, as
showed in Figure 17: Aβ (1-42) maximum SAF intensity is almost 3-folds higher than its
counterpart. During these experiments, Aβ (1-42) yielded a higher SAF intensity than Aβ
(1-40) when aggregates became visible on the interface. From that moment, the SAF inten-
sity increased until a plateau is reached, demonstrating that the aggregates are adsorbed
durably and not reversibly. Since the results yielded a similar affinity of both peptides for
the lipids, this increase in surface fluorescence was likely the consequence of the deposition
and subsequent growth of these aggregates. More Aβ (1-42) adsorbed on the surface than
Aβ (1-40) because they were in oligomeric state. So, the "higher" affinity of Aβ (1-42) for the
SLB is nothing but a secondary factor to explain its higher SAF signal. Additionally, the fact
that Aβ (1-42) is the prior component of senile plaques in the brain[221, 222] supports the
hypothesis that it aggregates more rapidly than Aβ (1-40) and interacts durably with the
lipids at the early stage of the disease, while Aβ (1-40) is slower to oligomerize. In the ab-
sence of oligomers, the maximum adsorption of non-aggregated peptides is limited by the
saturation of the surface with monomers. Furthermore, the adsorption of monomers was
highly reversible, at least during the overshooting period (i.e. the desorption is observed
up to 30 minutes of incubation). This limitation would explain why the non-aggregating
Aβ (1-40) peptide yielded less signal than Aβ (1-42), prone to form oligomers.
To confirm this supposition, the evolution and average intensity of the non-aggregated
Aβ (1-42) layer was selectively monitored and compared with the data obtained from its
aggregates (Figure 18). From its constant SAF value, it is clear that the layer of adsorbed
non-aggregated Aβ is in equilibrium and saturation with the incoming flow of peptides
once the surface is saturated. Moreover, the SAF intensity of the non-aggregated layer
of Aβ (1-42) (Figure 18 a, bottom line) was similar to the average SAF intensity of Aβ (1-
40) in Figure 16 a. This confirms that the presence of Aβ (1-42) aggregates was the main
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Figure 18: (a)Evolution of SAF intensity as a function of time for non-aggregated layer and aggre-
gated sample of 10 µM fluorescent Aβ (1-42). (b) SAF imaging data with the tracking of
the aggregates over time displayed by colored circles (each colored circle corresponds to
one of the aggregates which remain at similar location). The SAF intensity of the first
aggregate (white circle) and non-aggregated area (blue box) are displayed in (a).
source for the discrepancies in maximum SAF intensity: without these aggregates, the two
peptides would exhibit comparable SAF signal. Unlike the non-aggregated peptide areas,
the fluorescent aggregates displayed in Figure 18 b exhibited an increasing intensity. The
aggregates were adsorbed tightly enough at the lipid bilayer so that most of them could
be "tracked down" by SAF imaging. This is represented in Figure 18 b where each circle
corresponds to the follow-up of one aggregate, a dashed circle indicating that the same
aggregate partially desorbed. They seemed to spread or desorb punctually, but the lateral
position of many of them remained similar over a time-span of more than 2 hours. These
measurements confirmed the assumption that both non-aggregated monomeric Aβ s show
a similar adsorption affinity. The discrepancies in the adsorption behaviour of Aβ (1-40)
and Aβ (1-42) were obviously caused by the aggregates and did not come from the affinity
of individual, non-aggregated, peptides.
3.1.4 Reversibility of the adsorption of Amyloid-β
Many proteins initially bind loosely on surfaces and only increase their affinity after struc-
tural changes have occurred over time. This behaviour was encountered in the last experi-
ment. Both Aβ s exhibited a successive adsorption/desorption phase and weak interactions
58 fluorescence measurements
Figure 19: SAF imaging of 5 µM fluorescent Aβ (1-42) (a) after 24 hours of incubation on SLB,
(b) after 15 min of washing with PBS, (c) after 1 hour of washing with PBS (average
intensities are displayed in the top). (d)Evolution of the SAF intensity of 5 µM Aβ after
washing with PBS. Each curve corresponds to a different time of incubation before the
washing step. (e) Evolution of half-life time (τ) and the minimum SAF intensity (I∞) in
function of the incubation time before washing.
with the SLB, before some aggregated structures adsorbed durably on the SLB. As an ex-
ample, quantification of the affinity of Aβ (1-42) using the SAF intensity of the short-time
adsorption would yield a Kd value of (33.51± 0.14)× 10−6 M. This represents an affinity
10-folds lower than found using the SAF intensity after a longer incubation, and usually
reported in literature. It also illustrates perfectly how the affinity of the peptide increased
through the restructuration of the molecule over time. As a result, desorption kinetic of
the peptides can strongly depend on the time that has been passed since the first adsorp-
tion events[223]. However, building this hypothesis from the adsorption curve only was
insufficient to elaborate a proper model for the adsorption of Aβ . For that purpose, the
reversibility of the adsorption after different times of incubation was investigated as well.
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Therefore, 5 µM of fluorescent Aβ was incubated on SLB 1 (DOPC:DOPS) and the flow of
peptides was exchanged with pure PBS buffer after various times of incubation has been
passed (Figure 19 a,b,c). The decrease in SAF intensity was fitted with an exponential de-
cay function (Figure 19 d), from which the half-life time τ (i.e. the time necessary for half
of the peptides to desorb) and minimum intensity I∞ were extracted (equations 10, 11).
I = I0 × e
−t/t1 + I∞ (10)
τ = ln2× t1 (11)
The first observation simply confirmed the results stated in previous section about the
respective affinities of the peptides : after the same time of incubation and washing, the re-
maining fluorescence of Aβ (1-42) was higher than the fluorescence of Aβ (1-40). Although
an attempt was made to find a linear dependence between the half-life time of Aβ (1-42)
and the time of incubation, τ was better described by a sigmoid function (Figure 19 e). The
same observation applied to I∞, indicating a good correlation between the two parameters.
The resilience of Aβ to washing exhibited a strong enhancement when aggregates started
to cover the surface (between 5 and 15 hours of incubation before washing). Next, both
I0, the half-life time, and I∞ reached a limit value. This showed that the affinity of the
aggregates increased over time during their coverage of the SLB, as suggested previously.
However, the non-linear evolution of τ - and, by extrapolation, the affinity - is interesting
for the discussion of the model of adsorption. While it is obvious that the affinity could
not increase indefinitely, the plateau at the beginning of the x-axis in Figure 19 e suggested
that the first adsorbed species, which are not aggregated, already exhibited their limit of
affinity. Only through the process of oligomerization, occurring after 5 to 15 hours of incu-
bation, would the peptides undergo a change of their affinity over time. Finally, the range
of minima intensities I∞(16.63− 60.57) after washing was small compared with the range
of initial intensities I0(24.08− 290.10) before washing. This information, coupled with the
SAF imaging, suggested that the remaining peptides species were similar, no matter how
long Aβ was incubated before washing. These remaining peptides were monomeric or
small oligomeric species and seemed already adsorbed on the surface before the cover-
age with the most massive aggregates. This is unexpected, as the aggregated species were
thought to be a decisive factor in the resistance of Aβ to washing from the SLB. This last
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Figure 20: (a) Plot of the adsorption model for Aβ elaborated from the results obtained in previous
experiments. (b) Cooperative adsorption model. (c) Three-states adsorption model. (d)
Scheme of the adsorption model of Aβ .
observation was critical for the elaboration of the adsorption model : it meant that a frac-
tion of monomeric or small oligomeric species have been subjected to a state-transition
that increased their affinity for the SLB. Hence, they were the very last peptides adsorbed
on the SLB after washing.
Combining the results of the adsorption process of Aβ and its reversibility, a model
of adsorption phenomenon can be elaborated. The model resemble those developed by
Rabe et al. with some adaptations (Figure 20 a, b, c). Briefly, the "cooperative adsorption
model" states that pre-adsorbed proteins on the surface attract bulk proteins vertically to
the surface due to the overlap of the electrostatic forces of the protein and the surface.
When the lateral electrostatic repulsions between the proteins is too strong, approaching
molecules are guided in the vicinity of pre-adsorbed proteins (Figure 20 b)[216]. On the
other side, the "three-states model" describes how an overshooting effect is obtained, due to
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the irreversible adsorption of first proteins which undergo fast orientation change toward
reversibly adsorbed species. A third relaxed and more stable adsorption state is slowly
reached and lead to a global increase of adsorbate after overshooting (Figure 20 c)[224].
The cooperative adsorption model corresponds remarkably to the images of aggregated
Aβ recorded in SAF, where the aggregates were closely packed and spread along the sur-
face. It also fits the washing experiments where I∞ converged toward a minimum range
after the time of incubation has reached a threshold. The three-states model is also inter-
esting because of its description of the overshooting effect followed by a second increase
of adsorbed peptides. However, it must be nuanced to account for the discrepancies about
the reversibility of adsorption. In the experiments with Aβ , no fully-irreversible adsorption
could be confirmed since the washing during the overshooting period still yielded a small
removal of peptides. It is assumed that (at least) two different states of Aβ with different
affinities adsorbed simultaneously on the SLB. Once the surface coverage had reached a
limit, peptides were too densely packed and the metastable states desorbed from the lipids
due to the electrostatic repulsion. Only the most stable states could withstand this repul-
sion. This process yielded the overshooting effect observed during the short-time adsorp-
tion. The ratio between stable and metastable states explains very well the discrepancies
between Aβ (1-40) and Aβ (1-42) concerning the desorption process. the latter is expected
to favour the adsorption of the more stable state on lipids, perhaps because of its longer
hydrophobic C-terminus[52]. Following the overshooting effect, the surface was mainly sat-
urated with stable peptides which can cooperatively attract bulk solution peptides in their
vicinity. This process leads to the formation of patchy aggregates on the surface. Alterna-
tively, pre-aggregated species can adsorb on the surface. In the two cases, aggregates were
obviously not the most stable species since some of them still desorbed entirely. However,
their affinity and resilience to washing still showed a slight enhancement over time. This
could be the consequence of a rooting of the aggregates as they attracted and stacked an
increasing amount of incoming Aβ s (Figure 20 d).
3.1.5 Influence of calcium ions on the adsorption of Amyloid-β
The probable bidirectional relationship between Aβ and calcium ions in Alzheimer disease
has long been hypothesized[225]. Aβ can disturb Ca2+ homoeostasis, notably by formation
of cation-selective channels[226–228]. On the other hand, dysregulation in the dynamics
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Figure 21: (a) Average SAF signal in function of different concentrations of adsorbed Aβ dissolved
in pure PBS or PBS with 2 mM of CaCl2 • 3H2O). (b) SAF imaging of 200 nM Aβ (1-42)
adsorbed on SLB when dissolved in pure PBS (left) or 2 mM calcium buffer (right).
of Ca2+ ions can modify the brain metabolism and trigger the release of Aβ peptides[229].
Interactions between Aβ and Ca2+ also promotes the formation of oligomeric species[198]
and would facilitate the binding of the peptide on the membrane via formation of ionic
bridges[210]. For all these reasons, some experiments described in this thesis have been
reproduced and compared, using PBS with 2 mM of CaCl2 • 3H2O instead of simple PBS.
Following the methods of other groups, the content in calcium of the buffer is largely
higher than the normal calcium concentration in cultured neurons (100-140 nM) [226, 230].
Therefore, the influence of Ca2+ on Aβ is expected to be exacerbated.
First, the monitoring of the adsorption of Aβ on SLB 1 (DOPC:DOPS) was reproduced
at low concentrations with the peptide dissolved in calcium buffer. The average fluores-
cence intensity of the area was measured after 5 hours of incubation with the peptides.
As a matter of fact, dissolution in membrane buffer increased the amount of adsorbed
peptides on SLB, compared with the adsorption of peptides dissolved in PBS (Figure 21 a).
This effect is thought to be the consequence of new interactions between Aβ and cal-
cium ions. Computational studies explain this effect by the formation of the previously
mentioned ionic bridges : Ca2+ is supposed to act as a link between the polar head group
of the lipids and the peptides, negatively charged at neutral pH[231]. It also strengthens the
electrostatic interactions between charged residues of Aβ and the SLB[232]. Analysis of the
SAF imaging reveals that Ca2+-containing buffer promoted a different way of adsorption
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than PBS (Figure 21 b) : Ca2+ clearly increased the amount of aggregated species on the sur-
face, even at concentrations as low as 200 nM. An increase of peptides aggregation could
be expected since the ion-bridges can also occur between two negatively charged peptides.
However, the non-aggregated adsorbed peptides exhibited a lower fluorescence intensity
of 29.53± 3.44 a.u. when Aβ was dissolved with Ca2+ ions, while the non-aggregated pep-
tides had a fluorescence intensity of 40.26± 5.81 a.u. when dissolved in PBS. It is then
assumed that although Ca2+ increased the amount of peptides near the surface, this effect
was mainly obtained through formation of peptide-peptide bonds promoting aggregation.
The surface of the SLB was not more saturated by Aβ in Ca2+ than in PBS buffer. The
reason why PBS still exhibited a higher saturation of the surface than the calcium buffer
can be due to their respective ionic strengths. The ionic strength of the calcium buffer was
slightly higher than pure PBS. Hence, the calcium buffer yielded a stronger screening of
the electrostatic charge of the lipid polar heads. This feature could have hindered the inter-
actions between peptides and the SLB (see previous section).
In addition, the increase of fluorescence intensity due to calcium was not observed at con-
centrations beyond 1-2 µM Aβ . Beyond 2 µM of peptides, aggregation had been observed
in PBS solution as well, and this factor is not specific of Ca2+-buffer anymore. From these
experiments, it is concluded that the presence of Ca2+ could mainly trigger the aggregation
of Aβ and occasionally act as a bridge between the peptides and the lipid bilayer. However,
the influence of this bridging effect on the adsorption is significant only at concentrations
lower than 1-2 µM. Beyond this limit, the flux of peptides coming from the bulk solution
toward the membrane is supposed to overcome the influence of the calcium and the bulk
concentration is high enough to yield aggregation without the influence of ionic bridges.
3.1.6 Characterization of the aggregation state of Amyloid-β samples
The exact role of Aβ in Alzheimer disease and its symptoms is still under debate, but nowa-
days the idea that the oligomeric species are responsible of the neurotoxicity is widely
spread[42, 65, 233]. However, the biological synthesis of Aβ from the amyloid-precursor-
protein releases the monomeric form of the peptide. Although some groups include pre-
aggregated peptides in their sample, this work aimed to mimic the interaction with Aβ
from scratch, hence starting with the monomeric peptides. Beyond this requirement, SAF
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Figure 22: Native-PAGE with subsequent Coomassie blue staining of Aβ (1-42) (a) dissolved 24h in
PBS, (b) dissolved 24h in membrane buffer (5 mM of Ca2+), (c) dissolved in PBS and
collected after 24h of incubation with SLB.
imaging showed the appearance of fluorescent peptide clusters, obviously in an aggre-
gated state. Therefore, the characterization of these aggregates is relevant for this thesis.
To check the oligomerization state of the peptide, Aliquots of Aβ (1-42) were dissolved
during 24 hours in the buffers used for the experiments, then separated by Native-PAGE
electrophoresis according to their mass (Figure 22). Dissolution in PBS only yielded the
monomeric form of the peptide after separation. The same result was obtained when dis-
solved in membrane buffer, despite its content in calcium ions, supposed to accelerate
the oligomerization of Aβ [198]. This conservation of the monomer can be the result of
the storage at room temperature instead of biological temperature. Yet, some aggregates
- or oligomers - of Aβ were formed and observed as fluorescent aggregates in previous
experiments. In order to determine the size of the oligomeric species in this type of sam-
ple, a fraction of 5 µM peptide solution was collected after 24 hours of incubation on
SLB 1 (DOPC:DOPS) and peptides were separated using the same technique (Figure 22 c).
On this gel, bands were visible at a higher mass than the monomer. Mainly dimeric and
trimeric forms of Aβwere collected, with traces of tetrameric oligomers. Based on the color
intensity of the bands, the dimeric form was dominant. However, from the intensity of flu-
orescence in previous experiments, it was supposed that bigger oligomers were formed
and adsorbed on the SLB. But because of their relatively low concentration, their bands
were barely visible and smeared at the top of the gel. From these experiments, it is showed
that the starting peptide material is preserved as monomers even in Ca2+-containing buffer.
Interestingly, the oligomerization process is triggered by incubation in the presence of the
lipid bilayer when the concentration of Aβ is too low to produce the nucleation of aggre-
gates in solution (i.e. below critical micellar concentration).
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Figure 23: (a) Axial detection profile of SAF objective with angle of acceptance of 62°-75°. The pos-
sibilities of diffusion of Aβ within the SAF detection volume are correlated to a fictional
detection efficiency. (b) SAF imaging of 5 µM Aβ (1-40)(top) and Aβ (1-42)(bottom) after
24h of incubation on SLB. Numbered circles design the aggregates targeted with FCS.
3.1.7 Characterization of the diffusion coefficient of Amyloid-β
Besides the quantification of the affinity of Aβ peptides for the lipid bilayer, their diffusion
around the surface was also determined. Fluorescence correlation spectroscopy (FCS) is a
method to measure the diffusion of emitting species by monitoring the variation of their
signal within a defined detection volume. The monitored signal can be the SAF collection,
hence analyzing the motion within the interfacial region. Fitting of the correlation curve
with the proper model allows to extract the diffusion coefficient (DL) of the fluorophore.
Aβ can theoretically diffuse in three dimensions: Aβ can diffuse in two dimensions along
the SLB surface (x and y axis) and/or adsorb on or desorb from the surface (z axis). How-
ever, the detection of the signal depends of the collection efficiency function, which is
subject to an exponential decay along the optical axis (z) in the case of SAF objective[202].
This feature forced to adapt the fitting of the SAF-FCS curve, so that the decaying sig-
nal of Aβ moving along the optical axis is properly integrated in the fitting (Figure 23 a).
Using the SAF 3D-FCS fitting, values of DL were calculated for 5 µM Aβ (1-40) and Aβ
(1-42) after 24h of incubation on SLB (Table 3). From the SAF imaging, monitored areas
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displayed inhomogeneous fluorescence and aggregates. This result recalled the previous
section, where different sizes of oligomers were identified with Native-PAGE. Fluorescent
aggregates were selectively targeted for FCS and sorted according to their size on the SAF
imaging : target 1 represented the first layer of adsorbed peptides without any visible ag-
gregation, target 2 was attributed to the smallest aggregates with a diameter between 1-3
µm, and target 3 referred to the aggregates whose diameter was equal to or greater than 4
µm (Figure 23 b). There was an inverse proportionality between the size of the aggregates
and the DL. As expected, bigger fluorophores diffused slower. However, there was also a
net difference in the diffusion of the two types of peptide. All targets considered, Aβ (1-42)
diffused approximately from 6 to 15-folds slower than Aβ (1-40). Considering the whole
set-up of the experiment being the same for both Aβ s, there are only two parameters that
can influence their diffusion near the interface: their mass and their affinity for the SLB.
The influence of the mass can be discussed using the equation of diffusion developed by





Where kB is the Boltzmann constant and η is the viscosity of the solvent. Considering Aβ
as a small globular protein and the mass m of a molecule to be proportional to the volume
4πr30/3 , it is found that DL ∝ 1/m
1
3 . Considering the target 1 as the signal emitted by
monomeric and dimeric Aβ (the two dominant species characterized by Native-PAGE), the
theoretical mass of the other targets was estimated by proportionality with DL (reported in
Table 3). From the mass calculation, the approximate number of peptides constituting the
aggregates was derived. Targets 2 in Aβ (1-42) contains around 2 times more peptides than
in Aβ (1-40). As for targets 3, Aβ (1-42) contains 4 - 5 times more peptides than in Aβ (1-
40). These results offer a potential explanation for the discrepancies in DL between the
two Aβ s. If Aβ (1-42) aggregates were more voluminous than Aβ (1-40) it is expected that
they would diffuse slower. However, even the diffusion of target 1 - supposedly of similar
size for both peptides - displayed a huge difference in DL despite the small difference in
molecular weight.
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DL(×10−12m2s−1) massfrom DL(#peptides)
Aβ (1-40)
target 1 29.6± 5.8 4329.9− 8659.8 (1− 2)
target 2 24.8± 5.6 13566.2− 16293.6 (≈ 3− 4)
target 3 20.15± 5.3 23276.2− 35598.3 (≈ 5− 8)
Aβ (1-42)
target 1 4.7± 0.8 4514.1− 9028.2 (1− 2)
target 2 2.3± 0.7 21911.3− 36315.1 (≈ 5− 8)
target 3 1.4± 0.5 108971.8− 170206.2 (≈ 20− 38)
Table 3: Values obtained for the diffusion coefficient of both types of Aβ peptide after 24h of incu-
bation on SLB. DL is extracted from SAF-FCS fitting of different targets (see Figure 23 b).
The theoretical mass and amount of peptides in each target is calculated from the DL and
equation 12.
Therefore, it seems evident that the mass of the peptides did not influence the diffusion
on its own, but the respective affinities of each peptide for the SLB also played a role. The
higher affinity of Aβ (1-42) for the lipids may have hindered its diffusion at the surface
and its desorption from the bilayer. From comparison between the molecular weight of the
two Aβ s and their respective DL, the interactions with the bilayer seems to exert a greater
influence on the diffusion near the surface than the mass of the peptides. The mass could
have a bigger impact on the diffusion once Aβ is completely desorbed from the SLB and
too far apart from the lipid molecules to interact with them. Moreover, the mass calculation
from FCS confirmed the assumption made in previous section, that aggregates bigger than
tetramers (i.e. up to 40 peptides) could be formed on the SLB. It seems that the formation
of these oligomers occurred rarely and their low amount prevented their detection with
the Native-PAGE electrophoresis. However, other studies about the aggregation of Aβ also
showed that oligomers of higher order (average amount up 50 peptides) were formed after
only few hours[234].
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3.2 fluorescent supported lipid bilayer
3.2.1 Formation of supported lipid bilayer of different compositions
Figure 24: Overview of the two general protocols for the establishment and washing of the sup-
ported lipid bilayers described in this thesis.
As written in Section 3.1.2 different compositions of SLB were attempted to be formed. The
basic protocol for the formation of SLB (explained in Chapter 2) required some adaptation
depending on the lipids present in solution. First, a study of the stability of the bilayer
was conducted with a protocol elaborated recently to study the interaction of SLB with α
Synuclein[160, 235]. The major concept of the protocol is to spread the solution of lipid
unilamellar vesicles (LUVs) on the substrate, then to rinse it with a determined buffer to
remove the undisrupted LUVs. Finally, the freshly formed SLB is let to equilibrate with
the buffer used in further experiments. During the first step, LUVs are dissolved in mem-
brane buffer (containing Ca2+). Ca2+ ions are known to destabilize the lipid structure[236].
While this effect is desirable to disrupt the vesicles adsorbed on the substrate and force the
desorption of non-disrupted vesicles, prolonged incubation with Ca2+ has been showed to
remove lipid molecules from the bilayer itself or to perturb its diffusion[237]. On the other
hand, EDTA-containing buffer has been showed to yield a restructuration and stabiliza-
tion of the SLB while complexing the Ca2+ ions[238]. Therefore, two methods were used
to form the SLB on the glass substrate. The first one consisted in a single rinsing step with
the membrane buffer before equilibration with PBS. The second one involved two shorter
rinsing steps : a preliminary washing with membrane buffer followed by a rinsing with
EDTA to remove the free calcium ions (Figure 24).
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Figure 25: (a) SAF imaging of the formation of a DOPC:DOPS SLB using protocol B (EDTA rinsing
step, see Figure 24). The white circle points the first zone of restructuration of the SLB.
(b) Evolution of the SAF signal and diffusion coefficient DL(c) of the SLB over one week,
with and without incubation with 5 µM Aβ (1-40).
In order to evaluate the stability of the SLB, fluorescent DOPE-Atto647 was incorporated
in the lipid mixture to visualize the bilayer with SAF upon its formation on the substrate.
The protocol B used by Hähl et al.[160] was the first to be tested and included the rinsing
step with EDTA. The progressive adsorption and disruption of the LUVs could be mon-
itored by SAF imaging. Lateral scanning lines became visible only few minutes after the
exchange of buffer and are characteristic of disrupted vesicles forming a lipid bilayer patch
(Figure 25 a). The stability of the SLB 1 (DOPC:DOPS) under constant flow of PBS was as-
sessed during a time span of 7 days by checking the bilayer integrity and fluorescence
intensity with SAF imaging, and the lipid diffusion DL by SAF-FCS (Figure 25 b,c). After
one week, the fluorescence intensity decreased of approximately 35% while the value for
DL remained constant. Also from the FCS curve, the values of G0, inversely proportional
to the amount of fluorescent molecules, raised from 0.137± 0.025 to 0.251± 0.009. This
means that some fluorescent molecules are lost from the bilayer over time, and the decrease
in fluorescence is not due to photobleaching. Still, these data showed that the SLB was per-
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fectly stable during at least 42 hours. At the same time, this type of SLB was incubated
with 5 µM Aβ (1-40) as a first observation of the impact of the interaction with the peptides.
The results are displayed in this section though, because they emphasize the resistance of
the SLB formed with Hähl’s protocol. Even after 7 days of incubation with Aβ , the SLB
exhibited no significant difference with the control. From the previous section, it is known
that at this concentration and after such a time of incubation, the peptides likely adsorbed
and aggregated on the bilayer. Therefore, it was surprising to observe no impact on the
SLB. Similar preservation of the fluorescence have already been observed for this type of
SLB with another peptide (α Syn)[237] while the same experiment with another protocol
for the formation of the SLB yielded different results[235]. One hypothesis to explain that
contradictory outcome is that the SLB formed after restructuration with EDTA was actu-
ally too stable and resilient to the influence of all peptides. The second hypothesis is that
the complete chelation and removal of all remaining calcium ions hinders the adsorption
of Aβ . Therefore, the protocol A without any rinsing with EDTA was conserved for the
formation of SLB in further experiments.
Using adaptation of the protocol A, SLBs of different lipid compositions were formed
(mentioned in Section 3.1.2):
1. (DOPC:DOPS) with a lipid ratio of (65:35)
2. (DOPC:DOPS:Chol) with a lipid ratio of (50:15:35)
3. (DOPC:DOPS:Chol:SM) with a lipid ratio of (40:10:25:25)
4. (DOPC:DOPS:Chol:SM:GM1) with a lipid ratio of (40:10:20:20:10)
Their stability during a time span of 48 hours and under a constant flow of PBS was
monitored and compared (Figure 26). The resistance of SLB1 is lower when formed with
protocol A than with protocol B, and its fluorescence dropped of 30-35% after only two
days instead of one week. This effect is thought to come from the absence of calcium
removal with ETDA. However, the stability is still considered sufficient for observing the
impact of Aβ in further experiments.
Compared with SLB 1, the stability of other SLBs remained similar, although slightly
higher after 40 hours of lifetime. It is assumed that incorporating other lipids in the bilayer
induces the formation of so-called "lipid rafts" which are produced by the interaction and
packing of sphingomyelin with cholesterol. Those lipid rafts confer an enhanced stability
and resistance to some detergents on the SLB[239]. Another proof of the formation of
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Figure 26: Evolution of the SAF intensity in function of time of SLBs prepared with protocol A
(without EDTA, see Figure 24) for different lipid compositions.
such micro-ordered domains in the lipid bilayers is provided by measuring their lateral
diffusion coefficient. The DL decreased with the sophistication of the SLB, as expected
when rafts or liquid-ordered phases appear within the membrane[240, 241] :
1. (DOPC:DOPS) DL = 2.51± 0.37× 10−12m2s−1
2. (DOPC:DOPS:Chol) DL = 1.47± 0.62× 10−12m2s−1
3. (DOPC:DOPS:Chol:SM) DL = 0.40± 0.28× 10−12m2s−1
4. (DOPC:DOPS:Chol:SM:GM1) DL = 0.47± 0.16× 10−12m2s−1
Despite the successful formation of all these SLBs, only the SLB 1 and 2 were selected for
further investigation of the interaction with Aβ . Their formation is more straightforward
than the other SLBs and was more reproducible. Besides, their lateral diffusion coefficient
were in the range of previous studies involving Aβ or amyloidogenic peptides, which
might prove helpful for a comparison purpose.
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Figure 27: (a) Evolution of the SAF intensity of SLBs in function of time of incubation with 0.5 µM
Aβ (1-40) and Aβ (1-42). (b) Correlation curves obtained from the SAF-FCS of fluorescent
SLB (DOPC:DOPS) incubated with the same conditions.
3.2.2 Influence of the interaction with Amyloid-β on the structure of supported lipid bi-
layers
In the previous sections, the model of adsorption of Aβ on SLB have been hypothesized
by characterizing its affinity of adsorption and the evolution of its structure over time, and
after washing with PBS. Yet, no information was gained concerning the impact of these
interactions on the substrate itself. Therefore, fluorescent SLB 1 (DOPC:DOPS) and SLB 2
(DOPC:DOPS:Chol) were incubated with non-labelled Aβ (1-40) and Aβ (1-42) at different
concentrations. The concentrations of the peptide were 0.5 µM, 5 µM, 25 µM and 50 µM.
Compared with quantifications made in the brain of rats, these concentrations are beyond
the average concentration of "free diffusible" Aβ in the brain (≈ 6 nM)[242, 243]. However,
they cover the range of concentrations used to mimic Alzheimer disease process in most
studies. Besides, estimation of the free diffusible concentration of Aβ does not or poorly
takes account of the local membrane concentration where peptides are gathered during
the progression of the disease.
Three different effects could be observed, depending on the concentration of peptides:
a decrease of the average SLB fluorescence intensity; the formation of fluorescent lipid
aggregates; and eventually the disruption of the bilayer. Incubated with these samples of
Aβ , images of the SLBs were recorded periodically in both SAF and UAF channels at
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different concentrations and at incubation times up to 48 hours. Within these 48 hours of
incubation, three different effects could be observed, depending on the concentration of
peptides: a decrease of the average SLB fluorescence intensity; the formation of fluorescent
lipid aggregates; and eventually the disruption of the bilayer.
Even at the lowest concentration of peptide (0.5 µM) the fluorescence exhibited a decrease
of approximately 25 % for SLB 1 and 35 % for SLB 2 (Figure 27 a). A lipid control con-
firmed that this effect was not only due to photobleaching or natural damaging but in-
deed reflected an influence of the peptides. The discrepancies between the two SLBs can
be explained by the results obtained in Section 3.1.2, where the preferential adsorption
of Aβ on cholesterol-containing membrane is reported. It seems logical that an enhanced
adsorption of peptides increased the impact of such adsorption on the substrate, hence
the bigger decrease in fluorescence when Aβ was incubated on SLB 2. When increasing
the concentration of peptides, this decrease of the SAF signal of SLB was also enhanced,
as expected if a larger amount of peptides (and likely aggregated oligomers) adsorbed on
the bilayer. However, this decrease of fluorescence reached a limit around 50% loss. The
curves obtained from the SAF-FCS measurement proved once more that this effect was
actually due to a lower amount of fluorophores rather than photobleaching. This finding
comes from the analysis of the G0, which increased with when the incubation with Aβ was
prolonged, implying a lower number of molecules in the detection volume (Figure 27 b).
Therefore, it is assumed that the fluorescence decrease is caused by a loss of fluorescent
lipids, namely that Aβ reduced the average amount of lipid molecules in the area of its ad-
sorption. Furthermore, when comparing the loss of fluorescence caused by Aβ (1-40) and
Aβ (1-42), the two peptides yielded similar results with no clear stronger impact for any of
them. The reduction of the amount of lipids is then assumed to come from unspecific and
similar interactions coming from both peptides.
Besides the conclusions coming from monitoring of the average fluorescence, information
about the structure and morphology of the SLBs could be collected from the analysis of
the SAF images. Modification of the SLB integrity could be observed by fluorescence imag-
ing, whose extent depended on the concentration of Aβ and the lipids composition. At a
concentration of 0.5 µM, the only observable effect was the decrease of fluorescence, hence
related to the loss of lipid molecules described above. The scale of the darkening increased
at 5 µM to reach 45-50% loss of fluorescence.
Another effect was visible on the SLB incubated with 5 µM Aβ : the formation of fluores-
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Figure 28: SAF and UAF imaging of SLBs recorded after 24 hours of incubation with Aβ (1-42)
peptide. (a) SLB 1 with 5 µM Aβ . (b) SLB 2 with 5 µM Aβ . (c) SLB 1 with 50 µM Aβ . (d)
SLB 2 with 50 µM Aβ .
cent clusters mainly observable in the UAF channel (Figure 28 a). The signal of these lipid
clusters was more intense in the UAF than in the SAF channel. This interesting feature can
be explained by a protrusion of the lipids growing beyond the interface and the maximum
detection efficiency of SAF. Since the SLB formation implies a preliminary washing of most
of the unbound lipid vesicles, lipids clusters should not have been caused by residual vesi-
cles and were more likely formed from the interfacial lipids themselves which protruded
above the bilayer. It is interesting to point out that the minimum Aβ concentration for the
formation of these lipid clusters coincides with the concentration at which peptide aggre-
gates were observed in PBS (cfr. Section 3.1.3). Therefore, it might be an indication that
peptide aggregation and lipid clustering are two concerted events. The clustering of lipids
also depended on the lipid composition: again, cholesterol-containing membrane (SLB 2)
accelerated the formation of the fluorescent lipid aggregates.
When Aβ concentration reached 50 µM, the formation of dark areas in the SLB could
be observed after approximately 15-24 hours of incubation with the peptide (Figure 28 b).
Such dark areas are likely attributed to a local desorption of the two lipid leaflets from the
interface. These “holes” within the SLB had an initial diameter around 2-3 µm. The forma-
tion of smaller pores with a diameter size of 16 nm have been reported after 20 min for Aβ
directly mixed with liposomes[244]. But such small pores were beyond the lateral resolu-
tion of our microscope (550± 50 nm). A longer monitoring showed the holes spreading
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Figure 29: Scheme of the hypothesized mechanism of toxicity of Aβ upon interaction with a lipid
bilayer. A progressive and concentration/aggregation-dependent lipid removal process
leads to a thinning and potential disruption of the SLB.
among the SLB and consequently resulted in a bilayer disruption. A comparison between
Aβ (1-40) and Aβ (1-42) was attempted but no reproducible trend could be observed. Both
peptides yielded similar impacts on the SLBs, with the most critical effects exhibiting varia-
tions between the two peptides from one experiment to another (i.e. the time of incubation
before the clustering of lipids or the disruption of the SLB).
From these results it appears that a part of the toxicity of the two amyloidogenic pep-
tides could arise from a progressive and concentration-dependent lipid removal process
(Figure 29). The interactions with the peptides can induce an extraction of some lipid
molecules from the bilayer, resulting in a decrease of fluorescence and thinning of the
membrane when the lipid-peptide complex desorbs from the surface. These extracted lipid
molecules could have clustered as a side-effect of the aggregation between peptides en-
countered at higher concentration, assuming that each peptide maintained its interaction
with the extracted lipids while aggregating. At some point, the aggregated lipid-peptide
structures may become too massive and unstable to withstand the flow of solution inside
the measuring cell, hence being washed away and forming holes within the bilayer. These
holes can eventually yield the disruption of the SLB. This hypothesis is in agreement with
other theories despite the discrepancies in SLB compositions, affinities or steady-state ex-
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periments within these studies[211, 235].
Although a concentration of 50 µM Aβ is physiologically irrelevant[243], lower concen-
tration of the peptide also yielded a loss of fluorescence, which is still attributed to an
extraction of lipid molecules. This effect could be sufficient to destabilize the structure of
the membrane bilayer by reducing its thickness. Such event can hinder biological functions
localized around the membrane and eventually promote cellular death.
3.2.3 Influence of the interaction with Amyloid-β on the diffusion coefficient of supported
lipid bilayers
Another important feature of lipid bilayers is the intrinsic mobility of lipid molecules and
their lateral diffusion within the lipid leaflets[75, 245]. Fluorescently labelled SLBs were
studied by SAF-FCS upon incubation with Aβ at different concentrations, using the sig-
nal collected by the SAF channel. Fluorescence correlation plots were then fitted with a
2-dimensional diffusion model. Fitting allowed calculation of the diffusion coefficient (DL)
which quantifies the lateral diffusion of lipid molecules inside the SLB (equations 4 and 5,
Table 4). When monitoring random areas of the bilayer, SLB 1 incubated with Aβ (1-40) did
not exhibit any significant change in the diffusion of its lipids, no matter how high was
the concentration of Aβ (1-40).
On the other side, Aβ (1-42) eventually decreased the diffusion of the lipids at a concen-
tration of 25 µM. This effect appeared after at least 3 hours of incubation. Such a delay
before displaying any impact on the DL of lipids likely correlates this influence with the
formation and adsorption of the aggregated peptide species. The formation of oligomers
has been observed with 5 µM Aβ (1-42) within an hour of incubation with SLB (cfr. Sec-
tion 3.1.3) but if they were still present during these FCS experiments, they seemed unable
to influence the diffusion coefficient of the SLB. Previous SAF imaging of the peptides
showed that after the time of incubation required to decrease the DL of lipids, massive flu-
orescent aggregates were already formed on the surface (see Figure 16 c). The difference
of influence between Aβ (1-40) and Aβ (1-42) could come from their difference of affinity
for the lipids and/or the size and amount of their aggregates (cfr. Section 3.1.7).
The affinity of each peptide for the SLB has already been characterized and seemed too
similar to exert a real influence of the hindrance of the lipids (Section 3.1.3).
The fact that the only peptide to promote an impact on the diffusion of the lipids was Aβ (1-
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DL of SLBs (×10−12m2s−1) before incubation after 20 h of incubation
SLB 1
0.5 µM Aβ (1-40) 2.88± 0.22 3.01± 0.10
5 µM Aβ (1-40) 2.78± 0.27 3.06± 0.07
50 µM Aβ (1-40) 2.91± 0.11 3.14± 0.05
0.5 µM Aβ (1-42) 2.94± 0.42 2.91± 0.40
5 µM Aβ (1-42) 2.96± 0.15 2.43± 0.06
25 µM Aβ (1-42) 2.95± 0.38 1.90± 0.18
SLB 2
0.5 µM Aβ (1-40) 1.43± 0.42 1.53± 0.39
5 µM Aβ (1-40) 1.23± 0.54 1.17± 0.13
50 µM Aβ (1-40) 1.89± 0.32 1.51± 0.40
0.5 µM Aβ (1-42) 1.36± 0.28 1.21± 0.46
5 µM Aβ (1-42) 1.61± 0.12 1.43± 0.35
25 µM Aβ (1-42) 1.31± 0.23 1.35± 0.17
Table 4: Values obtained for the diffusion coefficient of SLB 1 and 2 before and after 20h of incuba-
tion with both types of Aβ peptide.
42), and its higher propensity to aggregate, support the oligomeric hypothesis. In addition,
the hindrance of the lipids diffusion required a time of incubation with the peptides long
enough to assume that oligomers have been formed. This could be regarded as another
proof of the oligomeric nature of toxic Aβ , if the condition for the hindrance of the lipids
diffusion coincides with the adsorption of aggregated peptides.
SLB 2 was incubated with the same conditions, but no modification of DL was detected
after one day of incubation, even with Aβ (1-42). The absence of influence on the diffusion
of lipids is thought to come from the liquid-ordered phase within the SLB. Liquid-ordered
phase naturally slows down the diffusion of lipids, as showed by the value of DL before
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Figure 30: Plot of the change in diffusion coefficient of SLBs before and 20 hours after incubation
with Aβ (DL after/DL 0) in function of the concentration of peptide. DL has been calcu-
lated from SAF-FCS with both 2 and 3-dimensional fitting.
incubation and in Section 3.2.1. Therefore, Aβ aggregates probably diffused faster than the
lipids in SLB 2 and lost the property to hinder the motion of the lipids to which they bound.
This result indicates that the intrinsic mobility of the adsorbed peptide species could also
be an important factor to determine their ability to slow down the lipids diffusion.
From the previous conclusion came the idea that lipids only lost their freedom of motion
if they were bound and "anchored" on slower peptide aggregates which hindered their dif-
fusion. In that case, affected lipids should be dragged by the motion of Aβ ’s and follow
their displacements. But the motion of peptides is not limited to 2-dimensional translation,
as they might desorb and diffuse in the bulk solution. To uncover similarities between
the diffusion of lipids and peptides, the results of SAF-FCS for the SLB were also fitted
with the SAF-3D model. The values for DL obtained with the SAF-3D model were 10-folds
lower than with the 2D model, probably because the diffusion of the lipids was to slow for
a fitting assuming axial motion. But interestingly, the ratio of change in DL before and after
incubation with peptides (DL after/DL 0) was conserved (Figure 30). This result suggests
that the same movements are responsible for the fluctuations of fluorescence of the SLB,
before and after incubation.
Indeed, the diffusion of lipids before incubation is obviously limited to lateral diffusion
at the top of the interface, while the direction of diffusion of lipids after incubation was
yet unknown. If new directions of diffusion after incubation with Aβ had been observed
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(i.e. if the lipids have diffused axially) the ratios DL after/DL 0, both calculated by 2D or
SAF-3D fitting, would have given different results. On the contrary, identical ratios meant
that only the speed of diffusion was modified, but the direction of diffusion remained
identical. Since the initial diffusion of lipids is only lateral, similar motion before and after
incubation with Aβ implies that the targeted lipids are still diffusing by lateral translation
only. This is in contradiction with the previous assumption that peptides dragged the lipid
molecules interacting with them. However, the latter results were obtained by targeting ho-
mogeneous areas of the lipid bilayer (according to SAF imaging). When targeting the lipid
clusters mainly visible in UAF (cfr. Section 3.2.2) and fitting the FCS curves with the SAF-
3D model, their DL reached a value of (1.99± 0.17)× 10−12m2s−1 which was close to the
coefficient of diffusion of Aβ (1-42) aggregates. Similar DL for the peptides and the lipids
with SAF-3D fitting tends to confirm the hypothesis of lipids dragged by Aβ oligomers. It
is concluded that Aβ was only able to influence the diffusion of lipid molecules within the
SLB when the bigger oligomers were formed and massively adsorbed on the bilayer. The
diffusion of lipids hindered by the peptides was still limited to lateral diffusion for the
lipids forming the bilayer. On the other side, lipids already extracted from the bilayer and
clustered above the surface were dragged and followed the motion of the peptide, which
behaved like a lipid-carrier.
The last hypothesis still raised some contradiction with the previous experiments about
the bilayer integrity. Since Aβ (1-40) successfully promoted lipid removal from the surface
at the highest concentrations, it should also exhibit some of the oligomeric structures able
to hinder the lipid diffusion(see Section 3.2.2). Hence, the FCS experiment was adapted:
instead of averaging the diffusion of random spots of the SLB, lipids were specifically tar-
geted around the disruption of the bilayer (Figure 31 a, b). After fitting with a 2D model,
correlation curves showed that lipids next to a damage in the bilayer indeed had a slower
diffusion coefficient, hence a reduced mobility (Figure 31 b). Not only that, but the reduc-
tion of mobility was inversely correlated with the distance from these damages (Figure 31
c). Beyond a distance of 14-15 µm from the disruption of the SLB, lipids incubated with Aβ
(1-40) showed no reduction of DL anymore, like described in the beginning of this section.
On the contrary, incubation with Aβ (1-42) generally induced a reduction of lipids DL even
further from the holes in the SLB. It is concluded that the previous model is still valid : a
hindrance of lipid motion is obtained when massive oligomeric species are adsorbed on
80 fluorescence measurements
Figure 31: (a) SAF imaging of SLB 1 after 6h of incubation with 50 µM of Aβ (1-40) and localization
of FCS monitoring spots. (b) Corresponding autocorrelation curves of SLB 1 with anno-
tation of the diffusion time (τD). (c) Comparison of the change in diffusion coefficient
of SLBs before and 20 hours after incubation with Aβ (DL after/DL 0) in function of the
distance from the disruption of the bilayer.
the SLB. This condition is easily fulfilled when the bilayer is incubated with Aβ (1-42), but
is only met around the most critical damages of the SLB when incubated with Aβ (1-40).
3.2.4 Reversibility of the impacts of Amyloid-β on supported lipid bilayers
Different effects were elaborated in the previous sections, due to the interaction between
SLB and peptides. Additionally, the reversibility of the adsorption of Aβ on SLB was in-
vestigated in Section 3.1.4. Therefore, the subsequent reversibility of its effects was also
enquired. fluorescent SLB 1 was incubated with 25 µM Aβ (1-42) during 20 hours, then the
flow of sample was exchanged with pure PBS in order to rinse the surface from adsorbed
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Figure 32: SLB was incubated during 20h with 25 µM Aβ (1-42), subsequently washed with PBS
and not washed, respectively. (a) Evolution of the SAF intensity of SLB incubated with
Aβwith and without rinsing step. (b) Evolution of the diffusion coefficient DL of SLB cal-
culated from SAF-FCS with 2D fitting. DL dropped during incubation with the peptide,
then returned normal value after washing Aβ .
peptides. Obviously, the rinsing of adsorbed peptides did not reverse the fluorescence loss
encountered by the SLB. However, the decrease of fluorescence was stopped around the
actual value reached before washing, while prolonged incubation maintains the loss of flu-
orescence until lower values (Figure 32 a). This result implies that the process responsible
for lipid loss was quenched when Aβ was removed from the surface. From Section 3.1.4
it is known that few peptide species remain on the surface after rinsing but their impact
on SLB is then too small to induce more desorption of lipid molecules from the surface.
On the other side, the diffusion coefficient of lipids was also measured after washing Aβ
(Figure 32 b). DL decreased of about 30 % after few hours of incubation with 25 µM Aβ (1-
42), like in previous section. Interestingly, the rinsing procedure induced a reversion of the
mobility hindrance, back to normal diffusion after ca. one hour. This result confirmed the
assumptions made concerning the influence of Aβ on the diffusion of lipids. It is known
from Figure 19 a,b and c that only the smallest peptide species remained adsorbed on
the SLB after washing. In the present experiment, the desorption of bigger oligomeric
species through washing is associated with a recovery of the normal diffusion of the lipid
molecules. Also, the delay for recovery of original DL (approximately one hour) matches
the delay to reach the minimum of SAF intensity during the rinsing of fluorescent peptides
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Figure 33: Comparison of the SAF signal of SLB 1 incubated during 48 hours with Aβ (1-42) dis-
solved either in pure PBS or buffer containing 2 mM Ca2+.
(cfr Figure 19 d). This is considered as another proof of the oligomeric nature of the most
harmful Aβ species.
3.2.5 Influence of calcium ions on the effects of Amyloid-β on supported lipid bilayers
The influence of calcium ions on the adsorption process of Aβ has already been inves-
tigated in Section 3.1.5. It was found out that Ca2+ enhanced the adsorption and the
oligomerization of Aβ on SLB at low concentration (below 5 µM) when compared to pure
PBS solvent. Therefore, it was expected that calcium could also influence the effects of
the interaction of the peptides on the SLB. fluorescent SLB 1 was incubated with Aβ (1-
42) dissolved at different concentrations in PBS buffer containing 2 mM Ca2+. The results
were compared with the effects observed in previous sections when Aβ was dissolved in
pure PBS. Calcium ions enhanced the decrease in fluorescence of SLB when interacting
with the peptides at 0.5 µM (Figure 33). This outcome has several possible explanations.
As Ca2+ triggers the oligomerization of Aβ peptide at low concentration, it may promote
more damaging within the SLB since oligomers are thought to be the most toxic species.
Additionally, dynamic simulations showed that calcium ions stimulate a deeper insertion
of Aβ inside the bilayer[232], which is correlated with a stronger disordering or thinning
3.2 fluorescent supported lipid bilayer 83
DL of SLB 1 (×10−12m2s−1) before incubation after 20 h of incubation
5 µM Aβ (1-42) in PBS 2.96± 0.15 2.43± 0.06
25 µM Aβ (1-42) in PBS 2.95± 0.38 1.90± 0.18
5 µM Aβ (1-42) in Ca2+ 2.78± 0.20 2.39± 0.17
25 µM Aβ (1-42) in Ca2+ 2.81± 0.32 2.04± 0.22
Table 5: Comparison of DL values of SLB 1 incubated with Aβ (1-42) in PBS and with 2 mM Ca2+.
effect[246, 247]. Stronger disordering or thinning of the SLB means that the interactions be-
tween lipid molecules are weaker, hence more easily extracted out of the bilayer by Aβ . An-
other straightforward explanation is based on the previous conclusion that lipid removal
is a concentration-dependent process. Since calcium ions increase the amount of adsorbed
peptide – aggregated or not - the amount of extracted lipid molecules would be enhanced
as well. Nevertheless, a conclusion similar to the adsorption experiment (Section 3.1.5)
was made when the concentration of peptide was increased to 5 µM. At this concentration,
the adsorption and aggregation features of Aβ were identical when dissolved in PBS or
Ca2+ buffer. Similarly, the loss of fluorescence induced by 5 µM Aβ was identical for both
buffer. This tends to favor the idea that calcium acted through an enhanced adsorption
and oligomerization rather than a disordering effect.
Finally, the influence of the peptide over the mobility of the lipid was measured by
FCS. The values of DL of the lipids after incubation with the peptide in Ca2+ are close to
those obtained when Aβ is dissolved in PBS (Table 5). It was concluded in the previous
sections that the aggregation state of the peptides interacting with the SLB was the critical
parameter to influence the diffusion of the lipids. Since there was no further reduction of
the diffusion coefficient of SLB, the aggregation of high concentrated peptides interacting
with the SLB seemed unaffected by the change of solvent. This conclusion excludes an
enhanced oligomerization of Aβ at high concentration in Ca2+ buffer, compared with PBS.
Such outcome was predictable since the minimum concentration to observe an effect on
the diffusion coefficient of lipids was beyond 5 µM. At this concentration, it was already
observed that the aggregation process between Aβ peptides exhibited no change regarding
the buffer used for dilution.

4
R A M A N M E A S U R E M E N T S
4.1 raman spectroscopy of supported lipid bilayer
4.1.1 Detection of supported lipid bilayer in standard conditions
Raman spectroscopy is a label-free characterization technique whose sensitivity is lower
than fluorescence but gives an insight in the structure of the sample. The effects of the
interaction between Aβ and SLB were investigated in the previous chapter, but the re-
sults lacked details about the molecular structure of the molecules. Raman spectroscopy is
an ideal complementary method. Despite the fact that collected photons are inelastically
scattered instead of emitted, the principles behind the supercritical angle spectroscopy
technique can also be applied to Raman signal. Therefore, it was attempted to characterize
specifically the molecules involved in the interactions between Aβ and the SLB, namely the
molecules situated near the interface, by collecting the photons scattered above the critical
angle.
Such technique of characterization was referred to as supercritical angle Raman (SAR).
Classical Raman spectroscopy - or undercritical angle Raman (UAR) - was simultaneously
performed. First, the structure of the SLB 1 was investigated with SAR/UAR. A fluorescent
imaging control was performed to assess the proper formation of the bilayer on the surface,
while another fluorescence-free sample was used for Raman measurements. Although the
formation of the bilayer could be confirmed by fluorescence, it was found out that the cur-
rent system could not collect the Raman scattering from a unilamellar bilayer with SAR,
nor with UAR (Figure 34). The thickness of the SLB was measured to be only 4.93 nm[160],
fact that leads to a clear dominance of supernatant water molecules background in the
UAR spectrum, despite their intrinsic low Raman scattering cross-section. The interfacial
selectivity of the supercritical angle system prevented dominance of the water band at 3300
cm−1 in SAR. However, the characteristic peaks of the lipid molecules were still not visible.
As mentioned previously, the thickness of the SLB probably limited the amount of photons
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Figure 34: (a) SAF imaging of SLB 1. (b) corresponding SAR spectra of SLB 1 compared with pure
water.
scattered by the lipids, a drawback combined with the intrinsic low sensitivity of Raman
spectroscopy. These features explained the difficulty to detect the SLB. This disadvantage
was confirmed in other reports, therefore the study of such membrane model via Raman
spectroscopy is usually achieved by the use of enhancement techniques[248–250].
From the last results, it was concluded that a unilamellar SLB would not influence the Ra-
man spectrum of an experiment with both lipids and peptides. In other words, the Raman
signal of Aβ will not be disturbed by the scattering of the SLB, and will only display the
structure of Aβ .
4.1.2 Detection of supported lipid bilayer vesicles or multilayer
"Signal to noise" ratio of the SLB seemed to be the critical parameter to achieve its detection
with Raman. To confirm that the reduced amount of lipid molecules in the SLB was the
cause for its absence of Raman signal, measurements were performed while targeting spe-
cific areas of the sample exhibiting multilamellar bilayers or undisrupted vesicles. These
lipid structures were expected to gather enough molecules to overcome the dominance of
water background and to emit enough signal for its detection in UAR or SAR. Omission of
the extrusion process described in Chapter 2 yielded this stacking of phospholipids since
discrepancies in the size of the vesicles by preventing a proper disruption and fusion into
a single bilayer. The use of a minute amount of fluorescent lipids permitted to specifically
target these stacking areas by fluorescent mapping of the sample. The collected spectra
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Figure 35: (a) SAF imaging of lipid multilayers/vesicles typical of SLB 1 without the extrusion
step. (b) corresponding SAR/UAR spectra of multilamellar lipids structure/vesicles with
minute amount of DOPE-Atto647. See Section 4.1.2 for the interpretation of the peaks
displayed a great fluorescence band component, yet the peaks protruding from the fluores-
cence baseline allow the characterization of the lipids and proved this method to overcome
the low amount of signal of a single SLB which prevented its detection.
The main component of the SLB being DOPC, its Raman spectrum served as reference for
the interpretation of the following results. The C=O ester stretching vibration was detected
at 1742 cm−1 (1) and the peak around 1665 cm−1 (2) corresponded to C=C stretching vi-
bration from unsaturated fatty acid chains. A sharp CH2 scissoring mode at 1451 cm−1 (3),
a small CH2 twisting mode at 1309 cm−1 (4) and =C-H in plane deformation at 1265 cm−1
(5) were also observed, although these last two peaks are broadened in the SAR spectrum.
Another broad band situated at 1084 cm−1 (6) was attributed to C-C stretching mode. The
interpretation of the peaks at 2872 cm−1 (7) and 2902 cm−1 (8) in the CH region was
more suspicious since their shape fitted exactly the CH2 symmetric stretching and fermi
resonance peaks, appearing normally at 2847 cm−1 and 2882 cm−1 in references[251]. One
sharp peak at 958 cm−1 (9) corresponded to O-P-O symmetric stretching and was specific
of the SAR spectrum, hence the interfacial region[252]. The intensity of this peak might be
caused by the packing of lipid polar head near the interface.
In conclusion, the Raman spectra of lipid molecules could be obtained without enhance-
ment techniques by targeting multilamellar structures and increasing the amount of lipids
inside the detection volume. However, these multilamellar structures are not observed
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with the protocol of the experiments with Aβ . Therefore, other methods should be tested
in order to observe both the lipids and the peptides simultaneously with Raman.
4.1.3 Surface-enhanced-Raman spectroscopy of supported lipid bilayer
Apart from the stacking of lipid molecules, many other techniques are available to in-
crease the Raman signal of the sample. Among them, the use of plasmonic resonance
produced by silver or gold nanoparticles on vibrational light scattering is widely used
and known as surface-enhanced Raman spectroscopy (SERS). Various methods are used
to bring those metal plasmon in the vicinity of the sample. In this experiment, the knowl-
edge of our group to synthesize silicon nanofilaments (SNFs) functionalized for chemical
catalysis was exploited. SLB 1 was formed on the surface of a SNFs layer synthesized from
trichloromethylsilane (TCMS) and functionalized with gold nanoparticles (average diam-
eter size of 7.5 nm) (Figure 36 a). The nanofilaments were synthesized and characterized
by Zhang Xiaotian. Plasma treatment of the nanofilaments ensured that the substrate was
still hydrophilic to allow the proper adsorption of lipid vesicles.
The formation of the SLB on both unfunctionalized and gold-embedded SNFs was as-
sessed by fluorescence control before Raman experiments. SAF imaging of the surface was
possible although the focus could not be as precise as in other measurement, due to the
absence of water molecule directly above the glass coverslip. The successful formation of
the SLB was confirmed, but the bilayer exhibited some defects as the surface was less
homogeneous than for SLBs directly adsorbed on a glass slide (Figure36 b). The mobil-
ity of the SLB was also affected by the substrate, as showed by SAF-FCS measurements
(Figure 36 c). Fitting of the correlation curve with a 2-dimensional model yielded a DL
of (1.54± 0.67)× 10−12m2/s which is slower than the diffusion of normal SLB 1. How-
ever, those defects were considered not problematic for the Raman experiments, since this
technique will be used to extract information about the chemical structure and bonding,
not about the general morphology of the bilayer. Following fluorescence controls, Raman
measurements were conducted with a non-fluorescent SLB.
Two additional control experiments were performed before performing the SERS mea-
surements, to check the influence of the SNFs on the spectrum. Raman scattering of lipid
vesicles/multilayers were recorded for lipid adsorbed on the surface of unfunctionalized
SNFs (without gold nanoparticles, hence without surface-enhancement), and for SLB de-
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Figure 36: (a) Scheme of the SERS technique: gold nanoparticles embedded in silicon nanofilaments
serve as a support for the formation of the SLB. (b) SAF imaging of the SLB 1 formed on
nanofilaments substrate. Examples of defects are depicted by the white arrowheads. (c)
correspondent SAF-FCS curve of SLB.
posited on coverslip simply covered by a 20 nm layer of gold (i.e. similar to the standard
method for SERS). The latter was used to provide the surface-enhancement effect without
the physical influence of the SNFs bed.
The UAR spectra of lipids formed on SNFs without gold nanoparticles and on bare glass
were identical (Figure 37 a), adding another proof that the deposition of the lipids on the
SiNFs carpet did not cause severe alteration of the lipid structure. Peaks of the lipids were
observed at 1659 cm−1, 1448 cm−1, 1303 cm−1, 1270 cm−1 and 1082 cm−1; correspond-
ing to C=C stretching vibration, CH2 scissoring mode, CH2 twisting mode, =C-H in plane
deformation and C-C stretching mode respectively.
On the other side, the presence of the gold layer or gold nanoparticles profoundly affected
the Raman scattering of the lipids (Figure 37 a). A CH2 scissoring mode peak at 1430
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Figure 37: (a) Comparison of the UAR spectra of lipids deposited on a hydrophilic glass slide, on
SNFs, on SNFS functionalized with gold nanoparticles and on glass covered with a 20
nm thick layer of gold. (b) Comparison of the different UAR spectra obtained with SERS
effect. The inserted spectrum is the SERS of 1-nitropyrene on a layer of silver (from [253]).
cm−1 was the only lipid vibration remaining in the 500-2000 cm−1 range when the SLB
was formed on the layer of gold. Another peak observed at 1563 cm−1 was unexpected
and will be discussed below.
By comparison, the UAR spectra of SLB formed on gold-functionalized SNFs exhibited
sharp peaks characteristic of lipids (Figure 37 a). Those peaks coming specifically from
the vibration of the lipids will be extensively detailed with the analyze of Figure 38.
However, an intense peak at 1566 cm−1 was observed and recalled the previous peaks
obtained with a simple layer of gold. Another peak at 1339 cm−1 was also visible. The
interpretation of these two peaks was troublesome, since they correspond to the vibration
of aromatic/hetero-ring and nitro-compound containing nitrogen atoms. In Figure 37 b,
the inserted spectrum obtained from SERS of 1-nitropyrene on a 80 nm layer of silver also
showed a high similarity, which seemed to confirm the origin of those vibrations. However,
those chemical vibration unlikely originated from the lipid sample and did not correspond
to the Raman spectrum of the objective oil either (whose peaks could have affected the spec-
tra due to an improper focus). The maximum intensity of these peaks was correlated with
an exact focus on the surface of the coverslip covered with gold, and any displacement
of the focus of few nanometers was enough to discard these vibrations. More importantly,
these peaks could be observed even in the absence of any sample or background buffer
(Figure 37 b). It seemed that these two peaks specific from gold substrate or nanoparticles
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Figure 38: Surface-enhanced SAR and UAR spectra of SLB 1 formed on the layer of SiNFs function-
alized with gold nanoparticles to perform surface-enhanced Raman spectroscopy.
were due to the photoluminescence effect of the metal[254]. The origin of the photolumines-
cence is the same than the enhancement effect of SERS and consists in an amplification of
the electric field around the metal (approximately until 10 nm away from the surface plas-
mon). Therefore, the background signal of the layer of gold likely has hidden the scattering
of the SLB deposited on it. On the other side, gold nanoparticles disseminated within the
SNFs layer did not overload the Raman spectra with the metal photoluminescence, while
still allowing the SERS effect to amplify the signal of the SLB.
Apart from the gold photoluminescence, the SNFs functionalized with gold nanoparticles
used for SERS (UAR) and the supercritical angle equivalent (SESAR) allowed the detection
of photons scattered by a single supported bilayer (Figure 38). The peak at 1750 (UAR)
/ 1725 (SAR) cm−1 (1) is identified as C=O ester stretching vibration. SAR spectrum dis-
played a peak at 1630 cm−1 (2) attributed to C=C stretching vibration from fatty acid
chains. The correspondent peak in UAR is broadened by the photoluminescence effect
and shifted at 1615 cm−1. Both the C=O and C=C stretching peaks exhibited a red-shift
toward smaller wavenumbers with both detection angles when compared with reference
experiments. This is associated with a lower frequency of vibration. Since the deposition
of lipids on SNFs did not yield any change in the Raman spectra, their reduced frequency
of vibration is possibly the consequence of the gold nanoparticles which can hinder the
vibrations of the chemical bonds if they desorbed from the SNFs. Such desorption of the
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nanoparticles was indeed observed when using the functionalized SNFs for chemical catal-
ysis. The interaction of gold nanoparticles with lipid bilayer has been reported to increase
the ordering of the lipid phase[255], which in turn is expected to yield a decrease of the
frequency of vibration[256].
The peak at 1448 cm−1 (3) was easily attributed to CH2 scissoring mode, while the peaks
at 1339 cm−1 (4) and 1274 cm−1 (5) in UAR might correspond to blue-shifted CH2 twist-
ing mode and =C-H in plane deformation respectively. The last peaks at 2895 cm−1 (6) and
2947 cm−1 (7) were typically in the CH region and attributed to CH2 and CH3 asymmetric
stretching.
This experiment showed that the detection of an unilamellar supported lipid bilayer on
SNFs was made possible by the SERS technique, and can be applied to the supercritical
angle collection of scattered photons. However, some shifts were observed for the peaks of
the lipids, mainly attributed to an influence of the gold-functionalized environment. Even-
tually, the SERS/SESARS technique might be used to simultaneously gather information
about the structure of the SLB and Aβ peptides when they interact together.
4.2 raman spectroscopy of peptides
4.2.1 Detection and characterization of Bovine Serum Albumin
Raman spectroscopy can be used to characterize polypeptide chains by analyzing specific
regions of the spectrum which reflects the secondary structures present within the protein.
As it was the first time that the supercritical angle technique was used to detect Raman
signal of proteins, the first experiments consisted to ensure the efficient detection and
characterization bovine serum albumin protein (BSA). Indeed, the detection of the Raman
signal of proteins can be challenging due to the low probability of a photon to be inelas-
tically scattered and because of the small Raman cross-section of polypeptides[257]. BSA
was a good starting target because of its size and inexpensive acquisition. Furthermore,
its native structure is well known and consists mainly of α -helix. Therefore, different con-
centrations of BSA were dissolved in distilled water and Raman spectra were acquired for
both UAR and SAR detection.
Figure 39 (a) displays the SAR spectra acquired for concentration ranging from 10 to 60%
(w/v). At the lowest concentration, almost no signal could be distinguished with certitude
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Figure 39: (a) SAR spectra of BSA protein at different concentrations (w/v) in distilled water. (b)
SAR and UAR spectra of BSA protein at 60% (w/v) in distilled water.
from the background. This was not surprising considering both the low sensitivity of Ra-
man spectroscopy for peptides and the small volume of detection with the SAR technique,
limiting the amount of sample (cfr. Section 4.1.1). Starting from 20% (w/v) the peaks from
the CH2 scissoring mode (1467 cm−1) and the amide I region (1640-1690 cm−1) protruded
slightly from the background. A small but sharp peak was observed at 1651 cm−1 and
characteristic of the expected α -helix. However, at 40% (w/v) this α -helix peak became
broadened in a larger, dominant peak at 1674 cm−1. This peak was also dominant at 60%
(m/v) BSA. In the literature, such Raman shift in attributed to β -sheet secondary structure.
β -sheet is not typical of BSA protein, but is often related to toxic aggregation processes of
polypeptides. The conversion of BSA α -helix structure into β -sheet after some aggregation
process was surprising but not inconceivable since it was met at the highest concentra-
tions. At 60% (m/v) - which was equivalent to 10 mM of BSA - the sample even turned
into a "gel-like" solution due to the high density of proteins. In these conditions, the pro-
teins were likely to interact and aggregate. This is a disadvantage of the low sensitivity
of SAR, since it requires concentrations so high that the aggregation process dominates
native structures. Additionally, such "gel-like" solution might be inconvenient to handle.
Besides the peak from amide I, the peak of CH2, the peak of tryptophan residues (1342
cm−1) and amide III (1271 cm−1) were also visible at higher concentrations. The same re-
sults were obtained when analyzing the UAR spectra (Figure 39 b) although the signal was
more intense and had a better resolution. This effect is thought to be caused by the bigger
volume of collection of the UAR technique, which exhibits no exponential decay in the
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Figure 40: (a) UAR spectra of BSA protein at different concentrations (w/v) in distilled water and
after 24h of solvent evaporation. (b) Comparison of UAR spectra of BSA protein at 5%
(w/v) in distilled water and ethanol.
efficiency of collection and more scattered signal. The presence of bands around 1531 and
1568 cm−1 is characteristic of indole rings - from which tryptophan is a derivative - and
was the only significant difference between the peaks of UAR and SAR. The UAR spectrum
itself, however, was found to exhibit a specific broadband envelope underlying the peaks
in the whole range of Raman shift (Figure 40 a). This broadband was first thought to be
caused by fluorescence of the sample (like showed in Section 4.1.2) but prolonged exposi-
tion in order to photobleach the sample did not alter its intensity. Furthermore, a decrease
of the volume of water in the sample also promote the disappearance of this broadband.
On the other hand, an increasing concentration of protein resulted in an increase of both
the intensity of this broadband and the peaks of protein. Finally, a change of solvent for
ethanol decreased the intensity of the broadband for an equivalent concentration of BSA
(Figure 40 b). All these features excluded the fluorescence explanation as the source of this
broadband. It was previously observed and referred to as "pseudo-Raman" band because
of the incompatibility with fluorescence process [258]. This pseudo Raman band was sup-
posedly caused by the interactions between the polypeptide chains. Water exhibited the
greatest broadband because the solvent composed of the smallest molecules maximized
the interaction between the proteins. The size of ethanol molecules allowed fewer interac-
tions between the polypeptide chains, hence yielded a smaller broadband when used as a
solvent.
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Figure 41: (a) Comparison between the SAR spectra of the 60% (w/v) BSA sample before and after
solvent evaporation. (b) Evolution of the Amide I region of the SAR spectra from 20%
(w/v) BSA with progressive solvent evaporation.
However, dissolution in water was the prerequisite to mimic the natural interaction
between peptides and SLB, despite the concentration being the limiting factor of SAR. A
solution to partially overcome the need for high concentrations without relying on surface-
enhancement techniques was inspired by Angelis et al[259]. They used superhydrophobic
surfaces to let a droplet of highly diluted sample evaporate, hence concentrating the solute
inside an almost perfect sphere maintained by water repulsion. Although the SLB was not
a superhydrophobic substrate, progressive evaporation of the solvent would concentrate
the targeted proteins on the top of the surface, accessible to both SAR and UAR detection.
Constant recording of the Raman signal allowed to detect the characteristic peaks of the
proteins before complete evaporation of the solvent. In this way, the secondary structure of
the protein could be elucidated as soon as the collection of photon is sufficient. Therefore,
the technique was attempted with a BSA sample. First, a comparison between diluted
and dried BSA at 60% (m/v) was made. The dryness of the sample and the consequent
concentration reached at the surface drastically enhanced the detection and resolution
of the Raman peaks (Figure 41 a). In a second attempt, a solution of 20% (w/v) BSA
was monitored during several hours with SAR spectroscopy. The progressive evaporation
of the solvent rendered possible the detection of amide I peaks (Figure 41 b). The most
interesting observation was that the amide I peak of native α -helix could be detected
at 1653-1660 cm−1 before the concentration is high enough to induce aggregation into
another structure. From these results, it was expected that even Aβ might be detected and
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characterized with SAR despite the smaller size of this peptide, if the solvent is let to
evaporate. However, it must be noted that the concentration estimated for SAR detection -
roughly between 20 and 40% (w/v) - would represent a larger molar concentration for Aβ
than for BSA (typically between 50 and 100 mM Aβ ).
4.2.2 Differentiation of two proteins according to axial distance
The strength of supercritical angle spectroscopy is its selectivity for surface-bound emit-
ters. While the detection and characterization of BSA has been achieved with both SAR
and UAR in the previous section, the results showed an unique structure for both angles
of detection, hence did not exploit the axial distinction of the two techniques when they are
combined. In the following experiment, the success of this feature was tested through the
detection of two proteins of known and distinguishable structures, whose axial separation
and confinement was predictable.
This was accomplished by functionalization of a glass coverslip with biotin molecules. Bi-
otin was covalently linked through amide bonds after an amino-silylation of the glass
surface. The coverslip was then incubated with a first solution of streptavidin, which is
known to form one of the strongest non-covalent interactions with biotin and topped with
a solution of BSA. Therefore, a sample expected to yield surface-bound streptavidin and
bulk supernatant BSA would be differentiated by SAR/UAR combination (Figure 42 a).
First, the success of the substrate biotinylation was checked with attenuated total re-
flectance infrared (ATR-FTIR) spectroscopy (Figure 42 b). The starting step was the amino-
silylation of the glass surface with 3-aminopropyl triethoxysilane (APTES) dissolved in
toluene. All the IR spectra displayed an intense and broad peak in the 1000 cm−1 region
attributed to Si-O-Si network bonds. The peak also probably includes the Si-OH vibration
around 950 cm−1[260]. One of the asymmetric stretching modes of the Si-O-Si protruded
slightly more at 1155 cm−1 (1) after treatment with the APTES. Some other peaks were
more specific of the new chemical moieties. The new stretching modes of CH2 at 2932
cm−1 and 2886 cm−1 were initially absent from the glass slide. The absorption band be-
tween 3000 and 3300 cm−1 exhibited a particular shape which was associated with the
presence of symmetric and asymmetric stretching modes of NH2 (2), normally present at
3290 and 3300 cm−1[261]. Peaks at 1490 cm−1 (3) and 1567 cm−1 (4) were attributed to
NH2 deformation modes of the amine groups which, according to literature, are linked
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Figure 42: (a) Scheme of the experiment. A coverslip functionalized with biotin is used to ensure
the vicinity of streptavidin proteins near the surface, while BSA are floating in the bulk
solution. The former is expected to be detected by SAR while the latter would only be
detected in UAR. (b) ATR-FTIR spectra of the coverslip after each step of the functional-
ization with biotin.
through hydrogen-bonds with Si-OH group to form cyclic-like structures. Comparison
between the spectra of bare glass and glass after treatment with APTES confirms the suc-
cessful linkage of the amine group on the coverslip. The attachment of biotin molecule
was assessed with ATR-FTIR as well. The peak at 1567 cm−1 is still present but an amide
function at 1645 cm−1 (5) is slightly more protruding, indicating a partial attachment of
biotin to the glass via amide bonds. The intense peak at 1392 cm−1 (6) can be due to the
O-H bending of carboxylic acids, confirming that noncovalently bound biotin molecules
are still adsorbed on the sample. A final test of affinity was made by immersing the bi-
otinylated glass slide in a solution of fluorescent streptavidin for 1h, then by washing in
a PBS buffer and regular monitoring of the remaining fluorescence. By comparison with
a control coverslip without biotin, it was obvious that the functionalization of the glass-
slide permitted to retain more streptavidin than the control. Especially during the first two
hours when the gap is the most important, although the fluorescence intensity is still twice
higher after 20h of immersion in PBS. Therefore, a glass slide was subjected to the same
protocol and incubated with a solution of label-free streptavidin, on which was dropped
another solution of BSA. The final solution was composed of 40% (w/v) in streptavidin
and 20% (w/v) BSA, and was characterized with Raman spectroscopy (Figure 43).
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Figure 43: (a) Comparison of the remaining fluorescence between a control glass slide and a biotiny-
lated coverslip after incubation with fluorescent streptavidin (10 µg/mL) and continuous
washing in PBS buffer. (b) SAR and UAR spectra of the biotinylated coverslip incubated
with an first solution of streptavidin, then a solution of BSA (40% (w/v) and 20% (w/v)
respectively).
The UAR spectrum displayed three determinant peaks in the 1000-2000 cm−1 shift re-
gion. The amide I peak at 1659 cm−1 (1) and amide III peak at 1267 cm−1 (2) are attributed
to an α -helix secondary structure. Peaks from the CH2 scissoring and aliphatic side-chain
stretching vibrations are visible at 1458 cm−1 and 1322 cm−1 respectively. When compared
with literature, the shift and even the shape of these peaks seemed to faithfully match the
spectra of bovine serum albumin[262]. The SAR spectrum on the other hand brought a dif-
ferent characterization. The amide I peak was shifted at 1675 cm−1 (3), corresponding to
β -sheet structure which is typical of streptavidin protein. The discrepancy was even more
obvious for the amide III peak protruding at 1243 cm−1 (4), also attributed to β -sheet. The
tryptophan peak at 1554 cm−1 (5) is also slightly more resolved than in the UAR spec-
trum, as suggested by reference paper[263]. Although some influence from BSA could be
observed in the shape and width of the amide I and III peaks, the SAR/UAR comparison
could be used to successfully characterize two proteins in function of the axial distance
between their specific structure and the interface of the coverslip.
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4.2.3 Characterization of Amyloid-β
4.2.3.1 Amyloid-β (1-42)
In order to study the interaction between a lipid bilayer and Aβ , Raman spectroscopy was
used to elucidate the secondary structures exhibited by the peptide when adsorbed on the
surface of the lipids. Because of the relatively small size of the peptides (40 and 42 amino
acids), the secondary structure was considered to represent the general conformation of
the molecule despite the lack of resolvable tertiary structure. As stated in Section 4.1.1 and
Section 4.1.2, a standard unilamellar SLB could not be detected by classical Raman spec-
troscopy. Therefore, The Raman scattering of Aβ incubated on SLB 1 could be collected
without any contribution of the lipids in the resolved spectrum.
First, aliquots of Aβ (1-42) (0.22 mM - 0.1% (w/v)) were incubated on SLB 1. Because the
sensitivity of the classical Raman technique for the small peptide Aβ was really low, the
technique used to detect the signal of BSA was employed on Aβ samples (see Section 4.2.1).
Briefly, UAR and SAR signals were collected continuously et saved after averaging of 20
scans while the buffer was slowly evaporated. Special attention was given to the amide I
and amide III regions which contained the main information to elucidate the secondary
structure of proteins. Especially, the amide I peak was deconvoluted with Gaussian fitting
to characterize quantitatively the different secondary structures present within the sample.
Aβ (1-42) exhibited discrepancies between the UAR and SAR spectra (Figure 44 a). Firstly,
the UAR intensity was higher than SAR, and was explained by the bigger collection vol-
ume of the undercritical angle technique. In addition, the areas of the deconvoluted peaks
and their ratios were different between the UAR and SAR spectra. These variations of
the ratio between the deconvoluted peaks were independent of each spectrum intensity.
Finally, analogous peaks of UAR and SAR exhibited different Raman shifts. These observa-
tions showed that the Raman scattering - and by definition the structure - of the peptides
were influenced by their proximity with the interface and with the SLB.
Concretely, the SAR amide I of Aβ (1-42) could be deconvoluted into two peaks whose max-
ima were at 1660 and 1689 cm−1 respectively (purple and red in Figure 44 a). The former
had a shift value corresponding to a structure between an α -helix and a disordered struc-
ture, while the latter could be attributed to a β -sheet structure blue-shifted towards higher
frequencies of vibration. Both secondary structures seemed to appear in the supercritical
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Figure 44: (a) Amide I and III regions of SAR and UAR spectra of Aβ (1-42) incubated on SLB
1 after partial evaporation of the buffer (27h). (b) Hypothetical structure of Aβ (1-42)
adsorbed on SLB. α -helix (purple) is closer to the interface (detected in SAR) while β -
sheet structure (red) is dominant in bulk solution (detected in UAR).
angle scattering region, near the SLB. However, the β -sheet peak area only represented
46.9% of the α -helix peak, which was slightly dominant in SAR.
The UAR amide I was also deconvoluted into two peaks, situated at 1648 and 1683 cm−1
and attributed to α -helix and β -sheet. In the UAR spectrum, the area of the α -helix peak
only represented 3% of the β -sheet peak, and was hardly distinguishable from the base-
line. Another proof of the predominance of β -sheet in the UAR spectrum was found in the
amide III region where the peak at 1242 cm−1 was protruding from the baseline, and at-
tributed to the same β -sheet structure. This Amide III β -sheet peak was harder to observe
in the SAR spectrum, hence the structure was probably located further away from the SLB.
This reversed tendency of the secondary structure observed for Aβ (1-42) in UAR and
SAR was interpreted as a preferential folding towards the α -helix structure when the pep-
tide was close to the SLB. This explanation was in agreement with previous works where
an α -helix structure displayed an enhanced stability in organic solvent or other media of
low polarity[164, 264, 265]. According to these results, the electrostatic charge of Aβ is
more uniformly distributed in the α -helix structure, making its insertion into a non-polar
hydrophobic structure - such as a lipid bilayer - more favourable. On the opposite, Aβ
seemed prone to adopt a random coil structure in aqueous media, or to fold as β -sheet
when a critical concentration was reached. This was confirmed by the large predominance
of the β -sheet peak in the UAR spectrum, where most of the scattered light came from
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Figure 45: (a) Comparison between the amide I region of Raman spectra of Aβ (1-42) incubated
either on SLB 1 or on a bare glass slide. (b) Deconvolution and comparison of the Raman
amide I peak of Aβ (1-42) adsorbed on the two previous substrates.
the volume above the interfacial SLB. The most interesting conclusion about these UAR
and SAR spectra is that both secondary structures were observed simultaneously on the
same area of the sample and were only sorted by their axial distance from the SLB. This
differs from a common hypothesis about the fibrillation process in which there is a con-
version from the adsorbed peptide structure toward the fibril macro-structure (i.e. β -sheet
stacking)[212, 264, 266, 267]. In the results described in this thesis, the α -helix secondary
structure adopted by Aβ (1-42) at the beginning of its adsorption on the SLB still remained
as an "anchor-like" structure even after the aggregation of additional peptides into β -sheet
structure (Fig. 44 b).
To validate the assumptions about the selective folding of Aβ (1-42), an attempt was
made to elucidate its structure with Raman when the peptide was dissolved without the
presence of any lipid bilayer structure. No specific interactions were expected between the
peptide and the bare glass coverslip. As a consequence, the SAR signal of Aβ was more
difficult to observe because of the lower interfacial concentration, but the partial evapora-
tion of the buffer ultimately led some peptides in the supercritical angle detection range.
Comparison between the amide I peaks of the peptide with and without SLB is displayed
in Figure 45 (a) and the deconvolution is showed in Figure 45 (b). The first observation
was that the amide I peak was broadened in absence of any lipid bilayer structure. When
comparing the spectra with and without SLB, discrepancies were found for the Raman
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shifts and the areas under the peaks.
In the SAR spectrum, the β -sheet component only represented 18.8% of the α -helix (by op-
position, 46.9% when adsorbed on SLB), showing a decreased contribution of the β -sheet
structure. In addition, the peak at 1667 cm−1 displayed a higher intensity, which is corre-
lated to the scattering of unfolded peptides.
In UAR, the α -helix component of the amide I peak also became more prominent and
its proportion increase from 3% to 29% cm−1. It was also blue-shifted from 1648 to 1658
cm−1. The analysis yielded the same conclusion that the peptides exhibited fewer β -sheet
structures when there was no SLB to adsorb on. Theoretical models for the structure of
Aβ indicate that it folds in a predominantly α -helix structure with β -sheet conversion in
membrane-like, apolar media[268]. On the contrary, water turns the conformation of the
peptide into a compact series of loops and strand without defined α -helix or β -sheet[269].
Therefore it has been suggested that α -helix represents an intermediate step in the aggrega-
tion process of Aβ . However, a first transition from random coil toward α -helix is indicated
as the result of the addition of lipid vesicles in the peptides buffer. In the spectra of this
thesis, the increasing proportion of α -helix signal without SLB was contradictory. However,
it must be emphasized that the α -helix peak was either subjected to a blue-shift toward the
unstructured region, or adjacent to another band characteristic of this random coil (at 1667
cm−1). Therefore the α -helix structure, although present without lipid influence, seemed
to exhibit more variations than the helix adsorbed on the SLB and some peptides clearly
displayed a preferential unfolded conformation.
4.2.3.2 Amyloid-β (1-40)
Raman spectra of Aβ (1-40) were also recorded upon adsorption on SLB/bare glass and
analyzed similarly to Aβ (1-42) (Figure 46 a). The resolved secondary structures of the two
peptides after adsorption on SLB were different.
Aβ (1-40) adsorbed on SLB displayed a β -sheet peak at 1687 cm−1, which was dominant in
both SAR and UAR. In addition, the amide III peak at 1243 cm−1 in UAR also assessed the
presence of β -sheet in bulk solution. In the UAR spectrum, the left part of the amide I peak
was deconvoluted into a peak at 1639 cm−1 which could be attributed to the scattering of
the α -helix structure and represented 96.6% of the β -sheet peak area. However, despite
having almost identical ratios, the peak of α -helix is extremely broadened compared to the
β -sheet peak. It is supposed that although some α -helices were detected, their structure is
highly unstable and yielded structural variations exhibiting different vibrational scattering.
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Figure 46: (a) Amide I and III regions of SAR and UAR spectra of Aβ (1-40) incubated on SLB 1
after partial evaporation of the solvent (30h). (b) Scheme of the hypothetical structure
of Aβ (1-40) adsorbed on SLB according to the Raman results. α -helix (purple) is only
detected in UAR while β -sheet is present in both SAR and UAR spectra.
In the SAR spectrum, besides the β -sheet peak at 1687 cm−1, the deconvoluted amide I
yielded a peak at 1624 cm−1. However, α -helix could hardly be attributed to such a red-
shifted peak. In this experiment with Aβ (1-40), clear α -helix structures were only observed
far from the SLB since they appeared selectively in the UAR channel. This is opposed to the
results obtained for Aβ (1-42) and with the usual hypothesis of Aβ aggregation, although
the α -helix peak in UAR was so broadened that it maintained some uncertainty about the
characterization.
A possible interpretation of these results is that the peptides which were folded into an α -
helix structure upon aggregation on the SLB have desorbed and were not concentrated near
the lipid bilayer anymore, unlike Aβ (1-42). α -helices (or similar structures) were rather
mixed with the dominant β -sheet above the SLB (Figure 46 b). This desorption of α -helix
peptides could be due to the weaker adsorption and insertion of Aβ (1-40) within the SLB,
already reported in Section 3.1.3 and Section 3.1.4. The longer hydrophobic C-terminus
of Aβ (1-42) favoured the insertion inside the bilayer and the conservation of the α -helix
structure in folded peptides.[52]. On the other side, the shorter Aβ (1-40) folded into α -helix
structure were not inserted as deeply as Aβ (1-42). They could have desorbed more easily
and interacted with aggregates already formed, ending up beyond the axial detection of
the SAR technique. Alternatively, the lack of defined α -helix structures for Aβ (1-40) could
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Figure 47: (a) Comparison between the Raman spectra of Aβ (1-40) incubated either on SLB 1 or
on a bare glass slide. (b) Deconvolution and comparison of the Raman amide I peak of
Aβ (1-40) adsorbed on SLB or glass coverslip.
be the proof of a real conversion of α -helix toward β -sheet, induced by the interaction with
the SLB[268].
When incubated without SLB, Aβ (1-40) yielded other Raman diffraction spectra (Fig-
ure 47 a,b). In UAR, the general intensity of the amide I decreased, and the deconvoluted
peak assigned to α -helix shifted from 1639 cm−1 to 1650 cm−1 which was now exactly in
the range corresponding to the helix structure. In addition, its ratio with respect to β -sheet
slightly decreased down to 83.2%.
The changes were more pronounced in the SAR spectrum, where a peak appeared at 1645
cm−1, where there was initially no peak scattered from peptides adsorbed on the SLB. This
new peak had a ratio of 70.5% with the corresponding β -sheet scattering. These results
seemed to indicate that the conversion of α -helix into β -sheet hypothesized previously did
not occur without the presence of the lipid environment. However, the presence of α -helix
structure itself was previously related to membrane-like media.
It is possible that the structure observed was not a fully formed α -helix but another similar
structure : 310-helix. Vivekanandan et al. have reported that Aβ (1-40) in aqueous solution
could exhibit 310-helix as a tighter version of the α -helix, playing the role of an interme-
diate toward the fully structure helix. Structural similarities between the two helix could
explain the apparent results of Raman spectroscopy, meaning that only partially folded
intermediates were observed[270]. The ratio of the peaks of 310-helix and β -sheet were
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similar in both SAR and UAR, meaning that no preferential folding relative to the axial
distance from the interface was observed.
4.2.4 Surface-enhanced-Raman spectroscopy of Amyloid-β adsorbed on a supported lipid
bilayer
4.2.4.1 SERS of Amyloid-β (1-42)
In Section 4.1.3 the Raman spectrum of an unilamellar SLB was obtained by SERS using
a layer of silicon nanofilaments and gold nanoparticles as a substrate for the formation
of the bilayer. Afterwards, this SLB was incubated with an aliquot of Aβ (1-42) (0.22 mM
= 0.1% (w/v)) and the Raman signal was collected. The plasmonic surface-enhancement
allowed the direct detection of the signal of the peptides, without the need of evaporation
of the solvent.
The SAR spectrum before and after incubation with Aβ is displayed in Figure 48 (a). An
intense peak at 1651 cm−1 (purple arrow) correlated to the α -helix secondary structure ap-
peared after incubation with the peptide. The same structure was confirmed by the peak
protruding at 1266 cm−1 (purple arrow). A peak at 1561 cm−1 (1) was already observed
before incubation, but broadened with C=C signal and explained by the gold photolumi-
nescence (see Section 4.1.3). However its intensity increased drastically after incubation
with the peptide. Heterocyclic rings were now a plausible source for the increased inten-
sity of this peak, since each Aβ possesses three histidine residues (His6, His13 and His14).
The peak at 1561 cm−1 (1) and at 1327 cm−1 (2) were attributed to neutral imidazole side
chain by Ashikawa et al.[271] Indeed, the peak at 1327 cm−1 (2) was not visible before in-
cubation with the peptides. In addition to the analysis of the peak of the peptide with SAR,
the disappearance of the peaks of the SLB at 1448 cm−1, 1630 cm−1 and 1725 cm−1 was
observed. This effect was thought to be caused either by an overlapping with the signal of
the peptides or by the removal of the lipid molecules from the surface, as it was already
observed by fluorescence in the previous chapter (see Section 3.2.2).
The UAR spectrum is displayed in Figure 48 (b). An immediate identification could be
done on the amide I and amide III peaks appearing only after incubation with the peptide.
Peaks at 1651 and 1274 cm−1 (purple) were identified as α -helix but the peak at 1677 cm−1
and the small peak at 1244 cm−1 were specific of β -sheet structure. This result is an exam-
ple of how the selectivity between UAR and SAR could provide important results when
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Figure 48: Surface-enhanced SAR (a) and UAR (b) spectra of SLB 1 formed on a layer of silicon
nano-filaments functionalized with gold Nanoparticles, before and after incubation with
Aβ (1-42).
the two were combined, even with a surface-enhancement technique : the UAR spectrum
alone would only have permitted the detection of both α -helix and β -sheet structures with-
out any information about their localization. But the presence of only one specific structure
in SAR/SESAR (i.e. the α -helix) brought the conclusion that although it was also detected
with UAR, it was actually located near the surface of the SLB. On the other hand, SAR
spectrum alone would not have allowed the detection of all the structures exhibited by
Aβ . These results confirmed the previous hypothesis of Section 4.2.3.1 about the structure
adopted by Aβ (1-42) upon adsorption on the bilayer (Figure 44 b), but did not require the
solvent evaporation. This is an important feature that improves the validity of the model
elaborated so far.
Some other features were observable when comparing the UAR spectra before and af-
ter incubation with the peptides. The broad peaks situated between 1561 cm−1 and 1630
cm−1 seemed red-shifted to 1540-1600 cm−1 as if the correspondent chemical moieties
were subjected to a lower frequency of vibration. In addition, the characteristic peaks of
lipids at 1750 and 1448 cm−1 were not visible anymore after incubation with Aβ , as it was
already observed in SESAR. The very intense peak at 1394 cm−1 (1) could be characteristic
of the histidine residues of the peptides. The gold photoluminescence peak at 1330 cm−1
was broadened by the contribution of histidine vibration. The peak at 1205 cm−1 (2) was
hardly attributed since Raman charts correlate this shift with ethers or tryptophan. Finally,
the peak at 1126 cm−1 (3) corresponded to C-N bond and the one at 865 cm−1 (4) was
4.2 raman spectroscopy of peptides 107
attributed to Tyrosine residues. Not attributed peaks might be the enhanced signal of im-
purities.
In conclusion, surface-enhancement technique still permitted to detect the peaks of Aβ
peptides without the need to evaporate the solvent. Moreover, comparison of the data
from SERS and SESAR confirmed the assumptions made in previous sections about the
structure adopted by the peptides upon adsorption of the SLB. Unfortunately, no more
information about the structure of the lipid molecules could be extracted from this experi-
ments, since their signal disappeared after incubation with the peptides. The overlapping
of the signal of a unilamellar bilayer with the signal of high concentrated Aβ is likely the
cause of this loss of data.
4.2.4.2 SERS of Amyloid-β (1-40)
Incubation of SLB with peptides and characterization by surface-enhanced Raman was re-
peated with Aβ (1–40). The comparison of the SESARS spectra before and after incubation
with Aβ are displayed in Figure 49. The two main differences were the apparition of an
intense α -helix peak at 1640 cm−1 (purple) and a group of peaks around 1300 cm−1. This
region decomposed into three resonances: an amide III peak that was detectable at 1278
cm−1 and the confirmed presence of α -helix structures. The peaks at 1300 (1) and 1327
(2) cm−1 were attributed to the C-terminal methylene twisting vibration[272] and imida-
zole, respectively. The SERS (UAR) spectra are shown in Figure 49 (b). One feature that
is typical of the lipid bilayer was the disappearance of the carbonyl peak at 1730 cm−1
(1) after incubation with Aβ . In addition, a peak that initially protruded at 1280 cm−1
was correlated with =C-H in-plane deformation. After incubation with Aβ , this peak was
broadened into another peak at 1320 cm−1 (2), which was probably related to the peptide
and corresponded to a shifted imidazole signal. The amide III region was too broadened
for accurate characterization, and the amide I region was used instead to determine the
structure of the peptides. Two peaks were detected, corresponding to both α -helix (purple)
and β -sheet (red) secondary structures. This result was identical to the structures observed
for Aβ (1–42), indicating a preferential folding into helices near the membrane, with a con-
centration of β -sheets above the surface of the SLB. However, this seemed to be in contrast
to the structure that was extracted previously from Aβ (1–40) using the spontaneous Ra-
man signal (see Section 4.2.3.2), where no α -helices were observed near the SLB and only
a small fraction of their Raman scattering was above the bilayer. A possible explanation
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Figure 49: Surface-enhanced SAR (a) and UAR (b) spectra of SLB 1 formed on a layer of silicon
nano-filaments functionalized with gold Nanoparticles, before and after incubation with
Aβ (1-40).
for this apparent inconsistency is that results shown in Section 4.2.3.2 required a high lo-
cal concentration of peptides, which is a trigger for the folding of Aβ into β -sheet and
their stacking. The increased sensitivity of SERS allows the data to be recorded before the
conformation change. SERS data recorded after the evaporation of the buffer confirmed
this hypothesis: the β -sheet peak then became dominant in both spectra after, as in Sec-
tion 4.2.3.2 (see Figure 50).
It should be mentioned that the α -helix structure was already observed for Aβ (1–42)
with classical Raman spectroscopy, and preserved despite the high peptide concentration
used in Section 4.2.3.1. Conservation of the α -helix at higher concentration might be the
consequence of its stronger interaction with the SLB, as it limited its desorption from the
membrane, then remaining in the helical structure.
4.2.5 Elaboration of a model for the interaction and toxicity of Amyloid-β upon adsorption
on a supported lipid bilayer
The principal objective of this thesis was to investigate the interaction of Aβ with a model
of cell membrane and to determine the process and the consequences of such interaction.
Gathering all the results obtained with both fluorescence and Raman experiments, a propo-
sition of interaction pathway is elaborated in this section.
It is assumed that Aβ interacts with the SLB with unspecific adsorption since no specific
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Figure 50: SERS (UAR) and SESARS spectra of Aβ (1–40) incubated on SLB after buffer evaporation
over 24 h. Compared with the spectra in Figure 49 a) and b), the dominant secondary
structure turned into β -sheets (1673 cm−1). These changes from the spectra in Figure 49
to the spectra in Figure 50 seemed to demonstrate a conversion from the initial α -helix/β -
sheet superposition into a dominant β -sheet stacking structure.
binder of the peptide was present within the bilayer. It is also known that the latest stages
of interaction are featured by the presence of peptide aggregates which exhibit a β -sheet
structure. Such structure can eventually lead to the formation of characteristic fibrillar
aggregates around the neurons of Alzheimer patients, but was not observed in these ex-
periments. This was not a problem since the mechanism of toxicity of Aβ is supposed to
take place before this fibrillation process, when the peptides start to form smaller and
soluble oligomers. At physiological concentration, the early stage of adsorption of Aβ is
assumed to involve freshly produced monomers.
These conditions correspond to the lowest concentration described in this thesis. Aβmonomers
first adsorb reversibly on the lipid bilayer, exhibiting a so-called overshooting effect. From
the first adsorbed peptides, some will desorb while others remain at the surface of the SLB
(Section 3.1.3). It is thought that the selectivity between remaining and desorbing peptides
is due to different structures. Native structure of dissolved Aβ is considered to be unfolded,
only in SAR/UAR experiments when no lipids were present in the peptide samples. How-
ever, the α -helix structure was observed with SAR at the top of the lipid bilayer for the most
strongly adsorbed peptide (Aβ (1-42) - Section 4.2.3.1). The presence of this structure was
confirmed in other studies and described as a more stable conformation toward hydropho-
bic environment. From these data, it is hypothesized that Aβ monomers can adsorb on
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Figure 51: Hypothetical representation of the damaging process induced by Amyloid-β upon ad-
sorption on a supported lipid bilayer. Peptides are represented exhibiting the secondary
structures resolved with SAR/UAR experiments. "Toxic" damaging steps of the interac-
tion pathway are indicated with red arrows.
SLB with an unfolded structure, then potentially undergo conformational change toward
α -helix secondary structure which favours their interaction with lipid molecules. Aβ (1-42)
exhibited a slightly stronger adsorption than Aβ (1-40), and displayed more α -helix Raman
signal at the surface of the SLB therefore suggesting a correlation between the two obser-
vations. Not only does the α -helix structure enhance the stability of adsorbed Aβ inserted
inside the SLB but it is also reported to strengthen the interaction between the peptides
and lipid molecules.
Nevertheless, even the more stable peptides might be reversibly adsorbed, as showed by
washing experiments (Section 3.1.4). Subsequently, desorbing Aβ is thought to promote the
extraction of some lipid molecules from the SLB, when their mutual interactions overcome
the hydrophobic interactions between aliphatic chains of fatty acids (Section 3.2.2). This ex-
traction of lipid molecules can lead to a thinning of the lipid bilayer. Such modification of
the thickness would likely be involved in a weakening of the resistance of the membrane.
It is also logical to extrapolate such modification of the membrane to a hindrance of bio-
chemical functions (i.e. permeation to ions or hindrance of catalysis involving membrane
proteins).
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Higher peptide concentrations were correlated with a higher tendency to aggregate but
also with a more pronounced damaging of the SLB, such as a clustering of lipids or even
a disruption of the bilayer. It is possible that the aggregation of Aβ on the surface of the
SLB worsens the instability of the lipid-peptide structure. Too unstable aggregates are also
susceptible to desorb from the bilayer and the extraction of the numerous lipids bound to
the aggregates naturally results in a more severe alteration of the membrane.
4.2.6 Raman characterization of α Synuclein adsorbed on supported lipid bilayer
Previous experiments were conducted in our group with another amyloidogenic peptide
correlated to Parkison’s disease : α -Synuclein (α -Syn). The α -Syn peptide is more con-
served than Aβ and is composed of 140 amino acids[273]. However, similarities are ob-
served regarding their conformation: α -Syn is also reported to be natively unfolded in
aqueous solution and to adopt various α -helical structures when interacting with lipids
micelles or bilayers[274, 275]. Another likeness between Aβ and α -Syn lies in more recent
theories concerning the role of their aggregation in their respective diseases. According
to these hypotheses, the oligomers formed in the early stage of α -Syn aggregation would
be the toxic species rather than the amyloid fibrils formed after aggregation[276]. The in-
teraction between SLB and this peptide was previously investigated in our group, but no
supercritical angle Raman spectroscopy was used yet. Therefore, the characterization of
the structure of α -Syn was now attempted with SAR/UAR. As for Aβ , α -Syn Raman sig-
nal was monitored with and without interaction with a SLB substrate.
When incubated on a bare glass slide (Figure 52 a), α -Syn exhibited an amide I peak
centered at 1652 and 1654 cm−1 in SAR and UAR respectively. In SAR, another small peak
at 1660 cm−1 could also be found from the deconvolution. All these three peaks indicated
the presence of an α -helix structure.
In UAR, a peak could be fitted at 1690 cm−1, possibly caused by β -sheet photon scattering.
This peak still represented 31% of the main amide I component. The dominant structure
was an α -helix, although it was believed that α -Syn peptide gained a helical structure upon
interaction with phospholipids. This apparent contradiction was already encountered with
native Aβ in aqueous media (Section 4.2.3.1 and Section 4.2.3.2). However, characterization
of native α -Syn in lipid-free media remains a contentious issue. In fact, in was suggested
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Figure 52: (a) SAR and UAR spectra of α -Synuclein incubated on a bare glass coverslip. (b) SAR
and UAR spectra of α -Synuclein incubated on SLB 1. Both spectra were recorded after
solvent evaporation (31h-32h).
that α -Syn could exist in solution as a folded helical tetramer[277]. Although the amount of
units forming the oligomers of α -Syn could not be determine in this experiment, it seems
to confirm the possibility of a helical structure even in the absence of membrane-like media
to induced structure transition.
The other sample was composed of a SLB incubated with α -Syn before submission to
Raman spectroscopy (Figure 52 b). The amide I region was easily deconvoluted into two
peaks. In the UAR spectrum, one peak with a broad summit at 1660 cm−1 (purple) was
attributed to the expected α -helix. The other peak at 1689 cm−1 (red) was correlated to
β -sheet structure but only represent 10% of the area of the α -helix peak. This reduced
ratio compared with peptides incubated without SLB is surprising. There was no surface-
enhancement in this experiment with α -Syn peptide, implying that the peak of α -helix
structure was not artificially intensified and that α -helix is really dominant in the bulk so-
lution. The amide III peak showed a broad band which was unsuccessfully deconvoluted
but whose center was situated at 1255 cm−1. Considering that the amide III peak of α -helix
would be around 1270 cm−1 and β -sheet peak would be around 1240 cm−1, the detected
broad peak at 1255 cm−1 was interpreted as the presence of both secondary structures in
the detection volume. A possible explanation for the smaller propensity of α -Syn to form
β -sheet when incubated in presence of lipids is that the SLB favourized the helical struc-
ture and could even induce a transition from β -sheet to α -helix[278].
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In the SAR spectrum, the amide I region was also deconvoluted into two peaks. The peak
at 1653 cm−1 (purple) was also featuring the α -helix structure but the peak at 1705 cm−1
(red) seemed excessively blue-shifted to correspond to the β -sheet structure. However,
since no other vibration or chemical structure was more appropriate, the latter peak would
cautiously be attributed to β -sheet. A compression of the global peptide structure might
cause such increase in the frequency of vibration.
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4.3 summary and outlook
Aβ peptide is closely related to the infamous Alzheimer disease which spread among el-
derly people and causes many symptoms, the most remarkable being a progressive loss
of memory. The main subject of this thesis was to carry out a close monitoring of the in-
teraction between Aβ and a model of lipid membrane, then to observe, characterize and
quantify the consequences of this interaction.
While being naturally produced in healthy individuals, Aβ still has no known function
attributed to its presence in the brain. It has been hypothesized that in low concentration,
it might have a protective effect for neuron membrane against metal ions. However, Aβ
is mostly known for being the main constituent of aggregated substance surrounding the
dead neurons of Alzheimer patients. Aβ belongs to a family of proteins and peptides which
are prone to aggregate into β -sheet rich fibrils and induce severe diseases. The triggers for
the aggregation process and the increase of Aβ concentration are still unknown (except
for natural accumulation over aging) and conditions that favour the aggregation are not
easily met in vivo, hence the profusion of in vitro experiments to elucidate the mechanisms
of aggregation. In addition to the aggregation pathway, the exact cause for the death of
neuron cells under the influence of Aβ is also in debate. The current scientific consensus
is that the fibrils generated later during aggregation are not the most toxic species, but
small oligomers would be more prone to induce toxicity towards the neurons, notably at
the level of their lipid membrane. These toxic processes include lipid oxidation, formation
of pores within the membrane and dysregulation of ionic homeostasis.
Although many information and hypotheses about Aβ are accepted by a great part of
the scientific community, there are almost as many different models of study as there are
different groups of research. Computed dynamic simulation[279], cell culture[280], pep-
tides aggregated without lipid substrate[164], lipid membrane cross-linked with Aβ [244]
or polymer-encased lipid-nanodiscs[281] are but few examples. Considering the diversity
of models to study the interaction between Aβ and the lipid membrane, it seemed interest-
ing to use a simple model which mimics the very beginning of this interaction, i.e. when
the peptide starts to adsorb at the interface with the lipids. As the membrane curvature of
the bigger cells could locally be considered as a flat surface, a supported lipid bilayer (SLB)
model was selected. This model is straightforward to set-up and was formed on a trans-
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parent glass coverslip which match perfectly the conditions for visible light spectroscopic
measurements. The composition of the SLB was identical to previous studies with amy-
loidogenic peptides (α -Syn) for which the protocol of SLB formation has been optimized,
and contained one third of negatively charged lipids.
Various techniques are commonly used to elucidate the effects of Aβ , such as fluores-
cence[211], NMR[282], AFM[164], circular dichroism (CD)[213] and Raman[283]. We choose
to use supercritical angle spectroscopic techniques developed in our group, namely super-
critical angle fluorescence (SAF) and supercritical angle Raman (SAR). The principle of
the supercritical angle technique consists to collect the photons above the angle of total
internal reflection of a glass-water interface. Photons coming from this direction are specif-
ically emitted from surface-bound molecules or molecules located within few dozens of
nanometers from the interface. Hence, the supercritical angle technique allows to selec-
tively observe emitters located near the interface on which the SLB is formed. Therefore,
the signal from the SLB, or Aβ interacting with the SLB, can be isolated from the bulk
floating peptides which is still recorded on a separate channel. In addition to this selectiv-
ity, fluorescence was chosen for its sensitivity and imaging feature which would help to
elucidate the effect of Aβ interacting with the SLB. Raman spectroscopy, on the other side,
allows the characterization of molecular bounds and peptide secondary structures without
the need to label the target.
Two types of peptides were used, Aβ (1-40) and Aβ (1-42) which were 40 and 42 amino acids
long, respectively. Both are detected in the brain of Alzheimer patients and produced nat-
urally, but Aβ (1-42) is known to have a higher aggregation tendency and to promote the
aggregation of its counterpart as well.
At first, different compositions of lipids were used to yield a SLB similar to the natu-
ral composition of the membrane. This was done by including lipids such as cholesterol,
sphingomyelin and ganglioside into the SLB. The amount of adsorbed peptide on these
different SLBs were measurement by fluorescence and the more physiologically relevant
SLBs generally yielded a higher adsorption of peptides. However, only the most basic
(DOPC:DOPS) and cholesterol containing SLB (DOPC:DOPS:Chol) were used in further
experiments since their formation were more reproducible than the other SLBs.
The affinity of adsorption of Aβ (1-40) and Aβ (1-42) on DOPC:DOPS SLB was quantified by
monitoring the increase of fluorescence on the surface of the lipids in function of the time
and concentration. The dissociation constant Kd was extrapolated and Aβ (1-42) showed
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a slightly higher affinity than Aβ (1-40). However, huge discrepancies in the total fluores-
cence intensity were measured between the two peptides. The main reason is that Aβ (1-42)
formed fluorescent aggregates faster than its counterpart. The aggregates were also more
tightly attached on the surface of the SLB, as showed by measuring the speed of diffusion
of these aggregates. Our Kd values were compared with other groups but the differences
in lipid models highly influenced the results. A rather good agreement was found with
the Kd measured by Ariga et al.[220] but Thomaeir et al. measured a Kd a hundred-fold
higher with a specific composition of lipids[284].
Through these experiments, a model for the adsorption of the peptide on the SLB was
proposed: the first adsorbed peptides were weakly interacting with the lipids and the
adsorption was highly reversible. However, some peptides could undergo a transition
toward a stronger interaction, probably a change in the structure of the peptide. Aβ (1-
42) was more prone to perform this transition than Aβ (1-40). In addition, a cooperative
component seemed to drive the adsorption of more peptides near the already adsorbed
ones, hence forming the nuclei of aggregation that has been reported for Aβ . Again, Aβ (1-
42) was faster to yield this aggregated state since the first adsorbed species were more
tightly bound within the SLB and offer stable nuclei of aggregation. The cooperative and
nucleation-dependent aspect of the aggregation was confirmed with Native-PAGE experi-
ment which showed that interaction between the peptides and the lipids was an important
trigger for the formation of multimeric peptide species. Besides the difference in the ki-
netic of aggregation, the type of aggregated species was also different between Aβ (1-40)
and Aβ (1-42), as found by fluorescence correlation spectroscopy. From FCS data the speed
of the different aggregates could be quantified and the mass and size of the oligomers
were extrapolated. In general, Aβ (1-42) aggregated species diffused 6 to 15 folds slower
and the mass of the oligomers was 2 to 10 folds higher than Aβ (1-40). The latter result
showed that Aβ (1-42) aggregates are not only formed faster and more tightly bound to the
SLB, but they are also more massive than those obtained from the aggregation of Aβ (1-40).
After having characterized the adsorption process of Aβ on SLB, the impact of such adsorp-
tion on the lipid membrane was investigated. Fluorescent SLB constituted of DOPC:DOPS
and DOPC:DOPS:Chol were incubated with Aβ at different concentration, ranging from
0.5 to 50 µM. Abnormal effects were observed and their intensity dependent on the con-
centration of peptides. Even at the lowest concentration (0.5 µM), some effects could be
observed on the SLB. After 24 to 48 h of incubation, the average fluorescence intensity of
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the SLB had decreased. Autocorrelation curves showed that this decrease of intensity was
due to a reduced number of fluorescent molecules in the detection area.
Increasing the Aβ concentration up to 5 µM yielded an additional effect as some areas
of the SLB surface exhibited fluorescent clusters of lipids detected further away from the
surface of the SLB. The protrusion of these lipid clusters is observed when incubated with
peptides whose concentration also yielded the presence of peptide aggregates in previous
experiment. Therefore, it is tempting to associate these two events, as aggregated peptides
could extract lipids from the SLB. It would be interesting to use Förster resonance energy
transfer (FRET) to prove this assumption.
Finally, increasing the peptide concentration up to 50 µM brought another effect as the
surface of the SLB sporadically showed a total disruption of the lipid membrane.
All these abnormal effects related to the integrity of the SLB were observed with similar
intensities for both Aβ (1-40) and Aβ (1-42). However, cholesterol-containing SLB tended to
exhibited a more severe damaging. Since the presence of cholesterol molecules increased
the amount of peptides adsorbed on the SLB, and the above-mentioned effects seemed re-
lated to the concentration of Aβ , the enhancement of the effects for cholesterol-containing
SLB is not surprising. The results obtained are also in accordance with theories stating
that Aβ can induce pore formation within the neuron membrane[244]. However, we ob-
served these effects after the adsorption of initially unbound peptides rather than with
peptides directly included within the membrane. In this aspect, our model seems closer to
the events happening in vivo, despite the high concentration of Aβ . The effects observed
in this thesis indicate that when Aβ interacts with the SLB, it promotes a concentration-
dependent removal of lipids from the bilayer, eventually leading to a thinning or even a
disruption of the membrane. In either case, such modification of the membrane integrity
could drastically affect the metabolism of the neuron cells.
Apart from the integrity of the SLB, the mobility of the lipids within the bilayer is also
an important feature of biological membranes. This aspect was also measurement during
incubation with Aβ by extracting the lateral diffusion coefficient from FCS fitting of dif-
ferent areas within the SLB. Despite both peptides being able to influence the integrity of
the SLB, the influence of the peptides over the diffusion of lipids was more specific. Under
incubation with Aβ (1-40), the diffusion of lipids remained unchanged except around local
defects such as lipid clusters and holes within the SLB. On the other hand, after incubation
with Aβ (1-42), a peptide concentration of 25 µM was able to decrease the average mobility
of lipids by around 30% even away from defects. The most probable explanation for this re-
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sult is that the more massive peptides oligomers are the species hindering the diffusion of
the lipids. Therefore, a general decrease of the diffusion of lipids is observed with Aβ (1-42)
forming bigger aggregates (cfr. above), while the same decrease is only observed locally
with Aβ (1-40) because its aggregates are more scarce and expected to be located near the
damages in the SLB.
Calcium is known to be involved in the metabolism of neurons and possibly affecting or
affected by Aβ . For example, Itkin et al. showed that calcium ions induced the formation of
Aβ oligomers[198], which seemed to be the most toxic species in our previous experiment.
Therefore, the fluorescence experiments measuring the affinity of Aβ for the SLB and its
effect were reproduced in a buffer containing 2 mM of calcium ions. It was observed that
at low peptide concentration (between 0.5 and 1-2 µM), the presence of Ca2+ enhanced
the adsorption of Aβ on the SLB. This was a direct observation of an effect predicted by
computer simulation[232]. As it could be expected, an enhanced adsorption of Aβ also
strengthened the removal of lipids from the SLB. However, Ca2+ had no impact on the
modified diffusion of lipids inside the SLB. This is probably because the range of peptide
concentration affected by Ca2+ was also unable to affect the mobility of the lipids either.
Finally, after the determination of the effects occurring when Aβ was incubated with SLB,
the peptide conformation responsible for these effects was investigated. Supercritical an-
gle Raman spectroscopy was the method used to characterize the secondary structure
exhibited by the peptides situated close to the surface of the SLB. The use of Raman
spectroscopy to study Aβ is common, but the targets vary drastically between research
groups. Amyloid senile plaques[283], pre-formed oligomers[285, 286] or simply dissolved
without lipids[287] have been characterize with Raman spectroscopy. But a basic model of
interaction between initial monomers left to aggregate in the presence of lipids would be
valuable.
The main drawback of the method was the low sensitivity of Raman for peptides and
proteins, which was accentuated when combined with the supercritical angle technique.
Therefore, the protocol used by Angelis et al.[259] was applied to SAR: the sample con-
centration was artificially increased by letting some of the peptide buffer evaporate and
constantly recording the Raman scattering. Eventually, the spectrum of the peptides could
be obtained. By comparison between the Raman spectra of supercritical angle (SAR) and
classical Raman, a localization of different structures could be made and different for each
peptide.
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SAR spectra of Aβ (1-42) exhibited a dominant α -helix secondary structure, with a smaller
contribution of β -sheet structure. Classical Raman spectra showed instead a clear domi-
nance of β -sheet structure. These results were confirmed by the use of surface-enhanced
Raman spectroscopy (SERS) combined with supercritical angle spectroscopy. The main ad-
vantage of the SERS experiment was to confirm the structures observed previously, while
allowing to work without the need to increase the concentration in Aβ . Combining the
two sets of data, the model of adsorption was detailed further, with an adsorption of α -
helix-structured Aβ (1-42) prior to further aggregation of peptides which turned out to
yield the β -sheet stacking often reported during the formation of amyloid fibrils. A check
of the presence of these fibril structures with other analytical methods such as AFM or
ThioflavinT fluorescence could be interesting to confirm the structure.
Raman spectra of Aβ (1-40) displayed a different layout, as the SAR spectra were mostly
showing β -sheet and classical Raman spectra still exhibited a dominant β -sheet as well.
The lack of α -helix structure was unexpected but somehow make sense with the results
of the previous affinity experiments. Indeed, α -helix structure are reported to stabilize the
peptide conformation when immersed in an hydrophobic environment, such as the SLB.
The fact that Aβ (1-42) folded into such structure while Aβ (1-40) did not is a good ex-
planation for the discrepancies in affinity between the two peptides. Aβ (1-42) exhibited
a stronger interaction with the SLB because it folded into a structure favouring its inser-
tion within the lipid bilayer. These results add details to the common hypothesis about
the fibrillation process where the structure of adsorbed Aβ is totally converted into the
fibril macrostructure (β -sheet stack)[212, 264, 266, 267]. A mixture of α -helix and β -sheet
structures was also observed by Sahoo et al. for Aβ interacting with polymer encased lipid-
nanodiscs[281]. In their work, slightly acidic pH conditions and a lower peptide-to-lipids
molar ratio promoted an initial folding into helices, followed by a transition toward β -
sheet. Our data suggest that the helical secondary structure adopted by Aβ remained as an
“anchor-like” part even after the aggregation of additional peptides into another structure.
Combining all data of both supercritical angle fluorescence and supercritical angle Raman
allowed to elaborate a precise model for the interaction of Aβ with lipid membrane and a
possible cause for the death of neurons encountered in Alzheimer patients. The hypothet-
ical model is as follows: while Aβ (1-40) remains quite harmless at low concentration due
to its lower affinity for the membrane, the production of Aβ (1-42) is more critical. Aβ (1-
42) is prone to fold into an α -helix structure upon interacting with the membrane, hence
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strengthening its insertion within the lipids. Aβ which remain inserted for prolonged pe-
riod of time can act as nuclei promoting the cooperative adsorption and aggregation of
nearby peptides. When aggregates - or oligomers - reach a critical size and concentration,
they somehow induce the desorption of some lipid molecules from the membrane bilayer.
This effect alone can induce a thinning of the membrane and could easily perturb other
processes taking place at the membrane of neurons (including the transfer of electrical po-
tential). The desorption of lipids from the membrane due to the progressive accumulation
of peptides could even promote the formation of holes via the disruption of the bilayer.
Small-sized holes could be enough to perturb the ions homeostasis, while more important
damage could easily lead to a leakage of metabolites outside of the cell.
Figure 53: Hypothetical representation of the damaging process induced by Amyloid-β upon ad-
sorption on a supported lipid bilayer. Peptides are represented exhibiting the secondary
structures resolved with SAR/UAR experiments. "Toxic" damaging steps of the interac-
tion pathway are indicated with red arrows.
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